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ABSTRACT 
 Exercise has been given credits for promoting health in general. Research show 
various exercise-induced benefits for brain in both humans and rodents, including 
improvement of cognitive function, increase of adult neurogenesis, and protection against 
the onset of neurodegenerative diseases. Despite these demonstrated beneficial effects, 
the underlying mechanisms are not clearly understood yet. Here, we hypothesize that 
muscle-generated lactate mediates some of the exercise-induced benefits on brain. 
Identification of the mechanisms will enable us to better apply exercise prescription 
clinically, and will also allow us to find a direction to develop exercise mimetics for older 
adults. The goal of this dissertation work is to evaluate effects of exercise training below 
and above the lactate threshold on brain health, explore the related mechanisms, and 
provide scientific evidence for developing exercise mimetics. In this work, we attempted 
to answer these questions from the perspective of brain bioenergetics.   
 Chapter II was aimed to assess the effects of 6-week moderate-intensity exercise 
below the lactate threshold on liver and brain bioenergetic infrastructures in young adult 
mice. In liver, exercise training induced an increase in monocarboxylate transporter 2 
(MCT2) expression which is responsible for liver lactate uptake, and this change was 
accompanied by increased liver expression of peroxisome proliferator-activated receptor 
gamma coactivator 1-alpha (PGC-1), sirtuin 1 (SIRT1), p38, and Complex IV subunit 4 
(COX4), as well as increased AMP-activated protein kinase (AMPK) phosphorylation 
levels. Despite these changes, liver mitochondrial DNA (mtDNA) copy number and 
mitochondrial transcription factor A (TFAM) expression were reduced, suggesting the 
training shifted the liver’s bioenergetic profile to promote gluconeogenesis, but not 
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oxidative phosphorylation. The only altered brain parameter observed was a reduction in 
tumor necrosis factor alpha (TNF-α) expression. Brain bioenergetics were unlikely 
modified by moderate-intensity exercise. Our study showed that liver lactate import 
appears to be favored over brain lactate import, possibly limiting the ability, if any, of 
exercise-generated lactate to modify brain bioenergetics. We speculate that exercise-
mediated effects on brain may be robust only when lactate production exceeds the lactate 
threshold.  
 In order to test whether lactate mediates exercise-induced changes in brain, in 
Chapter III, we subjected young adult mice to 7-week supra-lactate threshold treadmill 
training (defined as training at exercise intensities above the lactate threshold). In liver, 
similar to what we found in studies described in Chapter II, training shifted the liver’s 
bioenergetic profile to promote gluconeogenesis, and the expression levels of respiration-
related genes were all down-regulated. In brain, PGC-1 related co-activator (PRC) 
expression and mtDNA copy number increased, suggesting mitochondrial biogenesis was 
induced by supra-lactate threshold treadmill training. Brain TNF-α expression fell, and 
vascular endothelial growth factor A (VEGF-A) expression increased. In another group 
of experiments, exogenously administered lactate over 14 days was found to reproduce 
some but not all of these observed liver and brain changes. Our data suggest that lactate is 
more than an exercise byproduct. It can mediate some of the exercise-induced changes in 
liver and brain, and lactate itself can act as a partial exercise mimetic. 
 In Chapter IV, the effect of supra-lactate threshold exercise on brain 
mitochondrial biogenesis was demonstrated in aged mice as well. 19-month old mice 
were subjected to supra-lactate threshold intensive treadmill training for 8 weeks. Brain 
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mitochondrial biogenesis was evidenced by increased brain PGC-1α and citrate synthase 
(CS) expression, as well as increased mtDNA content. Similar to the observations in 
young adult mice, a slight increase in brain VEGF-A expression was found in exercise 
group but brain TNF-α expression was unchanged. Our exercise training protocol did not 
affect aging-associated increase of plasma chemokine levels. In this study, we also tested 
the correlations between brain mitochondrial biogenesis, neurogenesis-related factors, 
and systemic/brain inflammatory factors to better understand the networking between 
exercise-induced benefits in brain, while no significant associations were detected. 
Nonetheless, together with the results from Chapter II and III, we conclude that supra-
lactate threshold exercise training induces brain mitochondrial biogenesis in both young 
and aged mice.  
 To investigate potential mechanisms of lactate’s effects on brain bioenergetics, in 
Chapter V, we treated SH-SY5Y human neuronal cells with lactate. Our results showed 
that, lactate treatment significantly decreased glycolysis flux and had a prolonged 
enhancement of mitochondrial respiration. Exogenous lactate gradually shifted the 
bioenergetic metabolism towards a more aerobic state. These changes in bioenergetic 
fluxes were accompanied by increased expression of PGC-1β, nuclear respiratory factor 1 
(NRF-1), and COX1, while mtDNA content was unchanged, indicating some components 
of mitochondrial biogenesis were up-regulated. Expression of VEGF-A was also 
increased. These lactate-induced effects were likely mediated by activation of AMPK, 
p38 mitogen-activated protein kinase (MAPK), and Akt signaling pathways to modify 
bioenergetic infrastructures. We also demonstrated that lactate treatment decreased 
mammalian target of rapamycin (mTOR) activation while increased forkhead box protein 
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O1 (FOXO1) activation, implying a potential role for lactate in longevity. The results 
from this study provide novel insights into bioenergetics-based pharmacological therapies 
for neurodegenerative diseases with altered brain bioenergetic fluxes. 
 In summary, this dissertation work suggests that exercise training above the 
lactate threshold is effective in promoting mitochondrial biogenesis, inducing expression 
of angiogenic/neurogenic factors, and/or reducing inflammation in mouse brains at 
different ages. Lactate seems to be mediating some of these changes, and appears to have 
additional beneficial effects including the modification of brain bioenergetic fluxes 
towards a healthier state. The results from this work have extensive therapeutic 
implications for persons with perturbed brain energy metabolism, such as Alzheimer’s 
and Parkinson’s diseases and other neurodegenerative disorders. 
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1. Exercise for brain health 
Physical exercise has been shown to have systemic beneficial effects such as 
alleviating hyperglycemia (Richter et al., 1992), hypercholesterolemia (Jia et al., 2012), 
and hypertension (Stewart, 2004) in both human and animal studies. As discussed below, 
exercise training is also beneficial for some organs other than muscle, including liver and 
brain.  
Exercise is a major challenge particularly for the liver due to its central role in 
maintaining glucose and lipid homeostasis as well as its function as energy supplier for 
the working muscle (Hoene & Weigert, 2010). Both human and animal studies have 
shown that aerobic exercise training could improve hepatic gluconeogenesis (Donovan & 
Sumida, 1997), reduce hepatic lipid level (Johnson et al., 2009), and also increase the 
expression of antioxidant enzymes (Wilson & Johnson, 2000; Navarro et al., 2004).  
While the underlying neuroprotective mechanism of exercise is still not clearly 
understood or remain controversial, studies based on both human subjects and rodent 
models have shown that long-term exercise enhances learning/cognitive function, 
increases brain volume, and also protects against the onset of neurodegenerative diseases 
[for review, (Lautenschlager et al., 2012; Marques-Aleixo et al., 2012)].  
There are several potential mechanisms mediating the beneficial effects of exercise 
for brain. It has been shown that exercise training increases the activity of several 
neurotrophic/vascular growth factors such as brain-derived neurotrophic factor (BDNF) 
(Vaynman et al., 2004; Berchtold et al., 2010; Wu et al., 2011) and vascular endothelial 
growth factor (VEGF) (Fabel et al., 2003b) to enhance neurogenesis and angiogenesis in 
the adult or aged brain. Long-term exercise training induces a decrease in central pro-
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inflammatory cytokines, such as tumor necrosis factor alpha (TNF-α), interleukin-1 beta 
(IL-1β), and increases neuroprotective chemokines, including chemokine (C-X-C motif) 
ligand 1 (CXCL1) and CXCL12, that improve neuronal-glial communication, possibly 
contributing to enhancement of learning and memory [for review, (Packer et al., 2010)]. 
Also, exercise may increase the activity of antioxidative enzymes to decrease free radical 
damage to neurons (Somani & Husain, 1996; Devi & Kiran, 2004). In terms of 
mitochondrial function, activities of complex I and IV on the brain mitochondrial 
electron transport chain (ETC) decrease upon aging, and regular treadmill exercise for 6 
to 12 months is able to prevent the age-associated decline in the activities of these 
enzymes in mouse (Boveris & Navarro, 2008). 
Here, in this dissertation, we focus on whether and how exercise training influences 
mitochondrial function and bioenergetic metabolism in the brain. We also discuss the 
possible networking between brain bioenergetics, neuronal plasticity and central/systemic 
inflammation under the condition of exercise.    
 
2. Mitochondrial biogenesis and balanced bioenergetics for brain health 
2.1. Regulation of mitochondrial biogenesis 
Improved mitochondrial function has been recognized as an important factor in 
health benefits including prevention of chronic diseases such as cardiovascular disease 
and diabetes as well as neurodegenerative diseases (Fontan-Lozano et al., 2008; Ren et 
al., 2010; Duncan, 2011). Previous studies have shown that peroxisomal 
proliferatoractivated receptor-gamma co-activator 1 (PGC-1) family acts as a group of 
master regulators of mitochondrial biogenesis and cellular energy metabolism, by binding 
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and activating nuclear respiratory factor 1 (NRF-1) which in turn regulates the 
transcriptional activity of mitochondrial transcription factor A (TFAM) (Fig. I-1) 
(Scarpulla, 2008b; Vina et al., 2009). TFAM is a nucleus-encoded protein that binds 
upstream of the promoters of mtDNA and promotes the transcription of mitochondrial 
DNA (mtDNA) (Uchiumi & Kang, 2012).  
The expression of PGC-1α, most studied member of PGC-1 family, is regulated by 
several mechanisms. AMP-activated protein kinase (AMPK) is a crucial sensor of the 
energy status of the cell, and it becomes activated when the AMP/ATP ratio is elevated. 
The activation of AMPK regulates PGC-1α activity by inducing phosphorylation of PGC-
1α at Thr177 and Ser538 (Jager et al., 2007). Silent mating type information regulation 2 
homolog 1 (SIRT1) is an enzyme that mediates NAD+-dependent deacetylation of target 
substrates. It is generally understood that when NAD+ amounts or the NAD+/NADH ratio 
increases, SIRT1 is activated. Under conditions of rich nutrients or low NAD+ levels, 
PGC-1α is heavily acetylated and biologically inactive (Rodgers et al., 2005). Thus, 
SIRT1-mediated deacetylation and activation of PGC-1α becomes an important response 
of the cell to enhance mitochondrial metabolism when energy demands increase 
(Fernandez-Marcos & Auwerx, 2011). P38 mitogen-activated protein kinase (MAPK) has 
also been shown to phosphorylate PGC-1α and enhance its stability and thereby controls 
its activity (Puigserver et al., 2001). In addition, cAMP response element-binding protein 
(CREB) is known to regulate hepatic gluconeogenesis by activating PGC-1α (Herzig et 
al., 2001). 
PGC-1β, another member from PGC-1 family, has high sequence similarity and 
similar tissue distribution as PGC1-α (Scarpulla, 2008b). PGC-1β also binds NRF-1 and 
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is its potent co-activator (Lin et al., 2002a). PGC-1β plays important roles in controlling 
mitochondrial capacity in both cultured cells and transgenic mice (Kamei et al., 2003; St-
Pierre et al., 2003; Sonoda et al., 2007). Moreover, in neurons, PGC1-α and PGC-1β 
regulate mitochondrial density in an additive manner, as when they are overexpressed 
together, the mitochondrial density increases more than it does when PGC1-α or PGC-1β 
is overexpressed individually (Wareski et al., 2009). Despite the functional similarities 
between these two PGC-1 family members, PGC-1α robustly activates gluconeogenic 
gene expression (PEPCK, phosphoenolpyruvate carboxykinase; G6Pase, glucose 6-
phosphatase) to a greater extent than PGC-1β does. On the other hand, PGC-1β is a 
stronger inducer of mitochondrial respiration-relevant gene expression (cytochrome c; 
ATP synthase) and promotes a much higher level of coupled respiration than PGC-1α, 
which may make the fine-tuning of mitochondrial function possible in response to 
specific metabolic needs (Lin et al., 2003; St-Pierre et al., 2003; Lin et al., 2005). 
PGC-1 related co-activator (PRC), the most recently identified member of PGC-1 
family, has been shown to associate with NRF-1 and NRF-2 as well (Scarpulla, 2008a). 
PRC also interacts with the estrogen-related receptor α (ERR-α) to induce 
mitochondrion-related gene transcription, and in general supports mitochondrial ATP 
production (Vercauteren et al., 2009; Mirebeau-Prunier et al., 2010). Silencing PRC 
results in mitochondrial dysfunction including abundant morphologically abnormal 
mitochondria, reduced ETC subunit expression and reduced ATP levels (Gleyzer & 
Scarpulla, 2011). 
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2.2. Biochemical methods to evaluate mitochondrial biogenesis  
 There are several ways to provide evidence for mitochondrial biogenesis or 
increased mitochondrial mass. Transcript or protein levels of cytochrome c oxidase 
(complex IV, or COX) subunits and ATP synthase subunits evaluated by quantitative 
reverse transcription-PCR or immunoblotting, respectively, should be elevated when 
mitochondrial biogenesis occurs. Another approach generally used is to assess the 
expression levels of key components of mitochondrial biogenesis pathway, such as PGC-
1α, PGC-1β, PRC, NRF1, NRF2, and TFAM, as discussed above.  
 In addition to evaluation at mRNA or protein level, it is more common to use the 
ratio of mtDNA copy number relative to nuclear DNA copy number to test whether 
mitochondrial biogenesis is induced. Mitochondria have their own DNA that is about 
16.5 kB. In humans, mtDNA codes for 37 genes including some subunits of complex I 
(NADH dehydrogenase), complex III (cytochrome bc1 complex), complex IV 
(cytochrome c oxidase), and ATP synthase (Fig. I-2). The quantity of DNA encoding for 
these proteins is supposed to be proportional to the number of mitochondria, but this 
should be corrected for the nuclear DNA level, such as the copy number of 18S 
ribosomal RNA (rRNA) (Medeiros, 2008). 
2.3. Perturbed bioenergetic metabolism in neurodegenerative disorders 
Mitochondrial dysfunction and perturbed bioenergetic balance increase with age 
in different organs (Navarro et al., 2004; Bratic & Larsson, 2013), and these bioenergetic 
changes are also observed in the brains of some neurodegenerative diseases (Lin & Beal, 
2006; Lezi & Swerdlow, 2012). For instance, decreased activity of complex I on 
mitochondrial ETC has been found in the brains of Parkinson’s disease (PD). Similarly, 
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reduced complex IV activity is observed in several areas of brains as well as platelets of 
Alzheimer’s disease (AD) patients. Complex I and II-III or IV dysfunctions are 
associated with familial or sporadic amyotrophic lateral sclerosis (ALS), respectively. In 
these neurodegenerative diseases, reduced mitochondrial respiratory function results in 
altered NAD+/NADH redox status, less ATP production and increased mitochondrial 
reactive oxygen species (ROS)/oxidative stress, possibly inducing or exacerbating 
mtDNA mutations. An accumulating body of evidence suggests that these serial adverse 
events may play a central roles in the pathogenesis or progression of the diseases (Lin & 
Beal, 2006; Swerdlow, 2011). Impaired mitochondrial biogenesis in the neurons 
undergoing degeneration further makes it difficult to compensate for the unbalanced 
mitochondrial bioenergetics observed in the diseases. Therefore, therapies targeting the 
perturbed brain bioenergetics have been proposed for neurodegenerative diseases, which 
will be discussed in 4.1. Exercise as a Bioenergetic Medicine Intervention.   
 
3. Exercise and brain bioenergetics 
It is well established that long-term exercise enhances mitochondrial biogenesis in 
muscles (Hood et al., 2006). Although previous rodent studies have reported that exercise 
training is likely able to reduce the oxidative stress in the brain by increasing the activity 
of several antioxidants enzymes, such as superoxide dismutase, glutathione peroxidase, 
and catalase [for review, (Marques-Aleixo et al., 2012)], only a few studies have focused 
on the effects of exercise on mitochondrial biogenesis and other bioenergetic pathways in 
the brain.  
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Two rat studies by the same research group have shown that when young/adult 
rats were subjected to short-term exercise training a few days after inducing cerebral 
ischemia, the mRNA levels and/or protein levels of brain PGC-1α, NRF1 and TFAM, as 
well as mtDNA content were increased when compared with the sedentary rats with 
ischemia (Zhang et al., 2012b; Zhang et al., 2012c). Another two groups recently 
published papers reporting that when they exercised aged rats or exercised young rats 
until early aging stage on treadmills, the PGC-1α – NRF-1 – TFAM pathway was up-
regulated and oxidative stress was reduced in the brain (Bayod et al., 2011; Marosi et al., 
2012). Based on our literature search, there was only one mouse study showing increased 
PGC-1α expression and mtDNA content after intensive treadmill training (25 m/min, 5 % 
incline, 1 hr/d, for 8 weeks) (Steiner et al., 2011).  
It appears that exercise indeed has an influence on mitochondrial function in the 
brain. However, what type/intensity of exercise training and how exercise-induced 
muscle activation affect non-muscle tissues, particularly brain, is not fully understood. 
This dissertation seeks to further explore the effects of moderate- and high-intensity 
exercise training on brain bioenergetics and the mechanisms mediating exercise-induced 
effects on non-muscle tissues, specifically, brain. 
 
4. Bioenergetic medicine and exercise mimetics 
4.1. Exercise as a bioenergetic medicine intervention 
 Bioenergetic medicine refers to the manipulation of a bioenergetic pathway to 
increase or decrease its associated fluxes to positively affect health. Bioenergetic 
medicine interventions intend to target mitochondrial respiratory flux as well as pathways 
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outside the mitochondria to indirectly modify mitochondrial function. (Swerdlow, 2013). 
Several bioenergetic flux-based therapy approaches have been proposed for 
neurodegenerative diseases, such as ketone body-based therapies, combination of malate, 
glucose and thiamine, and oxaloacetate treatment for AD and PD. These proposed 
therapies are based on their potential to modify NAD+/NADH redox status, glycolysis, 
or/and mitochondrial respiratory fluxes (Swerdlow, 2013), to provide a balanced 
bioenergetic state for neuron survival.   
 Exercise may also be considered as a type of bioenergetic medicine intervention, 
given its well-established effects of improving muscle mitochondrial respiratory function 
and energy metabolism. Although its bioenergetic modification ability for brain remains 
relatively unstudied, as mentioned before, it is significant that exercise training benefits 
the brain from other perspectives.  
For these reasons and others, regular physical exercise is often recommended for 
middle-aged or older adults to improve insulin resistance or prevent aging-related 
cognitive function decline. However, the exercise tolerance (especially exercise of 
moderate- and high-intensity) and compliance/adherence rate are of concern. Thus, there 
appears to be a great need for developing exercise mimetics. 
4.2. Exercise mimetics for muscle  
 Exercise mimetics for improving muscle function has been proposed recently. 
Here are several examples. 5-Aminoimidazole-4-carboxamide 1-β-D-ribofuranoside 
(AICAR), an analog of AMP, leads to AMPK activation, increased PGC-1α expression 
and increased activity of citrate synthase in muscles. In addition, it reprograms muscles 
towards a more oxidative phenotype and improves running performance in mouse (Wang 
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et al., 2004; Narkar et al., 2008). Similarly, muscle-specific overexpression of PGC-1α 
triggers a fast- to slow-twitch transformation resulting in an increase in oxidative 
metabolism, mitochondrial biogenesis, and fatigue resistance (Lin et al., 2002b). These 
studies have provided evidence for developing PGC-1α stimulants as exercise mimetics 
for muscles. Angiotensin II receptor antagonists, such as telmisartan, have been 
demonstrated to improve decreased exercise capacity and impaired mitochondrial 
function of skeletal muscles in wild-type mice and mouse model of type 2 diabetes (Feng 
et al., 2011; Takada et al., 2013). Resveratrol is a type of natural phenol and has been 
given extensive attention during the last decade because of its various benefits for health, 
especially its potential to extend lifespan. Treatment of mice with high doses of 
resveratrol induces expression of oxidative genes and mitochondrial biogenesis in 
skeletal muscle and improves running endurance (Lagouge et al., 2006). The possible 
mechanism may involve SIRT1-dependent deacetylation and activation of PGC-1α. 
4.3. Lactate as a potential exercise mimetic for brain 
 As discussed above, research has been conducted in exploring exercise mimetics 
for improving muscle function. On the other hand, it seems not easy to develop such 
mimetics for brain. Intensive investigation is needed first to explore and identify the 
mechanisms of exercise inducing benefits for the brain.   
 Lactate is known to be released by contracting muscles during exercise. It has 
long been believed to be a waste product from anaerobic glycolysis until two decades ago. 
In this section, we discuss the rationales for and potentials of lactate serving as an 
exercise mimetic for mammalian brain.  
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4.3.1. Lactate metabolism in brain 
 The transport of lactate occurs via monocarboxylate transporters (MCTs), proton-
linked membrane carriers that transport monocarboxylates including lactate, pyruvate and 
ketone bodies across the cell membrane. In liver, two isoforms of MCTs, MCT1 and 
MCT2, are expressed (Bonen et al., 2006), with MCT2 having higher affinity to lactate 
than MCT1 (Garcia et al., 1995; Broer et al., 1999).  Lactate uptaken by the liver could 
be a substrate for gluconeogenesis and help maintain the blood glucose level. There are 
also MCTs in the brain, and several isoforms exist. MCT4 is expressed mainly by 
astrocytes, whereas MCT2 is primarily neuronal (Pierre & Pellerin, 2005). 
 In 1994, Pellerin and Magistretti proposed a hypothesis called astrocyte-neuron 
lactate shuttle (Pellerin & Magistretti, 1994). The concept posits that (1) neural activity 
increases the extracellular glutamate concentration, and (2) the glutamate is uptaken by 
astrocytes with concomitant stimulation of Na+-K+ ATPase and glutamine synthetase 
activity, which (3) stimulates anaerobic glycolysis (the conversion of glucose to lactate) 
in astrocytes that subsequently release lactate, which then (4) is used by neurons to fuel 
their activity (Fig. I-3). This hypothesis has been supported by recent studies (Suzuki et 
al., 2011; Tarczyluk et al., 2013). 
 Human subject studies using nuclear magnetic resonance spectroscopy techniques 
have reported that blood lactate also is an important energy source for the brain during 
exhaustive exercise. When the blood lactate level increases either by exercise or 
intravenous infusion of lactate, the brain can import, oxidize and utilize it via the 
tricarboxylic acid (TCA) cycle (Quistorff et al., 2008; Gallagher et al., 2009; van Hall et 
al., 2009; Boumezbeur et al., 2010; Wyss et al., 2011). 
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4.3.2. Neuroprotective roles of lactate  
Lactate has also been shown to have neuroprotective roles. Hypoglycemia has 
neurological consequences, such as atrophy and loss of neurons in hippocampus, and 
transient cognitive problems. Systemic lactate injection, intraperitoneally or 
intravenously, is able to prevent hypoglycemia or hyperinsulinimia induced neuronal 
death and cognitive dysfunction in both rodents and human subjects (Veneman et al., 
1994; Won et al., 2012; Herzog et al., 2013). Berthet et al. have demonstrated that after 
inducing oxygen and glucose deprivation, treatment of rat hippocampal slices with lactate 
containing medium significantly protected against neuronal death. In addition, after 
inducing in vivo cerebral ischemia in mice, an intracerebroventricular injection of lactate 
significantly decreased the lesion size, and improved neurologic outcome (Berthet et al., 
2009). Moreover, two recently published rat studies have demonstrated that the lactate 
(released by astrocytes) import into neurons is essential for long-term memory formation, 
and glucose and lactate are not functionally interchangeable (Newman et al., 2011; 
Suzuki et al., 2011). 
4.3.3. Lactate induced modification of bioenergetic pathways 
 Little is known about lactate’s benefits for brain other than serving as an 
alternative energy source. Lactate has been previously shown to induce the expression of 
mitochondrial respiration-related genes, including PGC-1α and COX4 in L6 rat skeletal 
muscle cells (Hashimoto et al., 2007). Although studies have shown the possibility of 
exogenous lactate being oxidized in the brain through TCA cycle (Gallagher et al., 2009; 
van Hall et al., 2009; Boumezbeur et al., 2010), whether or not lactate induces changes in 
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mitochondrial respiratory function and bioenergetic infrastructure in brain has not been 
investigated straightforwardly.  
 
5. Purpose and significance of the study 
This dissertation aims to investigate whether and how, from the perspective of 
bioenergetics, exercise training influences non-muscle tissues, especially brain, in young 
and aged mice. We hypothesize that exercise-induced benefits for brain are mediated by 
lactate released from contracting muscles. We tested this hypothesis using the following 
approaches: exercising mice below and above the lactate threshold, peripherally 
administrating mice with lactate, and treating human neuronal cells with lactate. The 
results from this work are significant for clarifying the neuroprotective effects of exercise, 
and providing scientific evidence for designing exercise protocols for older adults or 
patients with neurodegenerative diseases. In addition, a better understanding of 
mechanisms mediating the exercise-induced changes in the brain will enable us to 
develop exercise mimetics or bioenergetic medicine intervention specific for the brain in 
near future.  
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Figure I-1. Illustration summarizing PGC-1 mediated pathways governing 
mitochondrial biogenesis and function. Illustrated in the nucleus (orange sphere) are 
the key transcription factors (NRF-1, NRF-2, ERRα, PPARα, and YY1) that are PGC-1 
targets and act on nuclear genes controlling mitochondrial biogenesis and energy 
production. Some of the pathways involved in regulation of expression or function of 
PGC-1 are also shown. Abbreviations: AMPK, AMP-activated protein kinase; CREB, 
cAMP response-element binding protein; ERRα, estrogen related receptor α; MAPK, 
mitogen-activated protein kinase; NRF, nuclear respiratory factor; PGC-1, peroxisomal 
proliferator activated receptor-gamma coactivator 1; PPARα, peroxisomal proliferator 
activated receptor α; SIRT1, sirtuin 1; TFAM, mitochondrial transcription factor A; YY1, 
Yin Yang 1. 
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Figure I-2. Schematic representation of human mitochondrial DNA (mtDNA). In 
most multicellular organisms, the mtDNA is organized as a circular, covalently closed, 
double-stranded DNA. In humans, mitochondrial DNA can be assessed as the 
smallest chromosome coding for only 37 genes and containing only about 16,600 base 
pairs. Each mitochondrion is estimated to contain 2-10 mtDNA copies. Figure modified 
from (Scarpulla, 2008b). 
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Figure I-3. Schematic illustration of astrocyte-neuron lactate shuttle. According to 
this hypothesis, neural activity increases the extracellular glutamate concentration. The 
sodium-coupled reuptake of glutamate by astrocytes stimulates Na+-K+ ATPase and it 
also activates ATP-dependent conversion of glutamate to glutamine by glutamine 
synthetase. These two events stimulate anaerobic glycolysis (the conversion of glucose to 
lactate) in astrocytes that subsequently release lactate, which then is uptaken by neurons. 
Uptaken lactate is converted to pyruvate by lactate dehydrogenase, and pyruvate enters 
mitochondria in neurons to participate in tricarboxylic acid cycle. Abbreviations: Gln, 
glutamine; Glu, glutamate; Pyr, pyruvate. 
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Abstract 
To assess the effects of exercise on liver and brain bioenergetic infrastructures, we 
exposed C57BL/6 mice to 6 weeks of moderate-intensity treadmill exercise. During the 
training period fasting blood glucose was lower in exercised mice than it was in sedentary 
mice, but serum insulin levels were not reduced. At week 6, trained mice showed a 
paradoxical decrease in plasma lactate levels during exercise, which was accompanied by 
an increase in the liver MCT2 protein level (~30%, p < 0.05). Exercise increased liver 
PGC-1 expression (~2-fold, p < 0.001), SIRT1 protein (~30%, p < 0.05), p38 protein 
(~15%, p < 0.05), COX4I1 protein (~50%, p < 0.05), and AMPK phosphorylation (~40%, 
p < 0.05). Despite this, liver mtDNA copy number (~30%, p = 0.05), TFAM expression 
(~15%, p < 0.05), COX2 expression (~10%, p < 0.05), CREB phosphorylation (~60%, p 
< 0.05), and BDNF expression (~40%, p < 0.05) were all reduced and cytochrome 
oxidase and citrate synthase activities were unchanged. The only altered brain parameter 
observed was a reduction in TNF- expression (~35%, p < 0.05); TNF- expression was 
unchanged in liver. Our data suggest lactate produced by exercising muscle modifies the 
liver bioenergetic infrastructure, and enhanced liver uptake may in turn limit the ability of 
exercise-generated lactate to modify brain bioenergetics. Also, it appears that at least in 
the liver a dissociated mitochondrial biogenesis, in which some components are 
strategically enhanced while others are minimized, can occur.  
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Introduction 
 Physical exercise has systemic benefits. It favorably affects blood glucose levels, 
cholesterol, and blood pressure (Richter et al., 1992; Stewart, 2004; Jia et al., 2012). 
Some exercise effects result from an increase in muscle mitochondrial mass and 
bioenergetic efficiency (Rockl et al., 2008; Little et al., 2010). Mitochondrial mass is 
increased through the process of mitochondrial biogenesis, which in turn is regulated by 
energy and redox-sensing pathways that converge on the peroxisomal proliferator-
activated receptor-gamma coactivator 1 alpha (PGC-1α), nuclear respiratory factor 1 
(NRF-1), and mitochondrial transcription factor A (TFAM) co-transcription and 
transcription factors (Vina et al., 2009). Among these proteins, PGC-1α engagement is an 
upstream event. PGC-1α activates NRF-1, and this initiates TFAM expression (Vina et 
al., 2009). TFAM plays roles in both mitochondrial DNA (mtDNA) replication and gene 
expression.  
Although muscle is the primary tissue utilized during exercise, both the liver and 
brain are also engaged and modified. Antioxidant enzyme expression and activities 
increase in both tissues (Somani & Husain, 1996; Wilson & Johnson, 2000; Devi & Kiran, 
2004; Navarro et al., 2004). In brain, brain derived neurotrophic factor (BDNF) and 
vascular endothelial growth factor (VGEF) levels appear to rise, consequently driving 
angiogenesis and neurogenesis (Fabel et al., 2003b; Vaynman et al., 2004; Berchtold et 
al., 2010). One recent study even reported high-intensity exercise increases brain PGC-1α 
expression and several other markers of mitochondrial mass (Steiner et al., 2011).  
Why exercise-induced muscle activation modifies non-muscle tissues is not fully 
understood. This phenomenon presumably must be mediated by either a removal from or 
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release into the blood of specific molecules. Regarding the latter possibility, lactate 
constitutes a potential candidate since lactate produced by contracting muscles enters the 
bloodstream, from where it is taken up by liver, heart, and skeletal muscle 
monocarboxylate transporters (MCTs) (Bonen et al., 2006).  
Lactate figures prominently in both liver and brain bioenergetic metabolism. In 
the Cori Cycle, blood lactate is transferred to hepatocytes by MCT2 and enters 
gluconeogenesis. The glucose produced is released into the blood and helps prevent 
hypoglycemia during sustained exercise (Hoene & Weigert, 2010). When blood lactate 
levels are sufficiently elevated, lactate from blood can also enter the brain (Ide et al., 
2000; van Hall et al., 2009). This could affect brain physiology, since lactate is used by 
neurons to support oxidative phosphorylation (Pellerin et al., 2007), and lactate also 
appears to play a role in memory formation (Veneman et al., 1994; Berthet et al., 2009; 
Suzuki et al., 2011). 
The primary purpose of this study was to evaluate the effects of moderate exercise 
on mouse liver and brain bioenergetic infrastructures. To do this, we analyzed pathways 
and proteins that sense cell energy and redox states, mediate adaptive responses to cell 
energy and redox state changes, and execute these responses. As part of this analysis, we 
especially considered the potential role that muscle-generated lactate might play.  
 
 
Methods  
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Animals 
The animal work described in this study was approved by the Institutional Animal 
Care and Use Committee of the University of Kansas Medical Center, and efforts were 
made to minimize animal discomfort. Twelve male, four-month old C57BL/6 mice were 
obtained from the Jackson Laboratory. All mice were maintained on an ad libitum diet. 
The mice were housed four per cage on a 12:12 hour light:dark schedule. After a 1 week 
accommodation period, the 4.25 month-old mice were randomly placed into two groups, 
a control/sedentary group (CT, n = 6) or an exercise group (EX, n = 6).  
 
Exercise training 
EX mice were exercised 2 sessions per day on a six-lane treadmill designed for 
mice (Columbus Instruments, Columbus, OH). Each session consisted of a 3 minute 
warm-up at 15 m/min plus 42 minutes at 18 m/min. This speed approximates the lactate 
threshold for untrained C57BL/6 mice (Billat et al., 2005). The training was performed 5 
days per week for 6 weeks. CT mice were not subjected to any exercise training. In order 
to avoid confounding factors such as sound and light, during the training sessions CT 
mice were placed in the same room as the EX mice. After the 6 week training, EX mice 
were sacrificed by decapitation 30 minutes after the last session. CT mice were also 
decapitated on the same day. Liver and brain tissue were immediately frozen in liquid 
nitrogen, and saved at -80°C for later analysis. 
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Glucose, insulin, and lactate level determination 
Blood glucose levels were measured using a One-Touch Ultra Blood Glucose 
Monitoring System (LifeScan, Milpitas, CA, USA). Plasma samples were also prepared 
from tail vein blood that was collected in heparinized micro-hematocrit capillary tubes 
(Fisher Scientific, Pittsburgh, PA). Plasma insulin levels were measured using an insulin 
ELISA kit according to the manufacturer’s instructions (American Laboratory Products 
Company, Salem, NH). Blood glucose and plasma insulin levels were measured during a 
period of unrestricted food access (non-fasting), and after a 15 hour fast (fasting). Values 
for the homeostasis model assessment of insulin resistance (HOMA-IR) were calculated 
from the product of fasting serum glucose (mM) and insulin (microunits/ml) divided by 
22.5 (Matthews et al., 1985). Plasma lactate levels were assayed using a commercial L-
lactate assay kit (Eton Bioscience Inc., San Diego, CA), and the values were normalized 
to the mean lactate level of CT mice at rest on the same day in order to minimize day-to-
day variation. 
 
Complex IV and citrate synthase activity assays 
Crude mitochondrial fractions isolated from the left cerebral hemisphere and the 
right liver lobe were used to measure complex IV (cytochrome oxidase; COX) and citrate 
synthase (CS) Vmax activities. To isolate mitochondria, brain and liver tissue were 
homogenized in MSHE buffer (210 mM mannitol, 70 mM sucrose, 5 mM HEPES, 1 mM 
EDTA, 0.5% fatty acid free BSA, pH 7.2) using a Teflon homogenizer and centrifuged at 
800 x g for 10 minutes. The supernatant was centrifuged again at 8000 x g for 10 minutes. 
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The resulting pellets containing mitochondria were re-suspended in MSHE buffer and 
frozen at -80°C for later use. COX and CS Vmax activities were determined as 
previously described (Ghosh et al., 2007). COX Vmax activities were normalized to 
protein concentration, as well as to citrate synthase activity. 
 
Immunoblotting 
Protein lysates were prepared using the front half of the right cerebral hemisphere 
and the left lobe of the liver. For total protein lysates, Radioimmunoprecipitation Assay 
Buffer (Cell Signaling Technology, Danvers, MA) was used. The tissue was 
homogenized in the buffer and the homogenates were subsequently sonicated three times, 
for 5 seconds each time, at setting 4 using an F60 Sonic Dismembrator (Fisher Scientific, 
Pittsburgh, PA). To prepare crude membrane protein fractions, tissue was placed in ST 
buffer (250 mM sucrose, 10 mM Tris base, pH 7.5) and homogenized by 10 strokes of a 
Dounce homogenizer. The homogenates were centrifuged at 1000 x g for 5 minutes, and 
the supernatant was further centrifuged at 100,000 x g for 1.5 hours. The resulting pellets 
containing membrane proteins were re-suspended in ST buffer for further analysis. 
Protein concentration was measured using a BCA protein assay reagent kit (Thermo 
Scientific, Rockford, IL).   
Several energy-sensitive proteins or proteins that influence energy metabolism 
were analyzed by immunoblotting. MCT2, a proton-linked plasma membrane transporter 
that transfers lactate into hepatocytes and neurons, was also analyzed. Primary antibodies 
to the following proteins were used: MCT2 (1:200 dilution; sc-166925, Santa Cruz 
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Biotechnology, Santa Cruz, CA); phospho-Thr172 AMP-activated protein kinase (AMPK) 
(1:1000 dilution; 2531, Cell Signaling Technology); AMPK (1:1000 dilution; 2603, Cell 
Signaling Technology); cAMP-response element binding protein (CREB) (1:1000 
dilution; sc-25785, Santa Cruz Biotechnology), phospho-Ser133 CREB (1:500 dilution; 
9198, Cell Signaling Technology), p38 (1:1000 dilution; 9212, Cell Signaling 
Technology), phospho-p38 (1:1000 dilution; 4511, Cell Signaling Technology), 
mammalian target of rapamycin (mTOR) (1:1000 dilution; 2983, Cell Signaling 
Technology), phospho-Ser2448 mTOR (1:1000 dilution; 2976, Cell Signaling 
Technology), NAD-dependent deacetylase sirtuin-1 (SIRT1) (1:500 dilution; 2028, Cell 
Signaling Technology); PGC-1α (1:1000 dilution; 516557, Millipore, Billerica, MA); and 
cytochrome oxidase subunit 4 isoform 1 (COX4I1) (A21348, 1 : 2000; Invitrogen, 
Carlsbad, CA). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH, 1:2000 dilution; 
2118, Cell Signaling Technology) was used as a loading control for total protein lysates. 
Pan-cadherin (1:1000 dilution; ab16505, Abcam, Cambridge, MA) was used as a loading 
control for the membrane protein fraction. Primary antibody binding was detected using 
horseradish peroxidase-conjugated secondary antibodies (1:2000 dilution; Cell Signaling 
Technology) and SuperSignal West Femto Maximum Sensitivity Substrate (Thermo 
Scientific). Densitometry was performed using a ChemiDoc XRS with Quantity One 
software (Bio-Rad, Hercules, CA, USA).  
 
Quantitative real-time RT-PCR 
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Total RNA was prepared from frozen brain and liver tissue using the TRI Reagent 
(Life Technologies, Grand Island, NY). Reverse transcription was performed with total 
RNA (1 μg) using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, 
Foster City, CA). Quantitative real-time RT-PCR (qPCR) was performed using the 
TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) and ready-
to-use TaqMan Gene Expression Assays (Applied Biosystems) to quantify the mRNA 
levels of MCT2, PGC-1α, NRF-1, TFAM, COX2, COX4I1, tumor necrosis factor alpha 
(TNF-α), CREB, and BDNF. GAPDH was used as an internal loading control. Real-time 
RT-PCR amplification was determined utilizing an Applied Biosystems StepOnePlus 
Real-Time PCR System (Applied Biosystems). Relative mRNA levels were quantified 
using the StepOnePlus Software v2.1 based on the comparative ∆∆CT method. 
To quantify liver mtDNA, total DNA was extracted with a Dneasy Blood & 
Tissue kit (Qiagen, Valencia, CA). TaqMan Gene Expression Assays (Applied 
Biosystems) for two mtDNA-encoded genes, NADH dehydrogenase subunit 2 (ND2) and 
16S ribosomal RNA (rRNA), and the nuclear 18S rRNA gene were used. The relative 
mtDNA to nuclear DNA copy number ratio was determined using the comparative ∆∆CT 
method, in which ND2: 18S rRNA and 16S rRNA: 18S rRNA ratios were calculated.  
 
Statistical analysis 
Data were summarized by mean and standard error. Mean values were compared 
by two-sample t-test or paired t-test using SPSS 18.0. Pearson’s correlation analysis was 
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performed to determine relationships between MCT2 and PGC-1α. p-values less than 
0.05 were considered significant. 
 
 
Results 
Effect on weight, glucose, and insulin  
At the beginning of the study, body weights were comparable between the CT and 
EX groups. After 6 weeks, the CT mice gained significantly more weight (baseline: 29.28 
g ± 0.42; after 6 weeks: 30.82 g ± 0.40, p < 0.05, Fig. 1A), while the EX mice maintained 
their weight over the 6 weeks (baseline: 29.70 g ± 0.32; after 6 weeks of training: 29.95 g 
± 0.54, p > 0.05, Fig. 1A). After 3 weeks, the non-fasting plasma glucose trended down 
in EX mice (CT: 184.33 mg/dL ± 5.95; EX: 167.67 mg/dL ± 8.33, p = 0.06, Fig. 1B). At 
the 3.5-week point, fasting blood glucose levels were significantly lower in the EX mice 
(CT: 119.33 mg/dL ± 5.75; EX: 95.08 mg/dL ± 5.23, p < 0.05, Fig. 1B). At the beginning 
of the study, non-fasting plasma insulin levels and 15-hour fasting plasma insulin levels 
(both at rest) were comparable between the CT and EX groups (data not shown). After 6 
weeks of training, we did not observe inter-group differences in either the non-fasting 
insulin level (CT: 1.16 ng/mL ± 0.20; EX: 1.77 ng/mL ±0.27, p > 0.05, Fig. 1C) or the 
15-hour fasting insulin level (CT: 0.42 ng/mL ± 0.09; EX: 0.80 ng/mL ± 0.35, p > 0.05, 
Fig. 1C). The HOMA-IR calculation suggested that 6 weeks of moderate intensity 
treadmill training did not increase insulin sensitivity (CT: 3.04 ± 0.79; EX: 4.41 ± 1.72, 
p > 0.05, Fig. 1D). 
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Plasma lactate and MCT2  
After the 6 week training period, resting plasma lactate levels were comparable 
between the CT and EX groups (p > 0.05, figure not shown). At the end of the 6 weeks, 
we found that the plasma lactate level actually declined in the EX mice while they were 
running. The plasma lactate levels appeared to gradually return to its resting baseline 
level over the first 2 hours of the recovery period (Fig. 2). Protein levels of MCT2, a 
transporter responsible for cell lactate uptake, were significantly increased in EX mice 
livers (~30%, p < 0.05), although no inter-group difference was seen in mRNA 
expression (Fig. 3). Other investigators have also observed a similar dissociation between 
MCT2 protein levels and mRNA expression (Jackson et al., 1997). Exercise training did 
not change brain MCT2 mRNA expression or protein levels (Fig. 3). 
 
Mitochondrial enzyme activities 
Liver and brain COX Vmax activities, when normalized to protein concentration, 
were comparable between the CT and EX groups (Table 1). Normalizing COX activity to 
CS activity, a parameter sometimes used to independently control for mitochondrial mass, 
did not change this relationship. CS activities in both liver and brain were also 
comparable between the groups. 
 
Bioenergetics-related proteins 
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Liver but not brain PGC-1α mRNA was significantly increased in EX mice (~2-
fold, p < 0.001, Fig. 4A), while the liver and brain PGC-1α protein levels were 
unchanged (Fig. 4B). Liver PGC-1α mRNA and MCT2 protein levels were positively 
correlated (r = 0.67, p < 0.05, Fig. 5A). No correlation was seen between liver PGC-1α 
and MCT2 protein levels, liver PGC-1α and MCT2 mRNA levels, or liver PGC-1α 
protein and MCT2 mRNA levels (Fig. 5B-D). 
We assessed the status of several proteins that are known to regulate PGC-1α. The 
protein level of SIRT1, which activates PGC-1α by deacetylating it (Canto et al., 2009), 
was increased in the livers but not brains of the EX mice (~30% increase, p < 0.05, Fig. 
6A). AMPK, another important metabolic sensor that monitors intracellular AMP/ATP 
ratios (Hardie, 2007), showed increased Thr172 phosphorylation in the EX mice livers 
but not in brains. This increase was observed when normalized to either total AMPK or 
GAPDH (~40% increase, p < 0.05, Fig. 6B-C).  Liver and brain total AMPK protein 
levels were comparable between groups (Fig. 6D).  
We analyzed p38 MAPK activation by immunoblotting, since p38 MAPK has 
been shown to activate PGC-1α (Cao et al., 2005). When normalized to GAPDH, p38 
phosphorylation in the EX mouse livers trended towards an increase (~15% increase, p = 
0.087, Fig. 7A). When corrected for total p38, though, this trend was no longer apparent 
(Fig. 7B). The total p38 level, when normalized to GAPDH, was higher in EX mouse 
livers (~15% increase, p < 0.05, Fig. 7C), which suggests any apparent increase in liver 
p38 phosphorylation was a secondary consequence of increased total p38 protein. Brain 
total p38 levels were comparable between the EX and CT groups.  
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We assessed the activation status of mTOR, a kinase that regulates cell growth, 
size, and survival and which can form a complex with PGC-1α (Cunningham et al., 2007). 
There was no difference in mTOR Ser2448 phosphorylation, when normalized to either 
GAPDH or total mTOR, in either liver or brain (Fig. 7D-E). Liver and brain total mTOR 
protein levels were also comparable between the two groups (Fig. 7F).  
CREB can reportedly activate PGC-1α expression (Herzig et al., 2001). Liver 
CREB mRNA expression was lower in the EX mice than it was in control mice (Fig. 8A), 
although total CREB protein levels were comparable (Fig. 8B). Ser133 CREB 
phosphorylation was reduced in the EX mouse livers when normalized to GAPDH (~60% 
decrease, p < 0.05), but when normalized to total CREB this exercise-induced phospho-
CREB reduction did not remain statistically significant (Fig. 8C-D). No changes in brain 
CREB expression, total protein, or phosphorylation were observed. To further help 
address whether a functional reduction in liver CREB activity occurred, we measured the 
expression of BDNF, as CREB drives BDNF expression (Finkbeiner, 2000). BDNF 
mRNA levels were significantly lower in EX mouse livers (~40% decrease, p < 0.05, Fig. 
8E). Contrary to what has been reported in other studies of exercised mice (Chen & 
Russo-Neustadt, 2009; Liu et al., 2009; Rasmussen et al., 2009), but consistent with our 
observed lack of brain CREB changes, we did not observe changes in brain BDNF 
expression. 
NRF-1 and TFAM are regulated by PGC-1(Vina et al., 2009). Liver and brain 
NRF-1 mRNA levels did not differ between the groups (Fig. 9A). Liver TFAM 
expression, but not brain TFAM expression, was significantly reduced in EX mice (~15% 
decrease, p < 0.05, Fig. 9B). In accordance with this liver TFAM mRNA reduction, we 
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also observed that mtDNA content was lower in the EX mouse livers (16S rRNA/18S 
rRNA: ~25% decrease, p = 0.1; ND2/18S rRNA: ~30% decrease, p = 0.05, Fig. 10). The 
mRNA levels of cytochrome c oxidase subunit 2 (COX2), an mtDNA-encoded protein 
that constitutes part of the COX holoenzyme, was decreased in the EX group livers 
(~10% decrease, p < 0.05, Fig. 11A). Brain levels were statistically equivalent. 
Interestingly, levels of COX4I1 protein, a nuclear DNA-encoded constituent of the COX 
holoenzyme, were significantly increased in the EX mouse livers (~50% increase, p < 
0.05, Fig. 11B). COX4I1 protein levels were similar in brain, and liver and brain COX4I1 
mRNA expression between EX and CT mice was comparable (Fig. 11B-C).  
Bioenergetic metabolism is known to influence inflammation and inflammatory 
markers (Salminen et al., 2011). To assess the effects of exercise on a marker of 
inflammation, we measured liver and brain TNF-α expression. Although exercise did not 
alter liver TNF-α mRNA levels, TNF-α mRNA levels were reduced in EX mouse brains 
(~35% decrease, p < 0.05, Fig. 12). 
 
Discussion 
We found that when young male C57BL/6 mice were exercised regularly on a 
treadmill, at 18 m/min for 6 weeks, their ability to clear blood lactate increased. In 
conjunction with this adaptation, and likely contributing to it, liver MCT2 protein levels 
rose.  Liver but not brain PGC-1α expression increased. SIRT1, AMPK, p38, and CREB 
are all reported to activate PGC-1α activity or expression, and our data suggest SIRT1, 
AMPK, and p38 but not CREB may have contributed to the observed PGC-1α increase.  
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Although PGC-1α is known to coordinate mitochondrial biogenesis, and protein 
levels of the nuclear DNA-encoded electron transport chain COX4I1 subunit rose in the 
liver, liver TFAM expression, COX2 expression, and mtDNA content were reduced. In 
the liver, therefore, exercise appeared to induce at most a relatively selective 
mitochondrial biogenesis in which the respiratory capacity was not enhanced. This is 
potentially consistent with the fact that from a bioenergetics perspective, a key liver 
function is glucose homeostasis (Herzig et al., 2001). Under exercise conditions, it 
accomplishes this through gluconeogenesis. In our study, the liver bioenergetic 
infrastructure may have changed to facilitate gluconeogenesis at the expense of oxidative 
phosphorylation.  
If correct, these data could help explain why the transfer of mtDNA genes to the 
nucleus, a process that has played out over the course of evolution, remains incomplete. 
Activating nuclear genes that promote mitochondrial biogenesis, while downregulating 
mtDNA and transcription factors that promote mtDNA gene expression, would 
predictably shift mitochondrial function from respiration and towards other non-
respiratory activities such as gluconeogenesis. Retaining key respiratory chain subunit 
genes on the mtDNA, therefore, could help facilitate this high degree flexibility. 
Lactate produced during exercise appears to have initiated the liver changes we 
observed. This is suggested by the apparent correlation between PGC-1α expression and 
MCT2 protein. It is further supported by the fact that by the end of the training period, 
blood lactate levels actually decreased during exercise. We believe this represents 
evidence of an enhanced Cori Cycle, which would contribute to endurance by increasing 
the liver’s ability to maintain glucose homeostasis under conditions of sustained exertion. 
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Also, we selected a treadmill speed of 18 m/min because this speed reportedly 
corresponds to the lactate threshold of untrained C57BL/6 mice (Billat et al., 2005). By 
the end of the 6 week training period, the 18 m/min speed was clearly below the lactate 
threshold of our EX mice, which would correspond at most to a “moderate”-intensity 
human exercise regimen. 
Our data do not establish a role for lactate in mediating exercise’s brain effects, 
but the paucity of brain changes we observed perhaps provides indirect support for this 
possibility. Certainly, if lactate entering the brain from the blood can modify the brain 
bioenergetics infrastructure, then an inability to deliver exercise-generated lactate to the 
brain would blunt exercise’s brain effects. The enhanced ability of the liver to clear 
exercise-generated lactate, a consequence of training, would function in this capacity. 
Indeed, the only brain change we observed with exercise was a reduction in TNF-
α expression. This suggests that exercise may reduce brain inflammation set points, and 
that this effect occurs independently of lactate. Interestingly, we did not detect an 
increase in brain BDNF expression, a change that has been reported in other mouse 
exercise studies (Chen & Russo-Neustadt, 2009; Liu et al., 2009; Rasmussen et al., 2009). 
On this point there is a fair amount of equipoise, though, as other treadmill exercise 
studies have found brain BDNF does not increase or even decreases (Aguiar et al., 2007, 
2008; Wu et al., 2011). We wonder whether differences among these studies are due to 
methodological factors such as the age of the mice, the brain regions analyzed, or the 
exercise protocol that was used.  
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Similarly, while one study did report exercise increased mouse brain and liver 
COX activity (Navarro et al., 2004), we did not observe a COX activity change in either 
tissue. We suspect this may also reflect methodological factors, as the mice in the 
positive study were older than the mice we used. Certainly, it might be expected that the 
ability of exercise to reverse physiologic or biochemical declines is greater than its ability 
to enhance already optimally functioning bioenergetic systems. Finally, Steiner et al. 
recently reported exercise did increase PGC-1α expression in mouse brain, an effect we 
did not observe in our mice, but the intensity of the exercise protocol in that study (one 
hour treadmill sessions at 25 m/min and a 5% incline, 6 days a week for 8 weeks) was 
greater than in our study (Steiner et al., 2011) .       
 On other points our molecular findings and literature data are essentially 
consistent. A prior study using male C57BL/6 mice found that after a single session of 
high intensity treadmill exercise, liver PGC-1α expression increased (Hoene et al., 2009). 
Hepatic ATP concentrations significantly decrease while AMP increases immediately 
after exercise, which would be expected to activate AMPK (Camacho et al., 2006). We 
postulate this is why AMPK Thr172 phosphorylation, which is often used to assess 
AMPK’s activation status (Hawley et al., 1996), occurred in our mice.  
It is unclear to us why CREB phosphorylation was reduced in the livers of our 
exercised mice. To our knowledge, no previous studies have investigated the effect of 
exercise training on liver CREB expression, although one study did find that under 
fasting conditions CREB regulates hepatic gluconeogenesis through effects on PGC-1α 
(Herzig et al., 2001).  
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Exercise is known to minimize weight gain, and over the course of our 6 week 
study exercise did associate with weight stabilization. Exercise is also said to enhance 
insulin sensitivity, but our HOMA-IR calculation showed no evidence of increased 
insulin sensitivity. We feel it is possible that an exercise-induced increase in 
gluconeogenesis capacity may have confounded the HOMA-IR calculation. If the livers 
of the exercised mice were more efficient at producing glucose, a compensatory increase 
in insulin secretion could have been triggered. Such a change would tend to obscure 
shifts in insulin sensitivity. 
This study was limited by a relatively small sample size. Our results do show 
changes in the expression, level, or post-translational modification of several liver and 
brain proteins, but the power of our study to detect changes in either tissue was no doubt 
limited. Future studies with larger sample sizes could more sensitively define how 
exercise impacts non-muscle bioenergetics, and better reveal the mechanisms that 
mediate exercise-induced molecular changes. Despite this limitation, our study does have 
translational implications as it suggests that even a moderate intensity exercise program 
may enhance liver gluconeogenesis and reduce brain inflammation.  
In conclusion, our results demonstrate that training C57BL/6 mice at moderate 
exercise intensities enhances the liver’s ability to import lactate. This effect is associated 
with and potentially mediated by an increase in liver MCT2. Moderate exercise shifts the 
liver’s bioenergetic profile in ways that should promote gluconeogenesis, some aspects of 
mitochondrial biogenesis, but not oxidative phosphorylation. These effects are possibly 
lactate-mediated. Liver lactate import appears to be favored over brain lactate import, so 
exercise-mediated brain effects may be robust only when lactate production reliably 
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exceeds the lactate threshold. Further research is needed to investigate whether exercise 
training above the lactate threshold increases brain lactate delivery and alters energy-
sensitive pathways and proteins in that tissue.  
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Table 1. Brain and liver COX and CS activities. 
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Figure 1. Effects of treadmill exercise training on weight, glucose, and insulin. (For 
figure legend, see next page) 
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Figure 1. Effects of treadmill exercise training on weight, glucose, and insulin. (A) 
CT mice gained significantly more weight while the EX mice maintained their weight 
over the 6 weeks. (B) A trend toward lower plasma glucose level without fasting was 
seen in the EX mice after 3 weeks of training (p = 0.06). After 3.5 weeks of training, 
fasting blood glucose levels were significantly lower in the EX mice. (C) After 6 weeks 
of training, inter-group differences were not observed in the non-fasting insulin level and 
the 15 hour fasting insulin level. (D) The HOMA-IR value was unchanged by 6 weeks of 
moderate intensity treadmill training. CT, control group; EX, exercise group; HOMA, 
homeostasis model assessment; NS, non-significant. 
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Figure 2. Plasma lactate levels during exercise. At the end of the 6 weeks, plasma 
lactate levels declined in EX mice during treadmill running. Plasma lactate levels 
appeared to gradually recover over the first 2 hours of the post-exercise period. *p < 0.05 
relative to the at-rest lactate level. CT, control group; EX, exercise group. 
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Figure 3. Effect of exercise on MCT2. (For figure legend, see next page). 
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Figure 3. Effect of exercise on MCT2. (A) MCT2 protein increased in the EX mouse 
livers, but brain MCT2 protein levels were unchanged. (B) No changes in MCT2 mRNA 
were seen in liver or brain. *p < 0.05. CT, control group; EX, exercise group; MCT2, 
monocarboxylate transporter 2. 
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Figure 4. Effect of exercise on PGC-1α. (A) PGC-1α mRNA was increased in the EX 
group livers, but exercise training did not alter brain PGC-1α mRNA. (B) Exercise did 
not affect PGC-1α protein levels in either tissue. *p < 0.05. CT, control group; EX, 
exercise group; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; PGC-1α, 
peroxisomal proliferator-activated receptor-gamma coactivator 1 alpha. 
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Figure 5. MCT2 and PGC-1α relationships. (For figure legend, see next page). 
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Figure 5. MCT2 and PGC-1α relationships. (A) MCT2 protein and PGC-1α mRNA 
levels were positively correlated. (B-D) No correlation was seen between MCT2 protein 
levels and PGC-1α protein levels, between MCT2 mRNA levels and PGC-1α mRNA 
levels, or between MCT2 mRNA levels and PGC-1α protein levels. CT, control group; 
EX, exercise group; MCT2, monocarboxylate transporter 2; PGC-1α, peroxisomal 
proliferator-activated receptor-gamma coactivator 1 alpha. 
45 
 
0
0.4
0.8
1.2
1.6
p
‐A
M
P
K
/A
M
P
K
 R
e
la
ti
ve
d
en
si
ty
*
CT EX                CT     EX      
Liver            Brain
p‐AMPK
AMPK
0
0.4
0.8
1.2
1.6
p
‐A
M
P
K
/G
A
P
D
H
R
e
la
ti
ve
d
e
n
si
ty
CT EX                CT     EX      
Liver            Brain
*
p‐AMPK
GAPDH
 
 
Figure 6. Effect of exercise on SIRT1 and AMPK. (For figure legend, see next page). 
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Figure 6. Effect of exercise on SIRT1 and AMPK. (A) SIRT1 protein was increased in 
the EX group livers, but exercise training did not alter the brain SIRT1 protein level. (B-
D) AMPK Thr172 phosphorylation was increased in the EX mice livers. This increase 
was observed when corrected for both total AMPK and GAPDH. Exercise training did 
not alter brain AMPK phosphorylation and liver or brain AMPK protein levels. *p < 0.05. 
AMPK, AMP-activated protein kinase; CT, control group; EX, exercise group; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; SIRT1, NAD-dependent deacetylase sirtuin-
1. 
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Figure 7. Effect of exercise on p38 and mTOR. (For figure legend, see next page). 
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Figure 7. Effect of exercise on p38 and mTOR. (A-C) When normalized for GAPDH, 
liver p38 phosphorylation trended higher in the EX mice, but no inter-group difference 
was suggested when phospho-p38 was normalized to total p38. Total p38 was 
significantly increased in EX mouse livers. No inter-group difference was observed in 
brain phospho-p38 or total p38. (D-F) Brain and liver phospho-mTOR and total mTOR 
were comparable between groups. *p < 0.05. CT, control group; EX, exercise group; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; mTOR, mammalian target of 
rapamycin. 
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Figure 8. Effect of exercise on CREB and BDNF. (For figure legend, see next page). 
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Figure 8. Effect of exercise on CREB and BDNF. (A) Exercise training decreased 
CREB mRNA expression in the liver but did not alter its expression in the brain. (B-D) 
When normalized to GAPDH, CREB total protein was equivalent between groups while 
phospho-CREB (at Ser133) was significantly lower in the livers of EX mice. There was 
no difference in the phospho-CREB/CREB ratio. No changes in brain total or phospho-
CREB protein were observed. (E) Although exercise did not alter brain BDNF mRNA 
expression, liver BDNF mRNA expression was reduced in the EX mice. *p < 0.05. 
BDNF, brain-derived neurotrophic factor; CT, control group; CREB, cAMP-response 
element binding protein; EX, exercise group; GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase. 
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Figure 9. NRF-1 and TFAM expression. (A) Exercise training did not alter liver or 
brain NRF-1 mRNA levels. (B) TFAM mRNA expression was lower in the EX group 
livers, but unchanged in brain. *p < 0.05. CT, control group; EX, exercise group; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; NRF-1, nuclear respiratory factor 
1; TFAM, mitochondrial transcription factor A. 
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Figure 10. qPCR analysis of liver mtDNA content. Total DNA was extracted from 
liver tissue and mtDNA was analyzed by real-time quantitative PCR using primers 
targeting the 18S RNA nuclear gene and the ND2 or 16S RNA mtDNA genes. The 
16S:18S ratio trended lower in the EX mice (p = 0.1), while the ND2:18S ratio was at the 
significance cut-off in the EX mice. *p = 0.05. CT, control group; EX, exercise group; 
mtDNA, mitochondrial DNA; ND2, NADH dehydrogenase subunit 2; nDNA, nuclear 
DNA; rRNA, ribosomal RNA. 
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Figure 11. Effect of exercise on COX2 and COX4I1. (For figure legend, see next page). 
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Figure 11. Effect of exercise on COX2 and COX4I1. (A) Liver COX2 mRNA levels 
were decreased in the EX group, but were unchanged in the brain. (B-C) COX4I1 protein 
increased in the livers of EX mice, while liver COX4I1 mRNA expression did not change. 
Exercise did not alter brain COX4I1 expression or protein levels. *p < 0.05. CT, control 
group; COX2, cytochrome c oxidase subunit 2; COX4, cytochrome c oxidase subunit 4; 
EX, exercise group. 
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Figure 12. Effect of exercise on TNF-α expression. TNF-α mRNA expression was 
comparable in the livers but lower in the brains of EX mice. *p < 0.05. CT, control group; 
EX, exercise group; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; TNF-α, tumor 
necrosis factor alpha. 
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Chapter III 
 
Lactate Administration Reproduces Specific Brain and Liver Exercise-
Related Changes  
 
 
Lezi E, Jianghua Lu, J. Eva Selfridge, Jeffrey M. Burns, Russell H. Swerdlow 
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Abstract 
 The effects of exercise are not limited to muscle and its ability to mitigate some 
chronic diseases is under study.  A more complete understanding of how exercise impacts 
non-muscle tissues might facilitate design of clinical trials and exercise mimetics. Here, 
we focused on lactate’s ability to mediate changes in liver and brain bioenergetic-
associated parameters.  In one group of experiments, C57BL/6 mice underwent seven 
weeks of treadmill exercise sessions at intensities intended to exceed the lactate threshold. 
Over time the mice dramatically increased their lactate threshold, and to ensure plasma 
lactate accumulated during the final week the mice were run to exhaustion. In liver, 
mRNA levels of gluconeogenesis-promoting genes increased. PGC-1α expression 
increased, PGC-1β expression decreased, and overall gene expression changes favored 
respiratory chain down-regulation.   In brain, PGC-1α and PGC-1β were unchanged but 
PRC expression and mtDNA copy number increased. Brain TNFα expression fell, and 
VEGF-A expression rose. In another group of experiments, exogenously administered 
lactate was found to reproduce some but not all of these observed liver and brain changes. 
Our data suggest that lactate, an exercise byproduct, could mediate some of exercise’s 
liver and brain effects, and that lactate itself can act as a partial exercise mimetic.           
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Introduction 
Bioenergetic function plays a role in various chronic diseases including 
cardiovascular disease, diabetes, and some neurodegenerative disorders.  In these 
instances bioenergetic function is thought to constitute a viable therapeutic target 
(Fontan-Lozano et al., 2008; Ren et al., 2010; Duncan, 2011; Swerdlow, 2011).  Exercise, 
a non-pharmacologic intervention, affects cell and tissue bioenergetics.  While exercise’s 
effects on muscle bioenergetics are particularly robust these effects are not muscle-
limited and, at least to a minor degree, occur in other tissues.  It was recently postulated 
physical exercise might potentially delay or mitigate age-related central nervous system 
diseases such as Alzheimer’s disease (AD), perhaps through effects on brain 
bioenergetics (Rockwood & Middleton, 2007).   
In muscle, exercise facilitates mitochondrial biogenesis (Hood et al., 2006), and 
this confers some benefits of endurance training.  Exercise may also affect brain 
mitochondrial biogenesis.  One study found exercise increases brain peroxisome 
proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1α) mRNA levels 
(Steiner et al., 2011).  In several tissues PGC-1α acts as a master regulator of 
mitochondrial biogenesis and cell energy metabolism.  It binds and activates nuclear 
respiratory factor 1 (NRF-1), which in turn induces the expression of mitochondrial 
transcription factor A (TFAM) (Scarpulla, 2008b; Vina et al., 2009).  TFAM enables the 
replication, maintenance, and transcription of mitochondrial DNA (mtDNA).  Under 
some conditions exercise has been shown to increase brain mtDNA copy number (Bayod 
et al., 2011; Marosi et al., 2012; Zhang et al., 2012b; Zhang et al., 2012c).     
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Exercise has long been thought to primarily modify brain molecular physiology 
by increasing amounts of brain derived neurotrophic factor (BDNF) (Stranahan et al., 
2009), but other factors may also mediate the non-muscle effects of exercise, or perhaps 
lie upstream of BDNF changes.  Lactate, which is generated and released by exercising 
muscle, in particular appears to affect the brain.  Blood lactate accesses the brain via 
endothelial monocarboxylate transporters (MCTs) (Pierre & Pellerin, 2005).  Lactate 
imported from the blood to the brain is used to generate energy (Quistorff et al., 2008; 
Gallagher et al., 2009; van Hall et al., 2009; Boumezbeur et al., 2010; Wyss et al., 2011), 
protects ischemic neurons (Berthet et al., 2009), and facilitates memory formation 
(Newman et al., 2011; Suzuki et al., 2011).  For these reasons and others, we considered 
whether lactate itself might reproduce and perhaps mediate exercise-associated changes 
in brain bioenergetic infrastructures.   
 
 
Materials and Methods  
Animals 
The animal work described in this study was approved by the Institutional Animal 
Care and Use Committee of the University of Kansas Medical Center.  Whenever 
possible, efforts were made to minimize animal discomfort.  Fifty-four C57BL/6 male 
mice were included in these studies.  Our mice were obtained from the Jackson 
Laboratory, and were 4 months old when they reached our vivarium.  All mice were 
maintained on an ad libitum diet, and were housed 4 per cage on a 12:12 hour light:dark 
schedule. After a 1 week accommodation period, the mice were randomly placed into 4 
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groups, a sedentary group (SED, n = 11), an exercise group (EX, n = 12), a lactate 
treatment group (LAC, n = 16), and a lactate-free vehicle group (VEH, n = 15).  
Exercise training 
EX mice were exercised for 7 weeks, 2 sessions per day, on a six-lane treadmill 
designed for mice (Columbus Instruments, Columbus, OH). The back of each treadmill 
lane contained an electrified grid, which delivered a shock stimulus to stationary mice 
(0.2 mA, 200 ms pulses, 1 Hz). For the first 3 weeks each session consisted of a 3 minute 
warm-up at 15 m/min followed by 42 minutes at 18 m/min. This speed approximates the 
lactate threshold for untrained C57BL/6 mice (Billat et al., 2005). During weeks 4, 5, and 
6 the treadmill speed was progressively increased to 20 m/min, 22 m/min, and 25 m/min 
respectively.  In order to ensure that at least at the end of the training period exercise 
intensity exceeded the lactate threshold, during the last week (week 7) the mice did not 
run for a specified time interval at a specific speed, but instead ran to exhaustion. Mice 
were defined as exhausted if, for the third time, they remained on the shock grid for 
greater than 5 continuous seconds without attempting to run.  During these 7 weeks 
running sessions were performed 5 days per week.  
The SED mice served as the control group for the EX mice.  SED mice did not 
receive any exercise training.  To minimize potential confounding factors such as 
differences in sound and light exposure, during the EX mice training sessions SED mice 
were placed in the same room as the EX mice.  
At the conclusion of the 7-week training period, EX mice were sacrificed by 
decapitation 1 hour after the last session, and SED mice were also decapitated at 
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approximately the same time on the same day. Liver and brain tissue were immediately 
frozen in liquid nitrogen, and saved at -80°C for subsequent analysis. 
 
Lactate treatment 
LAC mice received 2g/kg of sodium lactate dissolved in phosphate buffered 
saline (PBS).  The lactate solution concentration was 200 mg/mL (~18 mM), and the pH 
was 7.4.  The controls for the LAC group, the VEH group, were administered PBS at a 
volume that approximated the average volume administered to the LAC mice. Injections 
were performed intraperitoneally, once a day, for 14 consecutive days. 1 hour after the 
final injection mice were sacrificed by decapitation, liver and brain tissue were 
immediately frozen in liquid nitrogen, and these tissues were saved at -80°C for 
subsequent analysis. 
 
Lactate, glucose, and insulin level determination  
Plasma lactate levels were assayed using a commercial L-lactate assay kit (Eton 
Bioscience Inc., San Diego, CA). In order to minimize day-to-day assay variation, EX 
mouse values were normalized to the mean lactate level of the SED mice assayed on the 
same day.  For the VEH and LAC groups, values were normalized to the mean lactate 
level of VEH mice assayed on the same day. 
Blood glucose levels were measured using a One-Touch Ultra Blood Glucose 
Monitoring System (LifeScan, Milpitas, CA). Plasma samples were also prepared from 
tail vein blood that was collected in heparinized micro-hematocrit capillary tubes (Fisher 
Scientific, Pittsburgh, PA). Plasma insulin levels were measured using an insulin 
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enzyme-linked immunosorbent assay kit according to the manufacturer’s instructions 
(American Laboratory Products Company, Salem, NH). Blood glucose and plasma 
insulin levels were measured after a 16 hour fast (fasting blood glucose and fasting 
plasma insulin). Values for the homeostasis model assessment of insulin resistance 
(HOMA-IR) were calculated as the product of fasting blood glucose level (mM) and 
plasma insulin level (microunits/ml) divided by 22.5 (Matthews et al., 1985).  
 
Quantitative real-time, reverse-transcription PCR 
Total RNA was prepared from frozen brain and liver tissue using the TRI Reagent 
(Life Technologies, Grand Island, NY). Reverse transcription was performed on total 
RNA (1 μg) using a High Capacity cDNA Reverse Transcription kit (Applied Biosystems, 
Foster City, CA). Quantitative real-time, reverse-transcription PCR (qPCR) was 
performed using TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, 
CA) and ready-to-use TaqMan Gene Expression Assays (Applied Biosystems) to 
quantify the mRNA levels of PGC-1α, PGC-1β, PGC-1 related co-activator (PRC), NRF-
1, TFAM, phosphoenolpyruvate carboxykinase 1 (PCK1), pyruvate dehydrogenase 
kinase 4 (PDK4), vascular endothelial growth factor A (VEGF-A), hypoxia-inducible 
factor alpha (HIF-1α), and tumor necrosis factor alpha (TNF-α). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as a house keeping gene. qPCR 
amplifications were performed using an Applied Biosystems StepOnePlus Real-Time 
PCR System (Applied Biosystems). Relative mRNA levels were quantified using the 
StepOnePlus Software v2.1 based on the comparative ∆∆CT method. 
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MtDNA copy number determination 
To quantify liver and brain mtDNA, total DNA was extracted using a phenol-
chloroform based method as previously described (Guo et al., 2009). Briefly, frozen 
mouse liver and brain (~15 mg) were homogenized by 10 strokes of a Dounce 
homogenizer in lysis buffer (10 mM Tris-HCl at pH 8.0, 1 mM EDTA, and 0.1 % SDS). 
After adding proteinase K, lysate tubes were incubated at 55 °C for 3 hours. Lysate 
solutions were vortexed vigorously and centrifuged at 8,000 g for 15 minutes. 
Supernatants were mixed with phenol/chloroform/isoamyl alcohol (25:4:1) (Sigma-
Aldrich, St. Louis, MO), and centrifuged again at 8,000 g for 15 minutes. The 
supernatants were mixed with an equal volume of chloroform and centrifuged at 8,000 g 
for 15 minutes. The resulting supernatants were mixed with sodium acetate and 
isopropanol, stored overnight at −20 °C to facilitate DNA precipitation, and centrifuged 
at 8000 g for 15 minutes to pellet the DNA.  
DNA pellets were then washed with 70% ethanol, air dried, and dissolved in 
nuclease-free water. DNA concentration and purity were determined 
spectrophotometrically by determining the absorbance at 260 nm and the 260 nm/280 nm 
ratio. Each real-time PCR reaction was performed using 10 ng of DNA as the template. 
We used TaqMan Gene Expression Assays (Applied Biosystems) to quantify the amounts 
of two target genes present on mtDNA, NADH dehydrogenase subunit 2 (ND2) and 
the16S ribosomal RNA (rRNA), as well as the amount of a nuclear target gene, the 18S 
rRNA. The relative mtDNA to nuclear DNA copy number ratio was determined using the 
comparative ∆∆CT method, in which ND2: 18S rRNA and 16S rRNA: 18S rRNA ratios 
were calculated.  
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Immunoblotting 
            Nuclear and cytoplasmic protein extracts from brain were prepared using NE-PER 
Nuclear and Cytoplasmic Extraction Reagents (Thermo Scientific, Rockford, IL) 
according to the manufacturer’s instructions. Protein concentrations were measured using 
a BCA protein assay reagent kit (Thermo Scientific, Rockford, IL). Cytoplasmic and 
nuclear HIF-1α protein levels (primary antibody: 1:500 dilution; Ab113642; Abcam, 
Cambridge, MA) were analyzed by immunoblotting. GAPDH (1:2000 dilution; 2118; 
Cell Signaling Technology, Danvers, MA) and histone deacetylase 1 (1:2000 dilution; 
PA1-860; Thermo Scientific) were used as loading controls for the cytoplasmic and 
nuclear fractions, respectively. Primary antibody binding was detected using horseradish 
peroxidase-conjugated secondary antibodies (1:2000 dilution; Cell Signaling Technology) 
and SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific).  
 
Statistical analysis 
Data were summarized by means and standard errors. Mean values were 
compared by two-way, unpaired t-tests or two-way, paired t-tests using SPSS 18.0 (SPSS 
Inc., Chicago, IL, USA). Pearson’s correlation analysis was used to test inter-parameter 
relationships. p-values less than 0.05 were considered statistically significant.   
 
 
Results 
Effect of treadmill training and lactate injection on plasma lactate levels  
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Treadmill training profoundly changed the exercise-related plasma lactate 
accumulation threshold (Fig. 1A). At the beginning of the first week of training, 
immediately after completing a treadmill session at 18 m/min plasma lactate levels were 
higher in the EX mice than they were in the SED mice. After one week of training at 18 
m/min, though, exercise at 18 m/min no longer increased the plasma lactate levels and at 
the end of weeks 2 and 3 post-exercise lactate levels were actually lower in the EX mice 
than they were in the SED mice.  Increasing the treadmill speed to 20 m/min, 22 m/min, 
and 25 m/min in weeks 4, 5, and 6 eventually eliminated this post-exercise lactate 
reduction, but did not increase the EX mouse post-exercise lactate level above the SED 
mouse lactate level. Only after running EX mice to exhaustion during week 7 did we 
again manage to exceed the lactate accumulation threshold and increase plasma lactate 
levels.  
In the LAC mice, 2 g/kg of intraperitoneal lactate rapidly increased the plasma 
lactate level (Fig. 1B).  Lactate levels peaked approximately 15 minutes after injection, 
remained significantly elevated over the pre-injection baseline for at least 1 hour, and 
returned to the baseline level by 3 hours. 
 
Effect of treadmill training and lactate injections on weight, glucose, and insulin 
At the beginning of the study body weights were comparable between the SED 
and EX groups, as well as between the VEH and LAC groups. At the end of the 7 week 
treadmill training period the EX mice did not increase their mean weight, while the SED 
mice did (SED baseline 28.36 ± 0.37 grams, increasing to 31.04 ± 0.55 grams; p < 0.05; 
Fig. 2A). After 14 days of lactate injections, LAC mice lost ~4% of their starting body 
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weight (LAC baseline 28.17 ± 0.55 grams, decreasing to 27.19 ± 0.61 grams; p < 0.001; 
Fig. 2A), while the VEH group maintained its weight.  
Over the course of the study fasting blood glucose levels did not change in the EX 
mice, while SED mouse blood glucose levels increased.  At the end of the 7 weeks, the 
SED fasting blood glucose was 111 ± 6.4 mg/dL, and in the EX mice it was 94.8 ± 4.61 
mg/dL (p = 0.05; Fig. 2B). In the LAC mice, blood glucose levels rose over the course of 
the study.  At the end of the 2 week injection period, the LAC mouse mean fasting blood 
glucose level rose from  91.25 ± 3.15 mg/dL to 110.31 ± 4.82 (p < 0.05; Fig. 2B).   
Fasting plasma insulin levels were higher in the EX group at the end of the 7-
week training period than they were in the SED group.  The final plasma insulin level in 
the SED group was 0.33 ± 0.06 ng/mL, and in the EX group it was 0.68 ± 0.11 ng/mL (p 
< 0.05; Fig. 2C).  At the end of the 2-week injection period, fasting plasma insulin levels 
were lower in the LAC group than they were in the VEH group. The final plasma insulin 
level in the LAC group was 0.24 ± 0.03 ng/mL, and in the VEH group it was 0.37 ± 0.05 
ng/mL (p < 0.05; Fig. 2C). The HOMA-IR calculation, interestingly, at face value 
suggested that 7 weeks of intensive exercise training actually decreased insulin sensitivity.  
In the SED mice the HOMA-IR value was 2.25 ± 0.34, and in the EX mice it was 3.94 ± 
0.64 (p < 0.05; Fig. 2D). HOMA-IR values trended lower in the LAC group when 
compared to those in the VEH group (1.61 ± 0.22 in the LAC group, 2.2 ± 0.27 in the 
VEH group), but this difference was not significant (p = 0.1; Fig. 2D). 
  
Effect of treadmill training and lactate injections on liver bioenergetics-related gene 
expression and mtDNA levels  
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Exercise and lactate injection enhanced the liver gluconeogenesis infrastructure.  
PCK1 expression was ~30% more in the EX group than it was in the SED group (p < 
0.05).  In the LAC versus VEH group comparison, PCK1 expression trended higher in 
the LAC group but this inter-group difference was not significant (p = 0.07) (Fig 3).  
PDK4 expression was ~120% higher in the EX group than it was in the SED group (p < 
0.05), and ~50% higher in the LAC group than it was in the VEH group (p < 0.05) (Fig. 
3).  
The co-transcriptional activator PGC-1α also influences hepatic gluconeogenesis 
(Herzig et al., 2001).  Relative to their respective control groups, PGC-1α mRNA levels 
were increased ~150% in EX mouse livers (p < 0.001), and ~75% in LAC mouse livers 
(p < 0.001) (Fig. 4).  Exercise and lactate, though, had the opposite effect on PGC-1β, 
another member of the PGC-1 co-transcription factor family.  Liver PGC-1β mRNA 
expression decreased by ~35% in the EX mice (p < 0.05), and by ~50% in the LAC mice 
(p < 0.001) (Fig. 4). mRNA levels of PRC, a third member of the PGC-1 family 
(Scarpulla, 2008b), were comparable between the EX and SED groups as well as between 
the LAC and VEH groups (Fig. 4). 
Both PGC-1α and PGC-1β mediate some co-transcriptional effects through the 
NRF-1 transcription factor (Lin et al., 2002a; Lin et al., 2003).  Liver NRF-1 mRNA 
levels were ~15% lower in EX mice than they were in SED mice (p < 0.05), and ~15% 
lower in LAC mice than they were in VEH mice (p < 0.05) (Fig. 4). TFAM mRNA levels 
were ~20% lower in EX mouse livers than they were in SED mouse livers (p < 0.001), 
but liver TFAM expression was equivalent between the LAC and VEH groups (Fig. 4).   
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mtDNA levels were assessed by determining mtDNA to nDNA copy number 
ratios. Liver 16S rRNA/18S rRNA and ND2/18S rRNA ratios were comparable between 
the EX and SED groups (Fig. 5). For the VEH and LAC groups, no differences in either 
the 16S rRNA/18S rRNA or ND2/18S rRNA ratios were observed, although the 
ND2/18S rRNA ratio arguably trended lower in the LAC group (p = 0.08, Fig. 5). 
Effect of treadmill training and lactate injections on brain bioenergetics-related 
gene expression and mtDNA levels 
We did not find significant inter-group differences in brain PGC-1α, PGC-1β, 
NRF-1, or TFAM mRNA levels.  We saw an equivalent expression of these genes 
between the SED and EX groups, and between the LAC and VEH groups.  Expression 
levels of PRC, though, increased by ~25% in the EX mouse brains compared to the SED 
mouse brains (p < 0.05), and by ~30% in the LAC mouse brains compared to the VEH 
mouse brains (p < 0.05) (Fig. 6).  As brain is not typically considered to be a 
gluconeogenic organ, we did not assess PCK1 and PDK4 expression.  
The brain 16S rRNA/18S rRNA ratio was ~20% higher in the EX mice than it 
was in the SED mice (p < 0.05), and the ND2/18S rRNA ratio was ~15% higher in the 
EX mice than it was in the SED mice (p < 0.05) (Fig. 7).  Brain mtDNA levels between 
the VEH and LAC groups were comparable.   
 We assessed the effects of supra-lactate threshold exercise and exogenous lactate 
treatment on the brain’s expression of TNF-α, an inflammation mediator, and VEGF-A, 
an angiogenenic/neurogenic growth factor (Jin et al., 2002).  Brain TNF-α mRNA levels 
were ~30% lower in EX mouse brains than they were in SED mouse brains (p < 0.05), 
but were comparable between VEH and LAC brains (Fig. 8). VEGF-A expression was 
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~20% higher in EX brains than it was in SED brains (p < 0.05), and ~15% higher in LAC 
brains than it was in VEH brains (p < 0.05) (Fig. 8).   Despite this VEGF increase, 
mRNA and protein levels of HIF-1α, a protein that activates VEGF transcription (Pugh & 
Ratcliffe, 2003), were equivalent between the EX and SED brains and between the LAC 
and VEH brains (data not shown). 
We examined the relationship between brain VEGF-A and PRC mRNA levels. 
When data were combined from all 4 groups, a strong positive correlation between 
VEGF-A and PRC mRNA levels was observed (r = 0.665, p < 0.001) (Fig. 9). 
 
 
Discussion 
Our current study shows supra-lactate threshold exercise and lactate itself in some 
ways similarly alter brain and liver bioenergetic infrastructures.  Overlapping changes 
involve the expression of genes that monitor, respond to, and modify cell bioenergetic 
states.  Our data suggest that in the liver, exercise-generated lactate enhances 
gluconeogenic infrastructure while reducing expression levels of some proteins that 
maintain respiration-associated infrastructures.  In the brain, exercise-generated lactate 
enhances PRC and VEGF expression and does not down-regulate respiration-related 
infrastructures.  In general, in the liver and brain, lactate itself to some extent functions as 
an exercise mimetic.  These findings have clinical and clinical trial-design implications.  
In this study hepatic gluconeogenesis data come from mice exercised above the 
lactate threshold.  Our current findings are consistent with a previous study in which mice 
exercised below the lactate threshold (E et al., 2013a).  The liver plays a central role in 
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the Cori Cycle, in which exercise-generated lactate is removed from the blood and used 
to generate glucose. It is not surprising, then, that the expression of two gluconeogenic 
genes, PCK1 and PDK4, increased in the livers of EX and LAC mice and that mRNA 
levels of PGC-1α, which promotes hepatic gluconeogenic gene expression (Herzig et al., 
2001), also increased.   
PGC-1α is the most studied PGC-1 family member; the effects of exercise on 
PGC-1β and PRC are not well known.   In general, PGC-1β drives gluconeogenic gene 
expression less robustly than PGC-1α, but is a stronger activator of NRF-1 and inducer of 
respiration-relevant gene expression (Lin et al., 2002a; Lin et al., 2003).  PGC-1β, 
therefore, likely supports cell respiration to a greater extent than PGC-1α.   
The liver, of course, helps avoid hypoglycemia.  To counter hypoglycemia under 
conditions of increased glucose utilization, a state that exercise may induce, the liver 
imports lactate from the blood, converts it to glucose, and releases glucose into the blood. 
An increase in hepatic respiration could theoretically compete with this role.  Avoiding 
this competition could perhaps explain why exercise associates with increased liver PGC-
1α expression but decreased PGC-1β expression.  
We also explored the ability of exercise and lactate to modify the expression of 
bioenergetics-associated genes in the brain.  Lactate certainly appears to play a critical 
role in brain energy metabolism (van Hall et al., 2009; Boumezbeur et al., 2010; Wyss et 
al., 2011), and while most brain lactate is regionally generated by astrocytes in response 
to local metabolic activity, externally generated lactate accesses the brain via MCTs 
(Pierre & Pellerin, 2005).  In this study, we found supra-lactate threshold exercise and 
intraperitoneal lactate injections both increase brain VEGF-A mRNA expression.  This 
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suggests exercise-generated lactate could at least partly mediate exercise’s ability to 
increase brain VEGF-A mRNA levels.  VEGF-A expression is also elevated within tumor 
cells, which frequently overproduce lactate (Siemeister et al., 1998; Walenta & Mueller-
Klieser, 2004).  The possibility that tumor-generated lactate might contribute to increased 
tumor VEGF-A expression seems worth considering. 
VEGF is believed to play a critical role in exercise-induced neurogenesis (Fabel et 
al., 2003a; Tang et al., 2010; Latimer et al., 2011).  In general, this signal protein binds 
specific cell membrane tyrosine kinase receptors (VEGFRs), and this binding stimulates 
angiogenesis (Cross et al., 2003). Exercise induces VEGF expression in mouse and rat 
brains, where it drives dentate gyrus, cerebellum, and hippocampus angiogenesis (Black 
et al., 1990; Fabel et al., 2003a; Pereira et al., 2007). Angiogenesis in general is activated 
by hypoxia, which initiates HIF-1α nuclear translocation, and HIF-1 complex formation 
activates VEGF transcription (Pugh & Ratcliffe, 2003). While one study found intense 
exercise reduced brain mitochondrial O2 (Secher et al., 2008), because HIF-1α mRNA 
and protein levels did not change we cannot implicate hypoxia as the cause of our 
observed brain VEGF increase.  
PGC-1α, interestingly, increases VEGF expression via estrogen-related receptor 
alpha (ERR-α) co-activation (Arany et al., 2008).  While PGC-1α expression was not 
increased in either EX or LAC mouse brains, we did not assess PGC-1α protein levels or 
activation states. We therefore cannot conclude PGC-1α did not mediate VEGF 
expression.   
 mRNA levels of PRC, another PGC-1 family member, increased in both EX and 
LAC mouse brains. PRC also interacts with ERR-α to induce mitochondrion-related gene 
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transcription, and in general supports mitochondrial ATP production (Vercauteren et al., 
2009; Mirebeau-Prunier et al., 2010).  Although it is not currently known whether PRC 
specifically stimulates VEGF expression, we observed a positive correlation between 
mouse brain PRC and VEGF-A mRNA expression.  This correlation suggests PRC may 
play a role in mediating exercise and lactate-associated VEGF expression changes.  
Unlike hepatocytes, which use lactate to support gluconeogenesis, neurons mostly 
use lactate to support respiration (Pellerin & Magistretti, 1994; Erlichman et al., 2008; 
Gallagher et al., 2009; Wyss et al., 2011).  While down-regulating respiration 
infrastructure in the liver may have physiologic advantages, it is difficult to envision 
situations in which down-regulating respiration infrastructure would benefit the brain. 
Perhaps for this reason brain PGC-1β, NRF-1, and TFAM expression did not decline with 
either supra-lactate threshold exercise or the administration of exogenous lactate.   
Our EX mice failed to increase brain PGC-1α mRNA expression, although 
Steiner et al. previously reported exercise can increase brain PGC-1α expression (Steiner 
et al., 2011).  In that study, mice exercised on a treadmill 1 hour per day, at 25 m/min and 
a 5% incline, for 8 weeks.  Differences between our exercise protocol and that of Steiner 
et al. may account for this inter-study discrepancy.  Our lactate injection data, though, 
suggest exercise-generated lactate did not drive the brain PGC-1α mRNA increase 
observed by Steiner et al.   
Similarly, we could not prove that lactate mediates an exercise-associated 
increase in brain mtDNA. While mtDNA content was higher in EX mice than it was in 
SED mice, mtDNA levels between LAC and VEH mice were equivalent.  Although our 
study joins several others that also found exercise increases brain mtDNA copy number 
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(Bayod et al., 2011; Steiner et al., 2011; Marosi et al., 2012; Zhang et al., 2012b; Zhang 
et al., 2012c), what causes this phenomenon remains unclear.  In addition to arguing that 
lactate is not solely responsible, our data further suggest PGC-1α expression changes are 
not a prerequisite.   
As we found in a study of mice exercised below the lactate accumulation 
threshold (E et al., 2013a), mice exercised above the lactate accumulation threshold have 
lower brain TNF-α expression.  LAC mice did not show reduced brain TNF-α mRNA, 
which suggests lactate does not account for this change.  The exercise-related mechanism 
that drives reduced brain TNF-α expression remains unknown.  
In this study, exercise training profoundly enhanced lactate thresholds and 
exceeding this threshold was not, from an exercise protocol perspective, straightforward. 
This suggests that over the long term, exercising human subjects with chronic illnesses 
above the lactate threshold will be impractical.  If it turns out that intensive exercise 
benefits the brain more than mild or moderate exercise, exercise mimetics will likely be 
needed.   
It is worth considering whether lactate itself could serve as a clinically useful 
exercise mimetic. Over the two-week lactate treatment period mild weight loss occurred; 
it is unclear whether this reflects an adverse or exercise mimetic-like effect.  Lactate, it is 
reported, may stimulate beta cell insulin secretion, suppress glycolysis, and cause insulin 
resistance (Meats et al., 1989; Choi et al., 2002). Although lactate treatment in our study 
increased blood glucose measurements, plasma insulin levels decreased and HOMA-IR 
values certainly did not rise.   
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In contrast to our lactate treatment HOMA-IR data, even though exercise is 
known to reduce insulin resistance our EX mice had elevated HOMA-IR values.  This 
was driven by increased fasting insulin levels. Other investigators report that in mice 
exercise training increases islet insulin secretion (Huang et al., 2011), although the 
underlying basis of this phenomenon is unclear.  Also, the HOMA-IR value primarily 
provides an estimate of liver insulin resistance (Bonora et al., 2000).  For this reason and 
others we do not believe exercise truly increased overall insulin resistance in our EX 
mouse group.     
For our two experimental groups, the exercised mice and the lactate-injected mice, 
we did not attempt to exactly match the pharmacokinetic parameters of brain and liver 
lactate exposure.  Maximum levels and daily exposure durations were almost certainly 
different between these groups, and the number of days of increased lactate exposure 
definitely differed.  This was partly a consequence of feasibility limitations, since 
accomplishing this would have required us to repeatedly sample mouse plasma lactate 
levels while the mice were running on the treadmill.  Our goal, though, was simply to test 
whether administering lactate itself induces some of the same bioenergetic infrastructure 
and bioenergetic-related changes that exercise induces.  Our data argue it does. 
We did not specifically test whether lactate affects liver and brain bioenergetic 
pathway flux dynamics in different or similar ways, although our molecular-based data 
predict differences should outweigh similarities.  Unlike the liver, the brain is not 
considered a gluconeogenic organ. Neurons do not express glucose-6-phosphatase, the 
enzyme that mediates the final step of gluconeogenesis (Bell et al., 1993; Lehninger et al., 
2005). Although astrocytes do express glucose-6-phosphatase, astrocytes 
75 
 
dephosphorylate glucose at much lower rates than they phosphorylate glucose. This 
contrasts with liver-derived observations (Bhattacharya & Datta, 1993; Gotoh et al., 
2000; Ghosh et al., 2005).  Further, astrocytes express the MCT4 monocarboxylate 
transporter isoform, which favors lactate export over import, while neurons express 
MCT2 transporters that favor lactate import (Pierre & Pellerin, 2005) . Overall, 
bioenergetic cross-talk between neurons and astrocytes seems designed to favor lactate 
production by astrocytes and lactate consumption by neurons.  For these reasons, we 
suspect that while liver lactate exposure increases liver gluconeogenesis, increasing brain 
lactate levels should cause no or little increase in brain gluconeogenesis. This prediction, 
though, remains experimentally unconfirmed.  
In conclusion, our results are consistent with the view that during exercise, 
muscle-generated lactate accounts for at least some exercise-associated brain and liver 
bioenergetic infrastructure and bioenergetic-associated adaptations.  These adaptations 
are tissue-specific, are defined by each tissue’s bioenergetic-related needs and obligations, 
and based on these needs and obligations are ultimately predictable.  Lactate enhances 
hepatic gluconeogenesis while probably limiting hepatocyte respiration. Although lactate 
probably does not account for all major exercise-related, bioenergetics-associated brain 
changes, it does appear that it is able to induce brain VEGF expression and through this 
may drive brain angiogenesis and neurogenesis. For this reason, exercise mimetics that 
reproduce lactate’s brain effects are worth developing for, and testing in, conditions with 
perturbed brain energy metabolism.   
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 Figure 1. Plasma lactate levels. (For figure legend, see next page). 
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Figure 1. Plasma lactate levels. A, Treadmill exercise at 18 m/min initially elevated 
plasma lactate levels, but over time the exercise intensity needed to boost plasma lactate 
concentrations increased. Measurements were performed immediately after the 
completion of an exercise session. *P < 0.05 relative to the lactate levels of the SED mice. 
B, In LAC mice, plasma lactate levels peaked approximately 15 minutes after an 
intraperitoneal injection, remained significantly elevated for at least 1 hour, and returned 
to baseline by 3 hours. *P < 0.05 relative to the lactate levels of the VEH mice. EX, 
exercise group; SED, sedentary group; VEH, vehicle group. 
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Figure 2. Effect of treadmill training and lactate injection on weight, fasting glucose, 
and fasting insulin. (For figure legend, see next page).   
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Figure 2. Effect of treadmill training and lactate injection on weight, fasting glucose, 
and fasting insulin. A, Over 7 weeks SED mice gained weight while EX mice did not.  
Over 2 weeks LAC mice lost ~4% of their starting body weight, while the VEH group 
maintained its weight. B, Over 7 weeks fasting blood glucose levels did not change in the 
EX mice but increased in the SED mice.  After 2 weeks LAC mouse blood glucose levels 
were higher than at the start of the experiment. C, at the end of the 7-week training period, 
fasting plasma insulin levels were higher in the EX group than in the SED group; at the 
end of the 2-week injection period, fasting plasma insulin levels were lower in the LAC 
group than in the VEH group. D, The HOMA-IR value increased in the EX group.  It was 
not significantly altered by lactate injection. *P < 0.05, **p < 0.001. EX, exercise group; 
HOMA-IR, homeostasis model assessment of insulin resistance; LAC, lactate group; 
SED, sedentary group; VEH, vehicle group. 
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Figure 3. Effect of treadmill training and lactate injection on liver gluconeogenesis. 
Compared to the SED mice, PCK1 and PDK4 mRNA levels were higher in the EX 
mouse livers.  Compared to the VEH mice, PCK1 expression trended higher in the LAC 
group livers, while PDK4 expression increased in the LAC group livers. *P < 0.05. EX, 
exercise group; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; LAC, lactate 
group; PCK1, phosphoenolpyruvate carboxykinase 1; PDK4, pyruvate dehydrogenase 
kinase 4; SED, sedentary group; VEH, vehicle group. 
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Figure 4. Effect of treadmill training and lactate injection on genes that regulate 
liver mitochondrial biogenesis. Relative to their respective control groups, EX and LAC 
group PGC-1α mRNA levels increased whereas PGC-1β mRNA levels decreased. PRC 
mRNA levels remained comparable. NRF-1 mRNA levels were lower in EX and LAC 
group livers. TFAM mRNA levels were lower in the EX group than they were in the SED 
group, and comparable between the LAC and VEH groups.  *P < 0.05, **p < 0.001. EX, 
exercise group; LAC, lactate group; NRF-1, nuclear respiratory factor 1; PGC-1, 
peroxisomal proliferator-activated receptor-gamma coactivator 1; PRC, PGC-1 related 
co-activator; SED, sedentary group; TFAM, mitochondrial transcription factor A; VEH, 
vehicle group. 
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Figure 5. Effect of treadmill training and lactate injection on liver mtDNA copy 
number. In liver, 16S rRNA/18S rRNA and ND2/18S rRNA ratios were comparable 
between the EX and SED groups. The 16S rRNA/18S rRNA ratio was comparable 
between the VEH and LAC groups.  Compared to the VEH group, the LAC group 
ND2/18S rRNA ratio trended lower but these values were not statistically different. EX, 
exercise group; LAC, lactate group; mtDNA, mitochondrial DNA; ND2, NADH 
dehydrogenase subunit 2; nDNA, nuclear DNA; rRNA, ribosomal RNA; SED, sedentary 
group; VEH, vehicle group. 
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Figure 6. Effect of treadmill training and lactate injection on genes that regulate 
brain mitochondrial biogenesis. Compared to their respective control groups, brain 
PRC expression increased in the EX and LAC groups.  Exercise and lactate injection did 
not alter brain PGC-1α, PGC-1β, NRF-1, or TFAM mRNA levels. *P < 0.05. EX, 
exercise group; LAC, lactate group; NRF-1, nuclear respiratory factor 1; PGC-1, 
peroxisomal proliferator-activated receptor-gamma coactivator 1; PRC, PGC-1 related 
co-activator; SED, sedentary group; TFAM, mitochondrial transcription factor A; VEH, 
vehicle group. 
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Figure 7. Effect of treadmill training and lactate injection on brain mtDNA copy 
number. 16S rRNA/18S rRNA and ND2/18S rRNA ratios were higher in EX brains than 
they were in SED brains. VEH and LAC brain mtDNA levels were comparable. *P < 
0.05. EX, exercise group; LAC, lactate group; mtDNA, mitochondrial DNA; ND2, 
NADH dehydrogenase subunit 2; nDNA, nuclear DNA; rRNA, ribosomal RNA; SED, 
sedentary group; VEH, vehicle group. 
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Figure 8. Effect of treadmill training and lactate injection on brain TNF-α and 
VEGF-A expression.  TNF-α mRNA levels were lower in EX brains than they were in 
SED brains, but were comparable between VEH and LAC brains. Brain VEGF-A 
expression was higher in EX brains than it was in SED brains, and was higher in LAC 
brains than it was in VEH brains. *P < 0.05. EX, exercise group; LAC, lactate group; 
SED, sedentary group; TNF-α, tumor necrosis factor alpha; VEGF-A, vascular 
endothelial growth factor A; VEH, vehicle group. 
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Figure 9. Relationship between brain VEGF-A and PRC mRNA levels. When data 
from all 4 groups were combined, a positive correlation between brain VEGF-A and PRC 
mRNA levels was observed. EX, exercise group; LAC, lactate group; PRC, peroxisomal 
proliferator-activated receptor-gamma co-activator 1 related co-activator; SED, sedentary 
group; VEGF-A, vascular endothelial growth factor A; VEH, vehicle group. 
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Chapter IV 
 
Supra-lactate Threshold Exercise Training Induces Brain 
Mitochondrial Biogenesis in Aged Mice: Is there a Connection between 
Brain Mitochondrial Bioenergetics, Inflammation, and Neurogenesis? 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Manuscript in preparation) 
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Abstract 
Intensive exercise training increases brain mitochondrial bioenergetics in young adult 
mice, while few studies have examined its effects on aging models. In this study, 19-
month old C57BL/6 mice were subjected to supra-lactate threshold intensive treadmill 
training for 8 weeks. We primarily aimed to test whether the training induces brain 
mitochondrial biogenesis in aged mice. Meanwhile, we assessed the expression of 
neurogenesis-related factors, and central/systemic inflammatory factors to better 
understand the networking between exercise-induced benefits on brain. We found that 
our exercise training significantly increased brain peroxisomal proliferator-activated 
receptor-gamma co-activator 1 alpha (PGC-1α), citrate synthase (CS), and mitochondrial 
DNA (mtDNA) content, suggesting mitochondrial biogenesis was induced. This was 
accompanied by a slight increase in brain vascular endothelial growth factor A (VEGF-A) 
expression, and a strong positive correlation between brain PGC-1 related co-activator 
(PRC) and VEGF-A expression. Expression of doublecortin (DCX), brain-derived 
neurotrophic factor (BDNF), tumor necrosis factor alpha (TNF-α), and C-C motif 
chemokine 11 (CCL11) in the brain was not altered by exercise training. No clear 
associations were detected between mtDNA content and neurogenesis-related factors or 
central/systemic inflammatory factors. Plasma CCL11 negatively correlated with brain 
DCX expression, supporting the view that systemic inflammation has a strong 
suppressive effects on neurogenesis, while our intensive exercise training protocol did not 
alter plasma CCL11 levels in aged mice. Considering these and our previously published 
findings, we conclude that supra-lactate threshold exercise training induces brain 
mitochondrial biogenesis in both young and aged mice. Future mechanistic study will be 
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needed to unravel the relationships between brain mitochondrial biogenesis, neurogenesis, 
and inflammation with exercise training. 
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Introduction 
 Endurance exercise training enhances mitochondrial biogenesis, and improves 
bioenergetic metabolism and insulin resistance in muscle. This has been well established 
in young, aging, healthy, and diseased models (Lira et al., 2010). How exercise training 
influences brain mitochondrial function and bioenergetics is relatively understudied. 
 A few studies have reported that long-term intensive exercise training induces 
brain mitochondrial biogenesis in healthy young adult rodents (Steiner et al., 2011; E et 
al., 2013b). Prolonged exercise training seems able to partially prevent aging-associated 
decline in the activities of brain mitochondrial electron transport chain (ETC) enzymes 
(Boveris & Navarro, 2008), while little is known regarding whether and how exercise 
training modulates brain mitochondrial biogenesis and bioenergetic metabolism in aged 
mice.  
 Considerable evidence has shown that exercise training induces neurogenesis in 
both young and aged mice (Fabel et al., 2003a; van Praag et al., 2005). Similar findings 
are also reported with older human subjects that long-term exercise increases brain 
volume, especially the hippocampus volume (Colcombe et al., 2006; Erickson et al., 
2011). The mechanisms of exercise inducing neurogenesis are not clearly understood. 
The involvement of neurotrophic factors, specifically brain derived neurotrophic factor 
(BDNF), has been suggested (Rothman et al., 2012), yet it is unknown what is mediating 
the exercise-induced increase of BDNF in the brain.   
 A recently published study has reported that increased plasma level of a member 
of C-C motif chemokine ligands (CCL), CCL11, has a strong suppressive effect on 
neurogenesis in mouse hippocampus, and the plasma level of this chemokine increases 
with age in both rodents and humans (Villeda et al., 2011). Besides systemic 
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inflammation, local inflammatory response in the brain induced by microglia activation 
has also been shown detrimental for neurogenesis in adult brain (Ekdahl et al., 2003). 
Mitochondria are one of the primary targets of inflammatory injury. Cytokines, such as 
TNF-α, have been shown to damage mitochondria through suppression of enzymes on 
mitochondrial ETC (Stadler et al., 1992; Samavati et al., 2008). Conversely, 
mitochondria-generated reactive oxygen species themselves also contribute to 
inflammatory response (Mukhopadhyay et al., 2012), which may result in a vicious cycle 
between mitochondrial dysfunction and increased inflammation. 
 The relationships between brain mitochondrial function, inflammation, and 
neurogenesis under the condition of exercise training remain unknown. We wonder 
whether there is a role for exercise-mediated mitochondrial protection as a partial 
mechanism for the increase of neurogenesis associated with decreased inflammation. 
 The primary purpose of this study was to evaluate the effects of supra-lactate 
threshold intensive exercise training on brain mitochondrial biogenesis in aged mice. In 
addition, we tested the expression of neurogenesis-related factors, and systemic/brain 
levels of inflammatory cytokine/chemokine in these exercise trained and untrained aged 
mice. The relations between mitochondrial bioenergetics, inflammation, and 
neurogenesis were analyzed to better understand the connections between exercise-
induced benefits on brain. 
 
 
Methods 
Animals 
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The animal work described in this study was approved by the Institutional Animal 
Care and Use Committee of the University of Kansas Medical Center. Whenever possible, 
efforts were made to minimize animal discomfort. Twenty-four C57BL/6 male mice were 
included in these studies. Our mice were obtained from the National Institute of Aging, 
and were 18 months old when they reached our vivarium.  All mice were maintained on 
an ad libitum diet, and were housed 2 per cage on a 12:12 hour light: dark schedule. After 
a one-month accommodation period, the mice were randomly placed into two groups, a 
control group (CT, n = 12), and an exercise group (EX, n = 12).  
 
Exercise training 
EX mice were exercised for 8 weeks, 5 days per week, 2 sessions per day, on a 
six-lane treadmill designed for mice (Columbus Instruments, Columbus, OH). The back 
of each treadmill lane contained an electrified grid, which delivered a shock stimulus (0.2 
mA, 200 ms pulses, 1 Hz) to the mice who refused to run. The treadmill was set at 5° 
incline. 
The EX mice were subjected to an incremental exercise training protocol in order 
to ensure that exercise intensity exceeded the lactate threshold. For the first week each 
session consisted of a 10 minute warm-up at 15 m/min followed by 30 minutes at 18 
m/min. This speed approximates the lactate threshold for untrained C57BL/6 mice (Billat 
et al., 2005). During the following 7 weeks, treadmill speed was progressively increased 
every week, based on the blood lactate levels measured immediately after a running 
session. Specifically, for weeks 2, 3, 4, 5, 6, 7, and 8, the treadmill speed was set to 21 
m/min, 22 m/min, 23 m/min, 24 m/min, 25 m/min, 25 m/min, and 26 m/min, respectively. 
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Starting from the second week, warm-up was reduced to 5 min at 15 m/min, and the 
duration of each running session was adjusted every week in order to keep the same 
workload (running distance) everyday throughout the study. For example, the workload 
for each session during the first week was 10 min x 15 m/min + 30 min x 18 m/min = 690 
m. During the sixth week, running time at 25 m/min was calculated as [690 m – (5 min x 
15 m/min)] ÷ 25 m/min = ~25 min. 
The CT mice did not receive any exercise training. To minimize potential 
confounding factors such as differences in sound and light exposure, during the EX mice 
training sessions CT mice were placed in the same room as the EX mice.  
At the conclusion of the 8-week training period, EX mice were sacrificed by 
decapitation one hour after the last session, and CT mice were also decapitated at 
approximately the same time on the same day. Brain tissue were immediately harvested 
and frozen in liquid nitrogen, and saved at -80°C for subsequent analysis. 
 
Lactate, glucose, and insulin level determination  
Blood lactate levels were measured using a Lactate Scout Analyzer (Senslab, 
Leipzig, Germany). Blood glucose levels were measured using a One-Touch Ultra Blood 
Glucose Monitoring System (LifeScan, Milpitas, CA). Plasma samples were also 
prepared from tail vein blood that was collected in heparinized micro-hematocrit 
capillary tubes (Fisher Scientific, Pittsburgh, PA). Plasma insulin levels were measured 
using an insulin enzyme-linked immunosorbent assay (ELISA) kit according to the 
manufacturer’s instructions (American Laboratory Products Company, Salem, NH). 
Blood glucose levels were measured during a period of unrestricted food access (non-
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fasting) and after a 17 hour fast (fasting), and plasma insulin levels were measured after a 
17 hour fast. Values for the homeostasis model assessment of insulin resistance (HOMA-
IR) were calculated as the product of fasting blood glucose level (mM) and plasma 
insulin level (microunits/ml) divided by 22.5 (Matthews et al., 1985).  
 
Quantitative real-time, reverse-transcription PCR 
Total RNA was prepared from hippocampus of left hemisphere preserved in 
RNAlater® Solution (Life Technologies), using the TRI Reagent (Life Technologies). 
Reverse transcription was performed on total RNA (1 μg) using an iScriptTM Reverse 
Transcription Supermix for RT-qPCR (Bio-Rad Laboratories, Hercules, CA). 
Quantitative real-time, reverse-transcription PCR (qPCR) was performed using TaqMan 
Universal PCR Master Mix (Applied Biosystems, Foster City, CA) and ready-to-use 
TaqMan Gene Expression Assays (Applied Biosystems) to quantify the mRNA levels of 
peroxisome proliferator-activated receptor gamma coactivator 1 alpha (PGC-1α), PGC-1β, 
PGC-1 related co-activator (PRC), nuclear respiratory factor 1 (NRF-1), NRF-2, 
mitochondrial transcription factor A (TFAM), cytochrome c oxidase subunit 2 (COX2), 
COX4, citrate synthase (CS), doublecortin (DCX), vascular endothelial growth factor A 
(VEGF-A), brain-derived neurotrophic factor (BDNF), TNF-α, and CCL11. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as a house keeping gene. 
qPCR amplifications were performed using an Applied Biosystems StepOnePlus Real-
Time PCR System (Applied Biosystems). Relative mRNA levels were quantified using 
the StepOnePlus Software v2.1 based on the comparative ∆∆CT method. 
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MtDNA copy number determination 
To quantify mtDNA, total DNA was extracted from cortex of left hemisphere 
using a phenol-chloroform based method as previously described (Guo et al., 2009). 
DNA concentration and purity were determined spectrophotometrically by determining 
the absorbance at 260 nm and the 260 nm/280 nm ratio. Each real-time PCR reaction was 
performed using 10 ng of DNA as the template. We used TaqMan Gene Expression 
Assays (Applied Biosystems) to quantify the amounts of three target genes present on 
mtDNA, NADH dehydrogenase subunit 1 (ND1), cytochrome c oxidase subunit 2 
(COX2) and ATP synthase F0 subunit 6 (ATP6), as well as the amount of a nuclear target 
gene, the 18S rRNA. The relative mtDNA to nuclear DNA copy number ratio was 
determined using the comparative ∆∆CT method, in which ND1:18S rRNA, COX2:18S 
rRNA, and ATP6:18S rRNA ratios were calculated.  
 
Immunoblotting 
            Nuclear and cytoplasmic protein extracts from brain cortex of left hemisphere 
were prepared using NE-PER Nuclear and Cytoplasmic Extraction Reagents (Thermo 
Scientific, Rockford, IL) according to the manufacturer’s instructions. Protein 
concentrations were measured using a BCA protein assay reagent kit (Thermo Scientific). 
10 μg of nuclear protein extracts or 40 μg of cytoplasmic protein extracts was loaded per 
lane, and subjected to electrophoresis on a 4-15 % Criterion TM TGX TM Precast Gel 
(Bio-Rad Laboratories). The proteins were then transferred to a nitrocellulose membrane 
using iBlot TM (Invitrogen, Carlsbad, CA). The membrane was blocked with phosphate 
buffered saline (PBS) containing 0.1 % Tween-20 and 5 % non-fat dry milk (Bio-Rad 
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Laboratories) for 1 hour at room temperature, and subsequently incubated with the 
primary antibody (diluted in the blocking solution) overnight at 4 °C. The membrane was 
then rinsed in PBS with 0.1 % Tween and incubated with the horseradish peroxidase-
conjugated secondary antibody (anti-rabbit IgG # 7074 or anti-mouse IgG # 7076; 1:2000 
dilution; Cell Signaling Technology, Beverly, MA) for 1 hour at room temperature. After 
rinsing the membrane with PBS with 0.1 % Tween, the protein bands were detected with 
a SuperSignal West Femto Maximum Sensitivity Substrate (Thermo Scientific). In order 
to quantify protein band intensity, densitometry was performed using a ChemiDoc XRS 
with Quantity One software (Bio-Rad).  
 Several proteins of bioenergetic pathways were analyzed.  Primary antibodies 
purchased from Cell Signaling Technology included antibodies to Akt (1:1000 dilution; 
#5373), phospho-Ser473 Akt (1:1000 dilution; #4060), glycogen synthase kinase 3 beta 
(GSK3β) (1:1000 dilution; #9315), phospho-Ser9 GSK3β (1:1000 dilution; #9322), 
mammalian target of rapamycin (mTOR) (1:1000 dilution; #2983), phospho-Ser2448 
mTOR (1:1000 dilution; #2976), TFAM (1:500 dilution; #7495), forkhead box protein 
O1 (FOXO1) (1:500 dilution; #2880), forkhead box O3a (FOXO3a) (1:500 dilution; 
#2497) , and GAPDH (1:2000 dilution; #2118). Primary antibodies purchased from 
Abcam (Cambridge, MA) included antibodies to PGC-1β (1:500 dilution; #ab61249), and 
citrate synthase (1:500 dilution; #ab96600). Antibody to NRF1 (1:200 dilution; #sc-
33771) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA). Antibodies to 
PGC-1α (1:1000 dilution; #PA5-22958) and histone deacetylase 1 (HDAC1) (1:1000 
dilution; #PA1-860) were purchased from Thermo Scientific. An antibody to COX4 (1: 
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2000 dilution; #A21348) was purchased from Life Technologies. GAPDH and HDAC1 
were used as internal loading controls for cytoplasmic and nuclear fractions, respectively.  
 
Plasma CCL11 levels 
 Non-fasting plasma samples were used to evaluate plasma CCL11 levels with a 
commercially available Mouse CCL11/Eotaxin Quantikine ELISA Kit (R&D Systems, 
Minneapolis, MN) according to the manufacturer’s instruction. Plasma CCL11 levels 
were measured in both CT and EX groups at baseline and at the end of 8-week study. 
 
Statistical analysis 
 Data were summarized by means and standard errors. Mean values were 
compared by independent samples t-tests or paired t-tests using SPSS 18.0 (SPSS Inc., 
Chicago, IL, USA). Pearson’s correlation analysis was used to test inter-parameter 
relationships. p-values less than 0.05 were considered statistically significant. 
 
 
Results 
Effects of treadmill training on blood lactate levels 
 In order to ensure that mice were running above the lactate threshold, blood 
lactate levels in EX group were measured every week immediately after a running 
session, and the treadmill speed was increased based on the measured levels. As shown in 
Fig. 1, blood lactate levels in CT group at rest were measured at week 1, 5, and 6, and the 
mean values ranged from 2.1 ~ 2.7 mM. Post-running blood lactate levels in EX group 
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ranged from 3.8 ~7.7 mM, and were always significantly higher than the resting levels in 
CT group.  
Effects of treadmill training on body weight, glucose and insulin 
 At the beginning of the study, body weights were comparable between CT and 
EX groups. After 8 weeks, the weights in EX group were ~5 % lower than they were in 
CT group (p < 0.05, Fig. 2A). Paired t test analysis also showed EX mice lost ~2 % of 
their starting body weight (p < 0.05, Fig. 2A), while CT group maintained its weight. 
 Non-fasting blood glucose levels were comparable between CT and EX groups at 
the beginning of the study, and after 8 weeks they trended lower in EX group compared 
with the levels in CT group, or compared with its own levels at baseline, but the 
differences were not significant (Fig. 2B). No inter- or intra-group differences were 
detected in 17-hour fasting blood glucose levels as well as 17-hour fasting plasma insulin 
levels (Fig. 2C-D). HOMA-IR values in CT group were trending higher after sedentary 8 
weeks when compared with the values at baseline, but the difference was not statistically 
significant (Fig. 2E). 8-week treadmill training did not alter HOMA-IR values.  
Effects of treadmill training on brain mitochondrial biogenesis 
 The PGC-1 family, a group of transcriptional co-activators, plays a central role in 
a regulatory network governing the transcriptional control of mitochondrial biogenesis 
and respiratory function (Scarpulla, 2011). Three members have been identified: PGC-1α, 
PGC-1β and PRC. These co-activators target NRF-1 and NRF-2 which in turn regulate 
the transcriptional activity of TFAM (Scarpulla, 2008b; Vina et al., 2009), and TFAM 
initiates the replication and transcription of mitochondrial DNA (mtDNA).  
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 Our results showed that mRNA levels of PGC-1α, PGC-1β, PRC, NRF1, and 
NRF2 were all comparable between CT and EX brains (Fig. 3A). TFAM mRNA 
expression was decreased in EX group compared to CT group (~10 %, p < 0.05, Fig. 3A). 
mRNA levels of complex IV subunit 2 and 4 were comparable between groups (Fig. 3A). 
CS mRNA levels were ~30 % higher in EX brains when compared to CT brains (p < 0.05, 
Fig. 3A).  
 While brain PGC-1α mRNA levels were comparable between groups, nuclear 
PGC-1α protein levels were significantly higher in EX brains than they were in CT brains 
(~50 % increase, p < 0.05, Fig. 3B). No inter-group differences were detected in nuclear 
PGC-1β or NRF1 protein levels. TFAM protein levels were also comparable between 
groups. COX4 protein levels trended higher in EX brains but the inter-group difference 
did not reach statistical significance (~35 % increase, p = 0.27, Fig. 3B). Protein levels of 
CS was comparable between CT and EX brains (Fig. 3B), despite the significant increase 
in the mRNA levels.  
 To further quantify mitochondrial biogenesis in the brain, relative brain 
mitochondrial DNA (mtDNA) copy numbers were assessed by quantitative real-time 
PCR. The ratios of ATP6/18S rRNA, COX2/18S rRNA and ND1/18S rRNA were all 
significantly higher in EX brains than they were in CT brains (40~50 % increase, p < 
0.05, Fig. 3C). 
Effects of treadmill training on bioenergetic metabolism related proteins in brain 
 Expression or phosphorylation levels of several bioenergetics-related proteins 
were analyzed by immunoblotting (Fig. 4). Cytoplasmic Akt phosphorylation at Ser 473, 
after correction for total Akt protein levels, was comparable between CT and EX groups. 
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Despite the unchanged levels of Akt phosphorylation, one of its downstream substrates, 
cytoplasmic GSK3β phosphorylation at Ser 9, after correction for total GSK3β protein 
levels, trended higher in EX brains, but the difference was not significant (~20 % 
increase, p = 0.09, Fig. 4A). When corrected for total mTOR protein levels, cytoplasmic 
mTOR phosphorylation at Ser 2448 in EX brains trended higher compared to CT brains 
(~25 % increase, p = 0.1, Fig. 4A). When corrected for internal loading control GAPDH, 
compared to CT group, cytoplasmic mTOR phosphorylation at Ser 2448 was 
significantly increased in EX group (~70 % increase, p < 0.05, Fig. 4A), and total mTOR 
protein levels were also higher in EX group (~40 % increase, p < 0.05, Fig. 4A). We also 
assessed the subcellular localization of FOXO1 as well as FOXO3a. Ratio of FOXO1 
protein level in the nuclear fraction over cytoplasmic fraction trended lower in EX group 
when compared to CT group (~20 % decrease, p = 0.2, Fig. 4B). Ratio of FOXO3a 
protein level in the nuclear fraction over cytoplasmic fraction was significantly lower in 
EX brains than they were in CT brains (~20 % decrease, p < 0.05, Fig. 4C).  
Effects of treadmill training on neurogenesis related factors and their associations 
with brain mitochondrial biogenesis  
 mRNA levels of three neurogenesis related factors, DCX, VEGF-A, and BDNF 
were evaluated (Fig. 5A). DCX is a microtubule-associated protein expressed specifically 
in young, immature neurons in hippocampus, and quantification of DCX-expressing cells 
allows for an accurate measurement of adult neurogenesis (Couillard-Despres et al., 
2005). VEGF, an angiogenic factor, and BDNF, a neurotrophin, have both been 
implicated in exercise-induced neurogenesis in rodents. (Jin et al., 2002; Fabel et al., 
2003a; Rossi et al., 2006). In the present study, due to technical issue, evaluation of 
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DCX-expressing cells in dentate gyrus was not conducted. Alternatively, mRNA 
expression of DCX in the hippocampus was measured; it was comparable between CT 
and EX groups (Fig. 5A). We found an insignificant increase of VEGF-A mRNA 
expression in EX brains when compared to CT brains (~12 % increase, p = 0.09, Fig. 5A). 
No inter-group difference was observed in BDNF mRNA expression (Fig. 5A). 
 Next, we tested the relations between the expression of neurogenesis-related 
factors and mitochondrial biogenesis. When combining the data from CT and EX groups, 
there was a slight insignificant trend for a positive correlation between brain DCX 
mRNA levels and ATP6, COX2, or ND1 copy number, respectively (DCX & ATP6: r = 
0.22, p = 0.3; DCX & COX2: r = 0.18, p = 0.4; DCX & ND1: r = 0.23, p = 0.27; Fig. 5B-
D). When analyzed by group separately, in CT group, significant positive correlations 
were detected between brain DCX mRNA levels and mtDNA content (DCX & ATP6: r = 
0.694, p < 0.05; DCX & COX2: r = 0.648, p < 0.05; DCX & ND1: r = 0.635, p < 0.05; 
Fig. 5B-D). Interestingly, no correlations were observed between DCX mRNA levels and 
mtDNA content in EX group (Fig. 5B-D).  
 There was no significant correlations between brain VEGF-A mRNA levels and 
mtDNA copy numbers when combining the data from both CT and EX groups, or 
analyzed by group separately (Fig. 5E-G). However, a strong positive correlation was 
detected between brain VEGF-A mRNA expression and brain PRC mRNA expression 
when combining the data from CT and EX groups (r = 0.614, p < 0.05, Fig. 5H). When 
analyzed by group separately, the strong positive correlation remained in both groups 
(CT: r = 0.751, p < 0.05; EX: r = 0.873, p < 0.001; Fig. 5H). These results are consistent 
with what we previously reported in young adult mice (E et al., 2013a). 
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Effects of treadmill training on brain and systemic inflammatory factors and their 
associations with brain mitochondrial biogenesis 
 Exercise training has been shown to decrease brain TNF-α expression in young 
adult mice (E et al., 2013a). In the present study, we did no observe changes TNF- α 
expression in aged mice subjected to 8-week treadmill training (Fig. 6A). No inter-group 
difference was seen in brain CCL11 mRNA levels as well (Fig. 6A). 
 We also tested the relations between brain TNF-α mRNA levels and mtDNA copy 
numbers, but did not observe significant correlations (data not shown). Similarly, plasma 
CCL11 levels were not correlated with mtDNA copy numbers (data not shown). 
 As shown in Fig. 6B, plasma CCL11 levels were comparable between CT and EX 
groups at baseline, and also comparable at completion of 8-week study. In both CT and 
EX groups, significant increases in plasma CCL11 levels were observed after completion 
of 8-week study, when compared to their respective levels at baseline (CT: ~30% higher 
after 8 weeks compared to baseline, p < 0.001; EX: ~40% higher after 8 weeks compared 
to baseline, p < 0.05; Fig. 6B).  
 Although we did not observe inter-group difference in brain DCX mRNA levels 
or plasma CCL11 levels, Pearson correlation analysis detected a moderate negative 
association between these two parameters when combining the data from CT and EX 
groups (r = -0.415, p < 0.05, Fig. 6C). When analyzed by group separately, in CT group, 
the strong negative correlation remained between brain DCX mRNA levels and plasma 
CCL11 levels (r = -0.666, p < 0.05, Fig. 6C), while no significant relation was detected in 
EX group (r = -0.263, p = 0.4, Fig. 6C). Loss of significance in the correlation in EX 
group was likely due to one outlier that falls in the leftmost part of Fig. 6C.    
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Discussion 
 Main findings of this study are that 8-week supra-lactate threshold treadmill 
training induces brain mitochondrial biogenesis and a slight increase of hippocampal 
VEGF-A expression in aged mice. A strong positive correlation exists between 
hippocampal PRC expression and VGEF-A expression. Also, plasma CCL11 levels are 
negatively associated with expression of hippocampal DCX in both trained and untrained 
aged mice, supporting the view that systemic inflammation has suppressive effects on 
neurogenesis.  
 Scientific evidence regarding the effects of exercise training of different duration, 
frequencies and intensities is needed to establish the rationale for clinically prescribing 
exercise for an individual or a certain population. In the present study, we are particularly 
interested in high-intensity exercise training above the lactate threshold. A previous study 
has shown that supra-lactate threshold treadmill training induces mitochondrial 
biogenesis and angiogenic/neurogenic factor expression, and drives reduction of 
inflammatory mediators in the brains of young adult mice (E et al., 2013a). On the other 
hand, exercise training below lactate threshold does not alter expression of brain 
mitochondrial biogenesis components in mice of same strain and same age (E et al., 
2013a). 
 Over the 8 weeks of training, we did not observe any adverse effects in EX group 
during or after a running session. Our incremental exercise protocol seemed important in 
adapting aged mice to such a high-intensity training program. We did observe a slight 
decrease in body weights after 8 weeks of training, but the training certainly did not alter 
blood glucose or plasma insulin levels in these aged mice. It is possible that running 
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above lactate threshold provides liver with more substrate, lactate, for gluconeogenesis to 
maintain blood glucose levels.  
 While several studies have demonstrated exercise training increases brain 
mitochondrial biogenesis in young rodents (Steiner et al., 2011; E et al., 2013a), to our 
knowledge, few have studied whether exercise training modifies brain mitochondrial 
function in healthy aged mice/rats, especially from the perspective of mitochondrial 
biogenesis. Brain complex I and IV activities decrease upon aging, and regular moderate 
treadmill exercise for 24 to 50 weeks was able to prevent the age-associated decline in 
the activities of these enzymes in mice (Boveris & Navarro, 2008). Safdar and colleagues 
studied the effects of exercise training in mtDNA mutator mice displaying symptoms of 
accelerated aging, elevated mtDNA point mutations, and a systemic reduction in 
mitochondrial function, evident as early as 6-month of age. After moderate-intensity 
treadmill training for 5 months, the decline in mitochondrial function was prevented in 
the brains of these mtDNA mutator mice, but no difference in brain PGC-1α expression 
was observed (Safdar et al., 2011). In another study, 12-month old rats were subjected to 
daily 30-minute treadmill exercise at 18 m/min for 15 weeks, and brain PGC-1α and 
NRF1 protein levels were found increased but mtDNA copy number or any other 
mitochondrial protein levels were not evaluated (Marosi et al., 2012). 
 With mtDNA copy number as the most commonly used biochemical marker for 
mitochondrial biogenesis (Medeiros, 2008), we have demonstrated that intensive exercise 
training that exceeds lactate threshold significantly increases brain mtDNA copy number 
as well as PGC-1α expression. Our results have important implication for preventing or 
treating aging-related neurodegenerative diseases, especially the most common form of 
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Alzheimer’s disease (AD), sporadic late-onset AD, that often occurs after age of 65. 
Numerous studies provide evidence that mitochondrial enzyme deficiency, reduced 
mitochondrial biogenesis, and increased mtDNA damage in the AD brains may play a 
central role in the pathogenesis and progression of the disease (Readnower et al., 2011; 
Selfridge et al., 2013; Swerdlow et al., 2013). Regular intensive exercise training may 
predispose aging individuals to healthier brain mitochondria that may be beneficial for 
preventing the onset of such diseases.  
 Although brain Akt phosphorylation was not increased in EX mouse brains, 
several downstream targets of Akt were likely activated. mTOR is one of them. Akt 
phosphorylates mTOR at Ser 2448, which leads to mTOR activation promoting protein 
synthesis and cell proliferation (Nave et al., 1999; Reynolds et al., 2002). mTOR is also 
known to control mitochondrial oxidative function through a Yin Yang 1 - PGC-1α 
transcriptional complex (Cunningham et al., 2007). Interestingly, inhibition of mTOR by 
rapamycin decreased expression of the genes encoding PGC-1α and cytochrome c, but an 
Akt inhibitor did not, suggesting mTOR positively controls mitochondrial biogenesis-
related gene expression in an Akt-independent manner (Cunningham et al., 2007). 
Significant increase of nuclear PGC-1α protein levels in EX brains were possibly 
mediated by elevated activity of mTOR.  
 GSK3β is a ubiquitously expressed serine/threonine kinase that phosphorylates 
and inactivates glycogen synthase. The activity of this kinase can be inhibited by Akt-
mediated phosphorylation at Ser 9 (Cole, 2012). GSK3β has been implicated in the 
development of AD, because it induces tau hyperphosphorylation, the major component 
of neurofibrillary tangles that are involved in the disease pathogenesis (Lee et al., 2005). 
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Transgenic mice overexpressing GSK3β develop tau hyperphosphorylation and other 
neurological defects (Lucas et al., 2001), while treatment of transgenic mice 
overexpressing mutant tau with a GSK3β inhibitor (lithium) reduces the number of 
tangles in their brains (Noble et al., 2005). In the present study, GSK3β was slightly more 
phosphorylated at Ser 9 in EX brains when compared to sedentary mice, indicating our 
treadmill training protocol may decrease GSK3β activity in aged mouse brain. Our results 
along with previous evidence showing treadmill exercise inhibits GSK3β activation in a 
transgenic mouse model of AD (Liu et al., 2013) further support the potential of aerobic 
exercise training in preventing AD development and/or progression.  
 Exercise-induced neurogenesis in mouse hippocampus has been reported 
previously in both young and older rodents (Fabel et al., 2003a; van Praag et al., 2005). 
Human subject studies have also evidenced that long-term moderate-to-intensive exercise 
(60 – 75% heart rate reserve) significantly increases hippocampal volume accompanied 
by improved memory function in older adults over 55 years old (Colcombe et al., 2006; 
Erickson et al., 2011). The most commonly applied method for evaluation of 
neurogenesis in rodents is using an exogenous cell tracer, 5’-bromo-2’-deoxyuridine 
(BrdU) in combination with endogenous neuronal markers, such as neuronal nucleus 
protein (NeuN), or quantification of DCX-expressing cells in dentate gyrus of the 
hippocampus with immunofluorescence technique (Wojtowicz & Kee, 2006). As 
mentioned before, DCX can be used to identify young, immature neurons specifically. In 
this study, due to technical issues, we did not quantify DCX-expressing neurons but 
alternatively estimated the mRNA expression of DCX in the hippocampus; however, it 
was not changed by 8-week exercise training.  
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 Impairment of hippocampal neurogenesis has been suggested to be involved in 
neurodegenerative diseases with cognitive dysfunction, such as AD and Parkinson’s 
disease (PD) (Winner et al., 2011). It is also significantly associated with aging 
(Couillard-Despres et al., 2011). All these conditions are associated with brain 
mitochondrial impairment, including dysfunction of mitochondrial ETC enzymes, 
mtDNA mutations, and decreased mitochondrial biogenesis as mentioned above. 
Whether mitochondrial impairment plays a mechanistic role in the reduction of 
neurogenesis remains relatively unstudied. Dysfunctioning mitochondria may impair 
neuronal progenitor cell differentiation, as it requires energy produced by mitochondria 
for growth of neuronal processes, cytoskeletal remodeling, and organelle transport 
(Voloboueva & Giffard, 2011). Here, we indirectly tested the relation between brain 
mitochondrial function and neurogenesis by correlating brain mtDNA content and 
neurogenesis-related factors in treadmill trained and untrained aged mice. When CT and 
EX groups were combined, we saw a trend for a positive association between DCX 
mRNA levels and mtDNA copy numbers. When we analyzed the relations in CT or EX 
group separately, significantly strong correlations were detected between brain DCX 
mRNA levels and mtDNA copy numbers in CT group but not in EX group. The 
discordant results might be explained by the possibility that decreased brain 
mitochondrial biogenesis would impair the process of neurogenesis, while exercise-
induced mitochondrial biogenesis may not directly improve neurogenesis, implying that 
other mediators, such as inflammation, may be involved in governing neurogenesis, 
which are discussed below. In addition, small sample size may also result in false positive 
or false negative results in correlation analysis. One thing to be pointed out here is that 
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these mRNA levels were measured with RNA extracted from hippocampi while mtDNA 
copy numbers were evaluated using DNA extracted from cortices. We need to take this 
technical factor into account when conclude about the relations between brain 
mitochondrial biogenesis and the expression of neurogenic factors in hippocampus. 
 VEGF-A, an angiogenic factor, has been implicated as essential in exercise-
induced neurogenesis (Jin et al., 2002; Fabel et al., 2003a; Font et al., 2010). Our data 
show that the ratio of nuclear to cytoplasmic protein levels of FOXO3a, known to repress 
VEGF-A expression (Karadedou et al., 2012), was significantly decreased, and VEGF-A 
expression levels trended higher in EX brains. Our previous study has shown that brain 
VEGF-A expression induced by exercise training is likely mediated by circulating lactate 
which is released by exercising muscles (E et al., 2013a).  
 While significant association between VEGF-A expression and mtDNA content 
was not detected in the present study, a strong positive correlation has been found 
between brain VEGF-A and PRC mRNA levels independent of exercise training. The 
results are consistent with what we found previously in young adult mice (E et al., 2013a). 
This strong positive correlation seen in both young and aged mouse brain suggests that 
PRC may play a role in mediating VEGF expression changes, and further implies an 
association between brain bioenergetic metabolism and the process of neurogenesis.  
 Inflammation may be involved in aging or neurodegenerative disease-related 
reduction of neurogenesis. A previous study has shown that lipopolysaccharide-induced 
inflammation mediated by microglia activation in rat hippocampus strongly impairs 
hippocampal neurogenesis (Ekdahl et al., 2003). In another study, it was reported that 
plasma CCL11 levels increased with age in both rodents and human subjects, and 
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increased plasma CCL11 level was identified as associated with reduction of 
hippocampal neurogenesis seen in aged mice (Villeda et al., 2011). Injecting CCL11 
intraperitoneally significantly decreases DCX-positive cells in the dentate gyrus of 
healthy young mice, and this decrease could be rescued by neutralizing CCL11 within the 
dentate gyrus by injecting CCL11-specific antibody to the area (Villeda et al., 2011).  
 In the present study, we found that after 8 weeks, the plasma levels of CCL11 
were increased in both CT and EX groups when compared to their respective levels at 
baseline. Also, plasma CCL11 levels (after 8-week study) are negatively correlated with 
DCX mRNA in the hippocampus. Our data support the notion that systemic CCL11 may 
exert suppressive effects on hippocampal neurogenesis.  
 Whether or not exercise training is able to reduce systemic CCL11 levels, which 
may potentially contribute to increased neurogenesis, was tested in the present study. 
However, we did not observe 8-week exercise training lowering plasma CCL11 levels as 
we expected, even though numerous studies have shown that long-term exercise training 
decreases the levels of pro-inflammatory cytokines in the blood of older human subjects 
(Woods et al., 2012). Future research with longer period (6-12 months) of exercise 
training may be able to address the effects of exercise in modifying plasma CCL11 levels.  
 Inflammation down-regulates neurogenesis, and multiple factors may be 
mediating it. Mitochondria can be one of them. Mitochondria play an important role in 
pro-inflammatory signaling, and vice versa, pro-inflammatory mediators may also alter 
mitochondrial function, resulting in a vicious cycle. Little is known whether 
mitochondrial protection is able to attenuate inflammation-induced decrease of 
neurogenesis. Although we found that intensive exercise training significantly increased 
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brain mitochondrial biogenesis in the aged mice, no clear correlations between brain 
mtDNA content and brain TNF-α, or CCL11 mRNA levels were detected. This is 
probably because in these aged mouse brains, expression of TNF-α and CCL11 was not 
altered by 8-week intensive exercise training, though similar training protocol reduced 
TNF-α expression in brains of young adult mice (E et al., 2013a). Also, no correlation 
between plasma CCL11 levels and brain mtDNA content was observed, suggesting the 
brain mitochondrial biogenesis induced by exercise training was unlikely mediated by the 
modification of inflammatory factors in the blood.  
In the present study, 19-month old C57BL/6 mice were able to tolerate supra-
lactate threshold treadmill exercise training over the 8 weeks, with the exception of four 
EX mice that often reached exhaustion before completing a running session. However, 
the data from these mice did not deviate from the others in the EX group, even though 
their exercise workloads (running distance) were less. Future studies may be needed to 
investigate the minimum exercise workload/intensity that is sufficient to induce brain 
mitochondrial biogenesis, which could provide more clinically relevant information for 
designing individualized exercise protocol for older adults.  
 In summary, we have demonstrated that supra-lactate threshold exercise training 
increases brain mitochondrial biogenesis in aged mice. The event is accompanied by a 
slight increase of brain expression of VEGF-A. While mitochondrial biogenesis is not 
clearly associated with neurogenesis or inflammatory factors in the brains of aged mice, a 
transcription factor and a co-activator that play important roles in regulating bioenergetic 
network (PRC; FOXO3a) are likely influencing a brain angiogenesis/neurogenesis 
mediator (VEGF-A). Meantime, our data support the view that systemic inflammation 
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has a strong suppressive effect on hippocampal neurogenesis, though intensive exercise 
training does not affect the aging-associated increase of plasma chemokine level. 
Nonetheless, together with our previously published study (E et al., 2013a), we conclude 
that supra-lactate threshold exercise training induces brain mitochondrial biogenesis in 
both young and aged mice, which has important therapeutic implications for neurological 
disorders with perturbed brain bioenergetics, such as neurodegenerative diseases. 
Mechanistic studies will be needed to identify the possible causal relationships between 
brain mitochondrial biogenesis, neurogenesis, and inflammation, under the condition of 
exercise.  
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Figure 1. Blood lactate levels. Post-running blood lactate levels in EX group were 
measured immediately after a running session every week. Blood lactate levels in CT 
group at rest were measured at weeks 1, 5, and 6. Post-running blood lactate levels in EX 
group were always significantly higher than they were in CT group at rest. The treadmill 
speed for each week is indicated. CT, control group; EX, exercise group. For weeks 1-4, 
the blood lactate levels in EX group were statistically compared to the levels in CT group 
from week 1; for week 5, the blood lactate levels in EX group were statistically compared 
to the levels in CT group from week 5; for weeks 6-8, the blood lactate levels in EX 
group were statistically compared to the levels in CT group from week 6. * p < 0.05, 
compared with CT group; ** p < 0.001, compared with CT group. 
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Figure 2. Effects of treadmill training on body weights, blood glucose levels, plasma 
insulin levels, and HOMA-IR. (For figure legend, see next page). 
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Figure 2. Effects of treadmill training on body weights, blood glucose levels, plasma 
insulin levels, and HOMA-IR. (A) 8-week exercise training significantly decreased the 
weights in EX group when compared to CT group at the end of the study. Paired t test 
analysis also showed a statistically significant decrease in EX group weights after 8-week 
exercise training when compared to baseline. (B) Non-fasting blood glucose level trended 
lower in EX group than that in CT group after 8-week training, but the difference was not 
significant. (C) No inter- or intra-group differences were detected in 17-hour fasting 
blood glucose levels. (D) No inter- or intra-group differences were detected in 17-hour 
fasting plasma insulin levels as well. (E) HOMA-IR values in CT group were trending 
higher after sedentary 8 weeks when compared with the values at baseline, but the 
difference was not significant. No intergroup difference was detected in HOMA-IR 
values. * p < 0.05. BSL, baseline; CT, control group; EX, exercise group; HOMA-IR, 
homeostasis model assessment of insulin resistance. 
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Figure 3: Effects of treadmill training on mitochondrial biogenesis in aged mouse 
brain (continued).  
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Figure 3: Effects of treadmill training on mitochondrial biogenesis in aged mouse 
brain (continued). 
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Figure 3: Effects of treadmill training on mitochondrial biogenesis in aged mouse 
brain (continued). (For figure legend, see next page). 
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Figure 3: Effects of treadmill training on mitochondrial biogenesis in aged mouse 
brain (continued). (A) mRNA levels of PGC-1α, PGC-1β, PRC, NRF1, and NRF2 were 
all comparable between CT and EX groups. TFAM mRNA expression was decreased in 
EX group. mRNA levels of complex IV subunit 2 (COX2) and subunit 4 (COX4) were 
comparable between groups. CS mRNA levels were significantly increased in EX brains 
when compared to CT group. (B) Protein levels of PGC-1α in nucleus were significantly 
higher in EX brains than they were in CT brains, while no inter-group differences were 
detected in nuclear PGC-1β and NRF1 protein levels. TFAM protein levels were also 
comparable between groups. COX4 protein levels trended higher in EX brains but the 
inter-group difference did not reach statistical significance. Protein expression of CS was 
comparable between CT and EX groups, despite the significant increase in its mRNA 
levels induced by treadmill training. GAPDH and HDAC1 served as an internal loading 
control for cytoplasmic and nuclear fraction, respectively. (C) Relative brain 
mitochondrial DNA (mtDNA) copy numbers were evaluated. ATP synthase F0 subunit 6 
(ATP6)/18S rRNA, COX2/18S rRNA and NADH dehydrogenase subunit 1 (ND1)/18S 
rRNA ratios were significantly higher in EX brains than they were in CT brains. * p < 
0.05, compared to CT group. ATP6, ATP synthase F0 subunit 6; COX2, cytochrome c 
oxidase subunit 2; COX4, cytochrome c oxidase subunit 4; CS, citrate synthase ; CT, 
control group; EX, exercise group; ND1, NADH dehydrogenase subunit 1; NRF, nuclear 
respiratory factor; PGC-1, peroxisomal proliferator-activated receptor-gamma co-
activator 1; PRC, PGC-1 related co-activator; TFAM, mitochondrial transcription factor 
A. 
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Figure 4. Effects of treadmill training on bioenergetic metabolism related protein 
levels in aged mouse brain. (For figure legend, see next page).  
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Figure 4. Effects of treadmill training on bioenergetic metabolism related protein 
levels in aged mouse brain. (A) Cytoplasmic Akt phosphorylation at Ser 473, corrected 
for total Akt protein levels, was comparable between CT and EX groups. Cytoplasmic 
GSK3β phosphorylation at Ser 9, corrected for total GSK3β protein levels, trended higher 
in EX brains than that in CT group, but the difference was not significant. When 
corrected for total mTOR protein levels, cytoplasmic mTOR phosphorylation at Ser 2448 
in EX brains trended higher compared to CT brains. When corrected for internal loading 
control GAPDH, cytoplasmic mTOR phosphorylation at Ser 2448 was significantly 
increased in EX group, and total mTOR protein levels were also higher in EX group, 
compared to CT group. (B) The ratio of FOXO1 protein level in nuclear fraction over 
cytoplasmic fraction was calculated to evaluate its compartmentalization. The ratio 
trended lower in EX group. (C) The ratio of FOXO3a protein level in nuclear fraction 
over cytoplasmic fraction was significantly lower in EX group than it was in CT group. 
All values were ratioed to the mean values in CT group. Cyto: cytoplasmic; nuc: nuclear. 
* p < 0.05, compared to CT group. CT, control group; cyto, cytoplasmic; EX, exercise 
group; FOXO1, forkhead box protein O1; FOXO3a, forkhead box O3; GAPDH, 
glyceraldehyde-3-phosphate dehydrogenase; GSK, glycogen synthase kinase; HDAC1, 
histone deacetylase 1; mTOR, mammalian target of rapamycin; nuc, nuclear. 
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Figure 5: Effects of treadmill training on neurogenesis-related factors in aged mouse 
brain. 
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Figure 5: Effects of treadmill training on neurogenesis-related factors in aged mouse 
brain (continued). (For figure legend, see next page). 
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Figure 5: Effects of treadmill training on neurogenesis-related factors in aged mouse 
brain. (A) mRNA levels for all genes are presented relative to the internal control 
GAPDH. DCX mRNA levels were comparable between CT and EX groups. VEGF-A 
mRNA levels were trending higher in EX group than they were in CT group, but the 
difference was not significant. BDNF mRNA levels were also comparable between 
groups. (B-D) shows the relations between brain DCX mRNA levels and mtDNA copy 
numbers. When combining the data from CT and EX groups, there was a slight trend for 
a positive correlation between brain DCX mRNA levels and ATP6, COX2, and ND1 
copy numbers, respectively, but without statistical significance. When analyzed by group 
separately, in CT group, significant positive correlations were detected between brain 
DCX mRNA levels and ATP6, COX2, and ND1 copy numbers, respectively. No 
correlations were observed between DCX mRNA levels and mtDNA copy numbers in 
EX group. (E-G) shows the relations between brain VEGF-A mRNA levels and mtDNA 
copy numbers. No significant correlations were detected when combining the data from 
both CT and EX groups, or analyzed by group separately. (H) A strong positive 
correlation was detected between brain VEGF-A mRNA levels and brain PRC mRNA 
levels. When analyzed by group separately, the strong positive correlation was observed 
in both CT and EX groups. AT6, ATP synthase F0 subunit 6; BDNF, brain-derived 
neurotrophic factor; COX2, cytochrome c oxidase subunit 2; CT, control group; DCX, 
doublecortin; EX, exercise group; ND1, NADH dehydrogenase subunit 1; PRC, 
peroxisomal proliferator-activated receptor-gamma co-activator 1 related co-activator; 
VEGF-A, vascular endothelial growth factor A.  
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Figure 6: Effects of treadmill training on brain and systemic inflammatory factors 
in aged mice. (For figure legend, see next page). 
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Figure 6: Effects of treadmill training on brain and systemic inflammatory factors 
in aged mice. (A) TNF-α and CCL11 mRNA levels were comparable between CT brains 
and EX brains. (B) Plasma CCL11 levels were comparable between CT and EX groups at 
baseline and after completion of 8-week study. In both CT and EX groups, significant 
increases in plasma CCL11 levels were observed after completion of 8-week study, when 
compared to the levels at baseline. (C) The relation between brain DCX mRNA levels 
and plasma CCL11 levels is shown. When combining the data from CT and EX groups, a 
strong negative correlation between brain DCX mRNA levels and plasma CCL11 levels 
was detected. When analyzed by group separately, in CT group, brain DCX mRNA levels 
were strongly negatively related to plasma CCL11 levels, while no significant relation 
was detected in EX group. * p < 0.05; ** p < 0.001. CCL11, C-C motif chemokine 11; 
CT, control group; DCX, doublecortin; EX, exercise group; GAPDH, glyceraldehyde-3-
phosphate dehydrogenase; TNF-α, tumor necrosis factor alpha. 
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Chapter V 
 
Lactate Treatment Modifies Bioenergetic Fluxes and Infrastructures in 
Human Neuronal Cells 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(Manuscript in preparation) 
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Abstract 
More than a metabolic waste, lactate has neuroprotective effects as an alternative energy 
source, and possibly mediates exercise-induced benefits for brain. Whether exogenous 
lactate modifies brain bioenergetic fluxes and infrastructures is however an unanswered 
question. In this study, we treated SH-SY5Y human neuronal cells with 10 mM or 20 
mM lactate for 6 hours. Lactate treatment significantly decreased glycolysis flux and had 
a prolonged enhancement of mitochondrial respiration. Over time exogenous lactate 
gradually shifted the bioenergetic metabolism towards a more aerobic state. An increase 
of NAD+/NADH ratio was observed in lactate-treated cells. The changes in these fluxes 
were not accompanied by alteration of mitochondrial coupling efficiency or overall ATP 
production. Although we did not observe changes in mitochondrial DNA (mtDNA) copy 
number, expression of peroxisomal proliferator-activated receptor-gamma coactivator 1 
beta (PGC-1β), nuclear respiratory factor 1 (NRF-1), and cytochrome c oxidase subunit 1 
(COX1) were significantly increased in lactate-treated cells, suggesting some components 
of mitochondrial biogenesis were up-regulated. We also found activities of COX and 
citrate synthase (CS) increased with lactate treatment. Expression of vascular endothelial 
growth factor A (VEGF-A), an angiogenic factor, was also raised. These lactate-induced 
expression changes were likely mediated by activation of AMP-activated protein kinase 
(AMPK), p38 mitogen-activated protein kinase (MAPK), and Akt signaling pathways to 
modify bioenergetic infrastructures. Additionally, lactate treatment decreased the activity 
of mammalian target of rapamycin (mTOR) but induced nuclear translocation of 
forkhead box protein O1 (FOXO1), suggesting a potential role for lactate in longevity. 
The results from this study provide novel insights into bioenergetics-based 
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pharmacological therapies for neurodegenerative diseases with perturbed brain 
bioenergetic fluxes. 
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Introduction 
Mitochondrial dysfunction and perturbed energy metabolism in different organs 
increase with age (Navarro et al., 2004; Bratic & Larsson, 2013). These bioenergetic 
dysfunctions are observed in brains of some neurological disorders, such as Alzheimer’s 
and Parkinson’s diseases (Lin & Beal, 2006; Lezi & Swerdlow, 2012). Bioenergetic 
medicine has been proposed for treatment of these diseases; it refers to the manipulation 
of mitochondrial respiratory flux as well as bioenergetic pathways outside the 
mitochondria to positively affect health (Swerdlow, 2013).  
Although lactate has long been considered a metabolic waste end product from 
anaerobic glycolysis, recent research supports the notion that lactate may be a potential 
therapeutic candidate in bioenergetic medicine. Previous studies have shown that exercise 
training shifts mouse liver mitochondrial function from respiration towards non-
respiratory activities, such as gluconeogenesis to help maintain blood glucose levels (E et 
al., 2013a). Systemic lactate administration induces same effects in mouse liver (E et al., 
2013a). In mouse brain, exercise training above lactate threshold and intraperitoneal 
lactate injection have similar effects in terms of increasing the expression of peroxisome 
proliferator-activated receptor gamma coactivator 1 (PGC-1) related coactivator (PRC), 
which has a role in inducing the activities of mitochondrial respiration related enzymes 
(Mirebeau-Prunier et al., 2010), as well as an angiogenic factor, vascular endothelial 
growth factor (VEGF) (E et al., 2013a). These studies suggest exercise-generated lactate 
partially accounts for exercise-induced modification of bioenergetics in liver and brain, 
potentially mediated by lactate-induced bioenergetic flux changes (Swerdlow, 2013). 
Here, we further study the possibility of lactate treatment as a strategy for 
bioenergetic flux manipulation, and investigate the underlying mechanisms using human 
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neuronal cells. In the present study, we report for the first time that lactate treatment 
increases mitochondrial respiratory fluxes while suppresses glycolysis rate in human 
neuronal cells. In addition, lactate modifies bioenergetic infrastructure to maintain the 
improved electron transfer via the mitochondrial electron transport chain (ETC), and it 
activates several signaling pathways that are involved in mitochondrial biogenesis as well 
as in longevity. 
 
 
Methods  
Cell culture 
Undifferentiated SH-SY5Y neuroblastoma cells (ATCC, Manassas, VA) were 
cultured at 37 ºC, 5% CO2 in regular growth medium (pyruvate-free DMEM containing 
25 mM glucose, purchased from Life Technologies, Grand Island, NY) and supplemented 
with 10% fetal bovine serum (FBS) (Sigma-Aldrich, St. Louis, MO) and 1% of a 
penicillin-streptomycin stock (Fisher Scientific, Pittsburgh, PA). Cells were cultured to 
60-80 % confluency in T75 culture flasks before use.   
 
Lactate treatment 
Cells were grown in SH-SY5Y regular growth medium, and medium was changed 
twice a day in order to minimize the effects by endogenously produced lactate. 24 hours 
after seeding the cells for the experiment, growth medium was removed, and cells were 
rinsed with and then incubated in FBS-free DMEM supplemented with 5mM glucose and 
1% penicillin-streptomycin (DMEM-5), for both control and treatment groups. After cells 
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have adapted to the condition with 5mM glucose and without FBS for overnight (18-20 
hours), for treatment groups (LAC), medium was changed to DMEM-5 with either 10mM 
or 25 mM sodium lactate (#L7022, Sigma-Aldrich, St. Loius, MO). The concentrations of 
lactate were selected as those levels were seen in human blood and muscles after 
intensive exercise (Ohkuwa et al., 1984; Cheetham et al., 1986). For all experiments, the 
cells were pre-incubated with lactate for 6 hours, except for the mitochondrial respiration 
and glycolysis assays (detailed treatment procedures for these two assays are described in 
both ‘Methods’ and ‘Results’). For the control group (CT), DMEM-5 without sodium 
lactate was added to the cell culture at the same time. 
 
Quantitative real-time, reverse-transcription PCR 
Total RNA was prepared from SH-SY5Y cells using the TRI Reagent (Life 
Technologies). Reverse transcription was performed on total RNA (1 μg) using an 
iScriptTM Reverse Transcription Supermix for RT-qPCR (Bio-Rad Laboratories, Hercules, 
CA). Quantitative real-time, reverse-transcription PCR (qPCR) was performed using 
TaqMan Universal PCR Master Mix (Applied Biosystems, Foster City, CA) and ready-
to-use TaqMan Gene Expression Assays (Applied Biosystems) to quantify the mRNA 
levels of PGC-1α, PGC-1β, PGC-1 related co-activator (PRC), nuclear respiratory factor 
1 (NRF-1), mitochondrial transcription factor A (TFAM), cytochrome c oxidase subunit 
1 (COX1), COX4, pyruvate dehydrogenase alpha 1 (PDHA1), pyruvate dehydrogenase 
kinase 4 (PDK4), pyruvate carboxylase (PC), malic enzyme 1 (ME1), malic enzyme 2 
(ME2), and vascular endothelial growth factor A (VEGF-A). Glyceraldehyde 3-
phosphate dehydrogenase (GAPDH) was used as a house keeping gene. qPCR 
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amplifications were performed using an Applied Biosystems StepOnePlus Real-Time 
PCR System (Applied Biosystems). Relative mRNA levels were quantified using the 
StepOnePlus Software v2.1 based on the comparative ∆∆CT method. 
 
Mitochondrial DNA copy number determination 
To quantify mitochondrial DNA (mtDNA), total DNA was extracted using a 
phenol-chloroform based method as previously described (Guo et al., 2009). DNA 
concentration and purity were determined spectrophotometrically by measuring the 
absorbance at 260 nm and the 260 nm/280 nm ratio. Each real-time PCR reaction was 
performed using 10 ng of DNA as the template. We used TaqMan Gene Expression 
Assays (Applied Biosystems) to quantify the amounts of two target genes present on 
mtDNA, NADH dehydrogenase subunit 2 (ND2) and the 16S ribosomal RNA (rRNA), as 
well as the amount of a nuclear target gene, the 18S rRNA. The relative mtDNA to 
nuclear DNA copy number ratio was determined using the comparative ∆∆CT method, in 
which ND2:18S rRNA and 16S rRNA:18S rRNA ratios were calculated.  
 
Immunoblotting 
            Nuclear and cytoplasmic protein extracts were prepared using NE-PER Nuclear 
and Cytoplasmic Extraction Reagents (Thermo Scientific, Rockford, IL) according to the 
manufacturer’s instructions. Protein concentrations were measured using a BCA protein 
assay reagent kit (Thermo Scientific). 10 μg of nuclear protein extracts or 40 μg of 
cytoplasmic protein extracts was loaded per lane, and subjected to electrophoresis on a 4-
15 % Criterion TM TGX TM Precast Gel (Bio-Rad Laboratories). The proteins were then 
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transferred to a nitrocellulose membrane using iBlot TM (Invitrogen, Carlsbad, CA). The 
membrane was blocked with phosphate buffered saline (PBS) containing 0.1 % Tween-
20 and 5 % non-fat dry milk (Bio-Rad Laboratories) for 1 hour at room temperature, and 
subsequently incubated with the primary antibody (diluted in the blocking solution) 
overnight at 4 °C. The membrane was then rinsed in PBS with 0.1 % Tween and 
incubated with the horseradish peroxidase-conjugated secondary antibody (anti-rabbit 
IgG # 7074 or anti-mouse IgG # 7076; 1:2000 dilution; Cell Signaling Technology, 
Beverly, MA) for 1 hour at room temperature. After rinsing the membrane with PBS with 
0.1 % Tween, the protein bands were detected with a SuperSignal West Femto Maximum 
Sensitivity Substrate (Thermo Scientific). In order to quantify protein band intensity, 
densitometry was performed using a ChemiDoc XRS with Quantity One software (Bio-
Rad).  
Several proteins of bioenergetic pathways were analyzed. Primary antibodies 
purchased from Cell Signaling Technology included antibodies to phospho-Thr172 
AMPK (1:1000 dilution; #2531), AMPK (1:1000 dilution; #2603), phospho-Ser133 
cAMP-response element binding protein (CREB) (1:500 dilution; #9198), p38 (1:1000 
dilution; #9212), phospho-p38 (1:1000 dilution; #4511), Akt (1:1000 dilution; #5373), 
phosphor-Ser473 Akt (1:1000 dilution; #4060), mammalian target of rapamycin (mTOR) 
(1:1000 dilution; #2983), phospho-Ser2448 mTOR (1:1000 dilution; #2976), TFAM 
(1:500 dilution; #7495), forkhead box protein O1 (FOXO1) (1:500 dilution; #2880), 
hypoxia-inducible factor 1-alpha (HIF1α) (1:1000 dilution; #3716), and GAPDH (1:2000 
dilution; #2118). Primary antibodies purchased from Abcam (Cambridge, MA) included 
antibodies to PGC-1β (1:500 dilution; #ab61249), PDHA1 (1:500 dilution; #ab110330), 
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phosphor-Ser 293 PDHA1 (1:200 dilution; #ab92696), and citrate synthase (1:500 
dilution; #ab96600). Primary antibodies purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA) included antibodies to CREB (1:200 dilution; #sc-25785) and NRF1 
(1:200 dilution; #sc-33771). Antibodies to PGC-1α (1:1000 dilution; #PA5-22958) and 
histone deacetylase 1 (HDAC1) (1:1000 dilution; #PA1-860) were purchased from 
Thermo Scientific. An antibody to COX4 was purchased from Life Technologies 
(A21348, 1: 2000). GAPDH and HDAC1 were used as internal loading controls for 
cytoplasmic and nuclear fractions, respectively. 
 
Mitochondrial stress test and glycolysis stress test 
Mitochondrial oxygen consumption rate and glycolytic rate of lactate-treated SH-
SY5Y cells were measured using a Seahorse XF24 Extracellular Flux Analyzer (Seahorse 
Bioscience, Billerica, MA) which gives real-time measurements in a 24-well plate. SH-
SY5Y cells were seeded in 24-well Seahorse V7 plates (Seahorse Bioscience) at a density 
of 5x104 cells/well in SH-SY5Y regular growth medium. Cells were treated with sodium 
lactate as above-mentioned in the ‘Lactate treatment’ section.  
The assays were performed as previously described with minor modifications 
(Silva et al., 2013). Briefly, for mitochondrial stress test, unbuffered DMEM (pH 7.4) 
containing 5 mM glucose and 1 mM glutamine was used as assay running medium. For 
LAC groups, the assay medium also contained either 10 mM or 25 mM sodium lactate. 
Oxygen consumption rate (OCR) was measured using a cycling protocol consisting of 3 
min mixing, 2 min waiting, and 3 min reading in one cycle. Basal OCR at 5 mM glucose 
(near physiological concentration) was measured during the first four reading periods. 
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Next, we injected oligomycin at final concentration of 1 µM to measure the proton leak 
rate for the three reading periods. The proton ionophore carbonylcyanide p-
trifluoromethoxyphenylhydrazone (FCCP) was subsequently injected at final 
concentration of 0.3 μM to measure the maximal respiration for another three reading 
periods. At last, the complex I inhibitor rotenone and complex III inhibitor antimycin A 
were injected at final concentrations of 1 μM and 0.2 μM, respectively, to shut down the 
mitochondrial respiration, yielding non-mitochondrial OCR of cells. For quantitation, the 
area under the OCR curve was used. The area under the curve will be referred to as AUC 
in this study. The OCR AUC at basal respiration, post-oligomycin injection, and post-
FCCP injection was calculated, and the non-mitochondrial OCR AUC value was 
subtracted. 
For the glycolytic stress test, unbuffered DMEM (pH 7.4) containing 1 mM 
glutamine and no glucose was used as assay running medium. For LAC groups, the assay 
medium also contained either 10 mM or 25 mM sodium lactate. The Seahorse Analyzer 
measures extracellular acidification rate (ECAR) that can be used as an indirect indicator 
of glycolysis rate. Initially, ECAR under glucose deprivation was measured for the first 
three reading periods. Next, to measure basal glycolysis rate, we added glucose at final 
concentration of 25 mM. For evaluating glycolysis capacity, oligomycin was 
subsequently injected at final concentration of 1 µM. At last, we injected 2-deoxyglucose 
(2-DG) at final concentration of 100 mM to yield non-glycolysis ECAR. Basal glycolysis 
rate was calculated by post-glucose injection ECAR AUC subtracting non-glycolysis 
ECAR AUC, and glycolysis capacity was calculated by post-oligomycin injection ECAR 
AUC subtracting non-glycolysis ECAR AUC. 
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In addition to pre-treating cells with lactate, we also tested the acute effects of 
lactate treatment on SH-SY5Y mitochondrial respiration and glycolysis rate. Cells were 
seeded in a 24-well Seahorse V7 plate in regular SH-SY5Y growth medium. Unbuffered 
DMEM (pH 7.4) supplemented with 5 mM glucose and 1mM glutamine but without 
lactate was used as assay running medium for all groups. After 3 reading periods of basal 
respiration in the Seahorse XF24 Analyzer, lactate was injected at final concentration of 
10 mM or 25 mM to the wells of LAC groups. For the control group, assay running 
medium of the same volume was injected. The fluxes were measured for five reading 
periods after the first injection. Oligomycin, FCCP, and rotenone plus antimycin were 
injected subsequently. 
 
Cytochrome c oxidase and citrate synthase activity assays 
We evaluated COX and citrate synthase (CS) Vmax activities of SH-SY5Y cells 
treated with 25 mM lactate for 6 hours. The cells were trypsinized and washed with ice-
cold PBS twice, and pelleted at 500 x g for 3 minutes. The pellet was resuspended in ice-
cold HBSS containing no magnesium and no calcium, at concentration of 30 x 106 
cells/mL. COX and CS Vmax activities were determined as previously described (Ghosh 
et al., 2007). COX Vmax activity was normalized to protein concentration, as well as to 
CS activity. 
 
ATP and ADP/ATP ratio assays 
            5x104 cells per well were plated in 96-well plates, and were treated with 25 mM 
lactate for 6 hours as described above. ATP levels and ADP/ATP ratios were determined 
138 
 
using a EnzyLightTM ATP Assay Kit and ADP/ATP Ratio Assay Kit (Bioassay Systems, 
Hayward, CA), respectively, according to the manufacturer’s instruction.  
 
NAD+/NADH assay 
Cells were seeded in 60 mm dishes at a density of 1.5 x106 cells, and were treated 
with 25 mM lactate for 6 hours as described above. The NAD+/NADH levels were 
measured using a commercially available Fluorescent NAD+/NADH Detection Kit (Cell 
Technology Inc, Mountain View, CA). Briefly, cells were harvested, washed with ice-
cold PBS, and divided into two different 1.5 mL tubes. Two separate extractions were 
prepared for measuring NAD+ and NADH levels individually, according the 
manufacturer’s instruction. Readings were taken with excitation at 530 nm and emission 
at 590 nm. NAD+ to NADH ratio was calculated, and absolute NAD+ and NADH levels 
were also calculated individually, after normalization to protein content. 
 
Statistical analysis 
Data were summarized by mean and standard error. Mean values were compared 
by Student’s t-test, or one-way analysis of variance (ANOVA) and Fisher’s Least 
Significant Difference (LSD) post hoc test, using SPSS 18.0 (SPSS Inc., Chicago, IL). p-
values less than 0.05 were considered statistically significant.   
 
 
Results  
Mitochondrial respiration and glycolysis rate of lactate treated SH-SY5Y cells 
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Mitochondrial stress test – 6-hour lactate pre-treatment  
 We first tested the effects of lactate treatment on mitochondrial respiratory flux in 
SH-SY5Y cells. The assays with Seahorse Extracellular Flux Analyzer demonstrated that 
6-hr pre-treatment with both 10 mM and 25 mM lactate significantly increased the basal 
mitochondrial OCR AUC by ~ 25%, when compared with CT group (p < 0.05, Fig. 1A-
B), and the increase was comparable between 10 mM LAC and 25 mM LAC groups. 
After injecting oligomycin to inhibit ATP synthase, while no significant difference was 
observed between CT and 10 mM LAC groups or between 10 mM LAC and 25 mM LAC 
groups, the proton leak associated OCR AUC was ~80% higher in 25 mM LAC group 
than that in CT group (p < 0.05, Fig. 1A, 1C). However, when we ratioed proton leak 
associated OCR AUC to basal respiration OCR AUC, it was comparable between groups 
(p > 0.05, Fig. 1A, 1D). The ATP production associated OCR AUC was calculated by 
subtracting proton leak OCR AUC from basal respiration OCR AUC. Then, we evaluated 
the percentage of ATP production associated OCR AUC in basal respiration OCR AUC, 
and no inter-group difference was seen (p > 0.05, Fig. 1A, 1E). The FCCP-induced 
maximal respiratory OCR AUC was ~40% higher in 10 mM LAC group and ~45% 
higher in 25 mM LAC group when either group was compared to the CT group (p < 0.05, 
Fig. 1A, 1F). To calculate maximal respiratory capacity, the maximal respiratory OCR 
AUC was ratioed to basal respiration OCR AUC, while they were comparable between 
groups (p > 0.05, Fig. 1A, 1G). Spare respiratory capacity, which is the extra 
mitochondrial capacity available in a cell to produce energy under conditions of increased 
work or stress, was calculated by subtracting basal respiration OCR AUC from maximal 
respiratory OCR AUC for each group. No significant inter-group differences (Fig. 1A, 
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1H). The results indicate that lactate treatment may increase mitochondrial oxygen 
consumption by enhancing overall mitochondrial electron transfer, but not necessarily 
increasing the coupling efficiency of oxidative phosphorylation (OXPHOS).  
Glycolytic stress test – 6-hour lactate pre-treatment  
 Next, we evaluated the effects of lactate pre-treatment on glycolysis rate. Fig. 2A, 
2B show that 6-hr lactate pre-treatment dramatically suppressed glycolysis rate in SH-
SY5Y cells when high concentrations of glucose (25 mM) was given (~50% decrease in 
10 mM LAC group and ~75% decrease in 25 mM LAC group, ANOVA p < 0.001, LSD 
post-hoc analysis p < 0.001 for both comparisons). Statistically significant difference was 
also detected between 10 mM LAC and 25 mM LAC group (LSD post-hoc analysis p < 
0.001). The glycolysis capacity was not altered by lactate pre-treatment (p > 0.05, Fig. 
2A, 2C). Glycolysis reserve was calculated by subtracting the glycolysis rate from 
glycolysis capacity. SH-SY5Y is a tumor cell line, and favors glycolysis over 
mitochondrial respiration, which is known as Warburg effect (Warburg, 1956). With 
plenty of glucose present in the medium, SH-SY5Y cells mostly rely on glycolytic ATP 
and have very low glycolysis reserve, but when given 10 mM and 25 mM lactate pre-
treatment, glycolysis reserve was dramatically increased by ~290% and ~340%, 
respectively (LSD post-hoc analysis: p < 0.05, and p < 0.001, respectively, Fig. 2D). No 
difference in glycolysis reserve was seen between 10 mM and 25 mM LAC groups. 
Mitochondrial stress test – acute lactate treatment  
 The results from acute lactate treatment showed that, in both 10 mM and 25 mM 
LAC group, OCR started to increase immediately after lactate injection (there are ~ 5 
minutes between lactate injection and the next measuring point), and the increase was 
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similar between 10 mM and 25 mM LAC groups (Fig. 3A). Although one-way ANOVA 
analysis did not show statistical significance for the inter-group difference in post-lactate 
or assay medium injection OCR AUC (p = 0.073, Fig. 3B), we clearly observed that the 
OCR continued to increase throughout the 5 reading periods after lactate injection, while 
OCR was unchanged in CT group in which assay medium was injected instead. Similarly, 
statistical analyses did not detect inter-group differences in proton leak OCR AUC (Fig. 
3C), while a trend towards an increasing was seen in maximal respiration OCR AUC 
with lactate injection (ANOVA analysis, p = 0.15, Fig. 3D). As shown in Fig. 3E, ECAR 
decreased immediately after lactate injection, and the effect was more obvious in 25 mM 
LAC group than that in 10 mM LAC group. Glycolysis ECAR AUC was not calculated 
for this experiment, because the experiment was not designed for testing glycolysis stress, 
and non-glycolytic ECAR was not measured for reference.    
Prolonged effects of lactate pre-treatment 
We also tested how long the lactate’s effect on mitochondrial respiration and 
glycolysis rate would last. Cells in group LAC-1 and LAC-2 were both pre-treated with 
25 mM lactate for 6 hours as described in ‘Lactate treatment’. The plate was placed in the 
Seahorse Analyzer for measuring continuously for ~5.5 hours. In LAC-1 group, 25 mM 
lactate was present in the assay running medium throughout the flux assay. In LAC-2 
group, at the end of 6-hour pre-treatment but before placement in the Seahorse Analyzer, 
lactate was washed out by rinsing the cells twice with assay running medium containing 
no lactate. Lactate was also absent in the running medium throughout the flux assay. 6-
hour lactate pre-treatment significantly increased the mitochondrial respiration in both 
LAC-1 and LAC-2 group (Fig. 4A). After washing out the lactate, cells in LAC-2 group 
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maintained higher but sustained OCR when compared with untreated CT cells (Fig. 4A). 
On the other hand, the OCR of LAC-1 cells kept increasing throughout the 5.5-hour long 
flux assay, with lactate present in the assay running medium (Fig. 4A). The OCR AUC 
was ~100% higher in LAC-1 group and ~50% higher in LAC-2 group when compared 
with CT group (p < 0.05, Fig. 4B), and a significant difference was also observed 
between LAC-1 and LAC-2 groups (p < 0.05, Fig. 4B).  
Fig. 4C shows that cells in LAC-2 group acted similarly to CT cells in terms of 
basal glycolysis rate. LAC-1 group had considerably lower glycolysis rate than LAC-2 
and CT groups (glycolytic ECAR AUC was not calculated due to the lack of non-
glycolytic ECAR as reference). Interestingly, ECAR was unchanged in CT group and 
was increasing in LAC-2 group during the first ~60 minutes of flux measuring, but then 
both started to decrease, while LAC-2 group in which there was 25 mM lactate present in 
the assay running medium had constantly decreasing ECAR throughout the assay. It is 
possible that in CT and LAC-2 groups, over the time, endogenously generated lactate 
through glycolysis was being exported continuously from cells and accumulated in the 
medium, and this accumulated lactate had similar glycolysis suppression effect observed 
in LAC-1 cells.  
OCR to ECAR ratio can be used as an indicator for cellular preference for 
OXPHOS versus glycolysis when mitochondria are coupled for oxygen consumption; the 
higher the ratio is, the more aerobic the cells are (Zhang et al., 2012a). According to the 
Seahorse Analyzer manufacturer, the OCR/ECAR ratios between 5 ~ 8 pmoles/mpH are 
indicative of normal cells or tumors that are non-invasive (Ferrick et al., 2006). While 
OCR/ECAR ratios of untreated SH-SY5Y cells and LAC-2 group were maintained at ~3 
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and ~4.5 pmoles/mpH, respectively, OCR/ECAR in LAC-1 group was constantly 
increasing over the time, which suggests that SH-SY5Y neuronal cells get more and more 
aerobic when lactate is constantly present in the extracellular environment (Fig. 4D).  
Energy and redox intermediates in lactate treated SH-SY5Y cells 
 Cells were either 1) untreated, 2) treated with 100 mM glycolysis inhibitor 2-
deoxyglucose (2-DG), 3) treated with 25 mM lactate, or 4) treated with100 mM 2-DG + 
25 mM lactate, for 6 hours. There was no difference in ATP levels between CT and LAC 
groups, as well as between 2-DG and LAC + 2-DG groups (Fig. 5A), while the levels in 
both 2-DG and LAC + 2-DG groups were considerably lower than those in the CT group 
(~80 % decrease, p < 0.001, Fig. 5A). We also evaluated the effect of lactate treatment on 
ADP/ATP levels in SH-SY5Y cells. ADP/ATP ratio has been used as a way to 
differentiate the different modes of cell death and viability. In general, higher ADP/ATP 
ratios indicate apoptosis or necrosis in the cells. Also, detection of the cellular ADP/ATP 
ratio is particularly valuable because this ratio indicates the actual free energy of ATP 
hydrolysis available for cellular reactions (Berg et al., 2009). ADP/ATP level was 
significantly increased in 2-DG group with glycolysis inhibited (~45% higher than CT 
group, p < 0.001, Fig. 5B), which was likely caused by reduction in ATP level (Fig. 5A). 
Lactate treatment lowered ADP/ATP level in SH-SY5Y cells when compared to CT 
group (~30% decrease, p < 0.001, Fig. 5B). Also, lactate treatment rescued the increase in 
ADP/ATP level induced by 2-DG (~60 % lower in LAC + 2-DG group than that in 2-DG 
group, p < 0.001, Fig. 5B), and ADP/ATP levels in LAC + 2-DG group were even lower 
than those in CT group (~30 % decrease, p < 0.05, Fig. 5B).   
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 When lactate dehydrogenase catalyzes the conversion of lactate to pyruvate in 
cytoplasm, there is a concomitant conversion of NAD+ to NADH. We speculated that 
lactate supplement increased mitochondrial respiration by it being converted to pyruvate 
which would participate in the TCA cycle. Therefore, we predicted that NADH levels 
would be increased in LAC group. To test this, we evaluated intracellular NAD+ and 
NADH levels in SH-SY5Y cells treated with 25 mM lactate for 6 hours, and also 
calculated NAD+ to NADH ratio to evaluate the redox state of the cells. However, our 
results showed that NAD+/NADH ratio was significantly ~20 % higher in LAC group 
when compared to CT group (p < 0.05, Fig. 6A). This increase was likely induced by the 
decrease in intracellular NADH level (~30% decrease, p < 0.05, Fig. 6B) with unchanged 
NAD+ level (p > 0.05, Fig. 6C). 
COX and CS Vmax activities of lactate treated SH-SY5Y cells 
 With the increase in mitochondrial respiration, we considered whether the activity 
of COX, an important regulator of OXPHOS, would increase in lactate treated SH-SY5Y 
cells as well. Spectrophotometrically measured COX Vmax activities were ~30 % higher 
in the LAC group (25 mM lactate, 6-hr pre-treatment) when normalized to protein 
content (p < 0.05, Fig. 7A). CS is an enzyme marker for mitochondrial mass. Thus, CS 
activity was measured in lactate-treated cells. Lactate-treated cells had significantly 
higher CS activities when compared with untreated cells (~10% increase, p < 0.05 Fig. 
7B). Despite the fact that LAC group had increased CS activity, when normalized to CS 
activity, COX Vmax activities were still ~15 % higher in the LAC group (p < 0.05, Fig. 
7C), suggesting that the mitochondrial electron transfer on the ETC is possibly enhanced 
by lactate treatment.  
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Effects of lactate treatment on the expression of components involved in 
bioenergetics in SH-SY5Y cells 
PGC-1α is known to act as a master regulator of mitochondrial biogenesis and 
cellular energy metabolism, by binding and activating NRF-1 which in turn regulates the 
transcriptional activity of TFAM (Scarpulla, 2008b; Vina et al., 2009). TFAM is a final 
effector essential for the replication, maintenance, and transcription of mtDNA. PGC-1β, 
another member from PGC-1 family, also binds and coactivates NRF-1(Lin et al., 2002a). 
It has been shown to robustly induce the expression of mitochondrial respiration related 
genes such as cytochrome c and ATP synthase to a greater extent than PGC1-α (Lin et al., 
2003). PRC also belongs to PGC-1 family; it interacts with estrogen related receptor-α 
(ERR-α) to induce mitochondrion-related gene transcription, and in general supports 
mitochondrial ATP production (Vercauteren et al., 2009; Mirebeau-Prunier et al., 2010). 
In lactate treated cells, PGC-1α mRNA and protein levels were both unchanged. 
However, PGC-1β expression was significantly increased in 25 mM LAC group at 
mRNA level (~35% increase, p < 0.05, Fig. 8A) and protein level (~65% increase, p < 
0.05, Fig. 8B), while its mRNA level was not elevated in 10 mM LAC group. 
Interestingly, PRC mRNA levels were ~20% lower in both 10 mM and 25 mM LAC 
groups when compared with CT group (p < 0.05, Fig. 8A). NRF-1 mRNA level was 
unchanged with 10 mM lactate treatment but was ~55 % higher in 25 mM LAC group 
that those in CT or 10 mM LAC group (p < 0.05, Fig. 8A), though we did not observe 
inter-group difference at protein level (Fig. 8B). Despite the changes in PGC-1β and 
NRF-1 expression in lactate treated SH-SY5Y cells, TFAM mRNA and protein levels 
were both unchanged in LAC groups (Fig. 8A, 8B). We also measured the expression 
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level of two subunits of COX, specifically, COX1, encoded by mtDNA, and COX4, 
encoded by nuclear DNA. The mRNA level of COX1 was unchanged in 10 mM LAC 
group but significantly increased in 25 mM LAC group when compared with CT or 10 
mM LAC group (~60% increase, p < 0.05, Fig. 8A). Although, we could not see lactate 
treatment induced changes in COX4 mRNA or protein levels (Fig. 8A, 8B). We also 
evaluated the protein levels of CS, but did not observe inter-group difference (Fig. 8B). 
The CS Vmax activity increase appeared uncorrelated with its gene expression level. 
MtDNA copy numbers were also assayed; they were comparable between untreated cells 
and lactate treated cells (data not shown).  
We then assessed the effect of lactate treatment on expression of VEGF-A, an 
angiogenic/neurogenic growth factor (Jin et al., 2002), in SH-SY5Y cells. VEGF-A 
mRNA levels were comparable between CT group and 10 mM LAC group, but ~75 % 
higher in 25 mM LAC group than those in CT or 10 mM LAC groups (p < 0.05, Fig. 7C).  
Effects of lactate treatment on energy metabolism sensitive proteins in SH-SY5Y 
cells  
 AMPK is a crucial sensor of the energy status of the cell, and it becomes activated 
when the AMP/ATP ratio is elevated. The activation of AMPK phosphorylates and 
activates PGC-1α (Jager et al., 2007). P38 MAPK, has also been shown to increase PGC-
1α activity (Puigserver et al., 2001). While no changes in PGC-1α at mRNA or protein 
levels were observed with lactate treatment, Fig. 9 shows that AMPK phosphorylation 
and p38 phosphorylation were significantly increased in SH-SY5Y cells treated with 25 
mM lactate for 6 hours, when compared to CT cells (p-AMPK: ~35 % increase, p < 0.05; 
p-p38: ~40 % increase, p < 0.05). CREB is known to activate PGC-1α (Herzig et al., 
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2001) and induce PGC-1β transcription through reactive oxygen species (ROS) (Ishii et 
al., 2009), and phosphorylation of CREB at Ser 133 is required for CREB-mediated 
transcription (Johannessen et al., 2004). In our study, nuclear CREB phosphorylation was 
~150 % higher in LAC group than that in CT group (p < 0.05, Fig. 9).  
Akt signaling regulates two key proteins that are involved in longevity: 1) mTOR, 
a protein kinase that regulates protein synthesis and cell proliferation (Reynolds et al., 
2002), and 2) FOXO1, a transcription factor playing important roles in energy 
metabolism (Furuyama et al., 2003). Reduced mTOR activity or increased FOXO1 
activity has been shown to increase mammalian lifespan (Daitoku & Fukamizu, 2007; 
Kenyon, 2010; Wilkinson et al., 2012; Wu et al., 2013). mTOR can be phosphorylated by 
Akt at Ser 2448, leading to its activation (Nave et al., 1999; Reynolds et al., 2002). On 
the other hand, FOXO1 activity is negatively controlled by phosphorylation through Akt 
signaling pathway: phosphorylated FOXO1 by Akt is translocated from the nucleus into 
the cytoplasm, resulting in reduced transcriptional activity, while reduced 
phosphorylation maintains active FOXO1 in nucleus (Furuyama et al., 2003). We found 
that Akt phosphorylation was significantly reduced with lactate treatment (~40% 
decrease, p < 0.05, Fig. 9). Consistent with this decrease, the level of mTOR 
phosphorylation at Ser 2448 was lower in LAC group than in CT group (~10% decrease, 
p < 0.05, Fig. 9). FOXO1 protein levels were ~20 % lower in the cytoplasm but ~130 % 
higher in the nucleus of LAC cells, when compared to CT cells (p < 0.05, Fig. 9). The 
data suggest a potential role of lactate in promoting longevity. 
Pyruvate decarboxylation and carboxylation in lactate treated SH-SY5Y cells  
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 The pyruvate dehydrogenase complex (PDHC) is a nuclear-encoded 
mitochondrial multienzyme complex that catalyzes the decarboxylation of pyruvate to 
acetyl-CoA, providing the primary link between glycolysis and the TCA cycle. PDHA1 is 
a subunit of one of the enzyme components of PDHC, and plays a key role in the PDHC 
function. PDK4, an enzyme located in the mitochondrial matrix, specifically inhibits the 
PDHC by phosphorylating PDHA1 at Ser 293 (Sugden & Holness, 2003). We presumed 
that lactate supplement increased mitochondrial respiration by providing more pyruvate 
to participate in the TCA cycle, as mentioned above. However, PDHA1 mRNA levels 
were ~10 % and ~15 % lower in 10 mM and 25 mM LAC groups, respectively, than 
those in CT group, and PDK4 mRNA levels were ~15 % higher in 25 mM LAC group 
than those in CT or 10 mM LAC group (p < 0.05, Fig. 10A). More interestingly, 
immunoblotting analysis showed that PDHA1 phosphorylation at Ser 293 was actually 
reduced in SH-SY5Y cells treated with 25 mM lactate (~20% decrease, p < 0.05, Fig. 
10B), suggesting PDHC in lactate-treated cells possibly had increased activity. The 
apparently discordant mRNA expression and protein phosphorylation levels may result 
from a negative feedback loop between the protein complex activity and its mRNA levels.  
We also considered the possibility of converted pyruvate being carboxylated to 
either oxaloacetate or malate, catalyzed by pyruvate carboxylase (PC) or malic enzyme 
(ME), respectively, to subsequently participate in the TCA cycle. However, the mRNA 
levels of PC, as well as two isoforms of ME, ME1 (NADP+-dependent, cytoplasmic) and 
ME2 (NAD+-dependent, mitochondrial), were all comparable between groups (Fig. 10C). 
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Discussion 
This is the first study to examine the effects of lactate on mitochondrial 
respiratory flux and glycolysis rate in human neuronal cells. Our data show that lactate 
supplement lowers glycolysis rate and increases mitochondrial oxygen consumption by 
improving the efficiency of electron transport on the mitochondrial ETC in SH-SY5Y 
cells. Lactate also triggers AMPK, Akt and p38 MAPK signaling pathways, which may 
have contributed to the increased expression of mitochondrial respiration-related genes as 
well as longevity factors. 
Lactate has been suggested to serve as an alternative energy source in the brain 
when blood glucose level decreases and/or blood lactate level increases (Dienel, 2012). 
Lactate also has neuroprotective effects. Under ischemic conditions, lactate is able to 
protect against neuronal death (Berthet et al., 2009), and it plays an important role in 
memory formation (Newman et al., 2011; Suzuki et al., 2011).  
In the present study, we demonstrate that electron transport on the ETC is likely 
accelerated or improved by lactate. In SH-SY5Y cells pretreated with either 10 mM or 25 
mM lactate, the basal mitochondrial respiration and maximal respiration induced by 
FCCP are considerably increased. In addition, the enzymatic activities of COX, the final 
electron transport chain enzyme, and CS are increased with lactate treatment. However, 
the ATP production associated OCR relative to basal respiration remained unchanged, 
suggesting that lactate treatment improves electron transfer on the ETC but probably does 
not alter the efficiency of OXPHOS coupling in SH-SY5Y cells.  
While addressing the improved mitochondrial respiration, we found that 
glycolysis rate was reduced with lactate treatment in SH-SY5Y cells. When cellular ATP 
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concentrations are high, glycolysis is slowed due to the allosteric inhibition of 
phosphofructokinase (PFK), the rate-limiting enzyme of glycolysis, by ATP (Lehninger 
et al., 2005). However, in lactate-treated SH-SY5Y cells, overall intracellular ATP levels 
were unchanged. The conformational transition between the low and high-affinity state of 
PFK is also regulated by intracellular H+: when pH falls, the affinity of PFK for its 
substrate, fructose-6-phosphate, decreases and hence the rate of glycolysis decreases 
(Trivedi & Danforth, 1966; Hames et al., 2000). When cells are treated with exogenous 
lactate, lactate is co-transported into cells with H+ via proton-linked monocarboxylate 
transporters, presumably decreasing the pH inside the cells. Thus, the glycolysis rate in 
lactate-treated cells is reduced probably due to the decrease of intracellular pH.  
An intriguing finding in the present study is that, when cells are kept in lactate 
enriched environment, mitochondrial oxygen consumption and glycolysis rate keep 
increasing and decreasing, respectively, making the cells more aerobic over the time. 
When lactate is washed out, the effect of lactate on mitochondrial respiration seems 
sustained for at least several hours, while the glycolysis suppression effect of lactate 
disappears sooner. After lactate is taken out from the medium, cells may have reset the 
glycolysis to the original rate, because there is likely no more co-transportation of lactate 
and H+ into cells. On the other hand, the prolonged effect of lactate on mitochondrial 
respiration indicates that: 1) the effect is not transient but sustainable; 2) lactate may not 
act only as a fuel; and 3) the mechanisms underlying lactate’s prolonged effects on 
mitochondrial respiration might involve signaling transduction to alter the bioenergetic 
infrastructures and therefore induce expression of mitochondrial respiration-related 
components to enhance respiratory function.   
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In the lactate-treated cells, it seems the decrease in glycolysis rate precedes and 
may drive the increase of mitochondrial respiration. In Fig. 3A and 3E where we assessed 
the acute effects of lactate treatment, immediately after lactate injection, glycolysis rate 
dropped rapidly, while the increase in mitochondrial respiration was gradual. This might 
also explain why increased oxygen consumption of lactate treated SH-SY5Y cells was 
not accompanied by more ATP production: mitochondrial respiration is enhanced to 
compensate the decrease in glycolytic ATP production, resulting in unchanged overall 
ATP levels. Especially for cells with tumor-like features, such as SH-SY5Y cells, 
glycolytic ATP are the primary and major source for cell functioning even under aerobic 
condition, due to Warburg effect (Warburg, 1956).  
Despite the unchanged ATP levels, lactate treatment does induce AMPK 
phosphorylation. AMPK phosphorylation is primarily considered to result from 
alterations in the intracellular AMP/ATP ratio under starvation, hypoxia or from 
increased ATP consumption (Hardie, 2007). Recent studies have shown that increased 
levels of intracellular reactive oxygen species (ROS) can stimulate AMPK activity, 
without a change in overall ATP levels (Toyoda et al., 2004; Emerling et al., 2009). In 
lactate-treated SH-SY5Y cells, increased oxygen consumption may be associated with 
more ROS production to some extent, and this might contribute to AMPK activation 
without a change in ATP levels.  
Indeed, it is paradoxical that lactate increases mitochondrial oxygen consumption 
but decreases intracellular NADH levels. We expected to see NADH increase in the 
lactate-treated cells, assuming lactate was converted to pyruvate. The possible 
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explanation is that less NADH is generated from slowed glycolysis but more NADH is 
consumed as substrate for complex I (NADH dehydrogenase) on the ETC.  
Previous human studies using nuclear magnetic resonance techniques have 
reported that peripherally infused C13-labeled lactate can be uptaken by brain and 
oxidized subsequently through TCA cycle (Gallagher et al., 2009; van Hall et al., 2009; 
Boumezbeur et al., 2010). We speculated that lactate, as a fuel, would feed into the TCA 
cycle by being converted to pyruvate which is subsequently decarboxylated to acetyl-coA. 
In our lactate-treated SH-SY5Y cells, evaluation of PDHC and PDK at mRNA and 
protein levels could not provide a clear conclusion to this assumption. The pathway(s) in 
which lactate is used as a carbon source for TCA cycle remain to be determined. 
With increased mitochondrial respiration and activities of mitochondrial enzymes, 
it is reasonable to predict that mitochondrial biogenesis occurs in lactate-treated SH-
SY5Y cells. While TFAM expression and mtDNA copy number are unchanged with 
lactate treatment in the present study, some components of mitochondrial biogenesis 
pathway are definitely increased. 25 mM lactate pre-treatment increases expression of 
PGC-1β at both mRNA and protein levels, as well as the mRNA levels of NRF-1 and 
COX1 in SH-SY5Y cells. Indeed, we did not observe a classic pattern of mitochondrial 
biogenesis with lactate treatment, but the increase in the expression of a PGC-1 family 
member other than PGC-1 α still has an important role in improving mitochondrial 
function. Unlike PGC-1α, PGC-1β and PRC are both poorly studied PGC-1 family 
members. PGC-1β is the closest homolog of PGC-1α and it shares extensive sequence 
identity. PRC has more limited homology. (Lin et al., 2005). Both family members 
interact with NRF-1 which regulates TFAM transcriptional activity (Wu et al., 1999; 
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Andersson & Scarpulla, 2001). Despite the functional similarities between the PGC-1α 
and PGC-1β, the latter is a stronger inducer of mitochondrial respiration-relevant gene 
expression and promotes a much higher level of coupled respiration than PGC-1α, which 
may make the fine-tuning of mitochondrial function possible in response to specific 
metabolic needs (Lin et al., 2003; St-Pierre et al., 2003; Lin et al., 2005). In this study, 
PRC mRNA levels were slightly decreased in both 10 mM and 25 mM LAC groups. 
However, due to the lack of antibodies, we were not able to evaluate the expression at 
protein level.  
The underlying mechanisms of lactate treatment inducing PGC-1β expression in 
SH-SY5Y cells may involve the activation of p38 MAPK signaling pathway. MAPKs are 
a family of proteins promoting a phosphorylation signaling cascade, leading to the 
activation of transcription factors (Turjanski et al., 2007). P38 phosphorylates and 
activates PGC-1α (Puigserver et al., 2001), while there is no evidence showing that p38 
MAPK directly activates PGC-1β or PRC. However, activation of p38 MAPK pathway is 
known to stimulate CREB phosphorylation (Xing et al., 1998), and previous studies have 
reported that PGC-1β is a direct transcriptional target of CREB (Ishii et al., 2009; Xia et 
al., 2013).  
A question arises as to whether the increase in mitochondrial respiration is driven 
by lactate serving as a fuel or is a consequence of lactate modifying bioenergetics-related 
signaling pathways. As evidenced by immediate increase of mitochondrial OCR after 
lactate addition to SH-SY5Y cells (Fig. 3A), lactate is likely to enhance mitochondrial 
respiration by feeding into mitochondria as a fuel first, as the regulation of gene 
expression presumably would take a longer period of time. However, lactate-induced 
154 
 
modification of bioenergetic infrastructure appears to have effects on mitochondrial 
respiratory capacity in SH-SY5Y cells. This is supported by the fact that maximal 
respiration is comparable between untreated cells and cells treated with lactate acutely, 
while it is significantly increased in cells pre-treated with lactate for 6 hours. It suggests 
that a longer treatment with lactate possibly increases expression and activities of 
mitochondrial respiration-related proteins by activating bioenergetic signaling pathways, 
and therefore it improves the efficiency and capacity of the ETC. 
VEGF-mediated brain angiogenesis plays a critical role in neurogenesis by 
providing the critical neurovascular niches for neuronal remodeling (Fabel et al., 2003a; 
Latimer et al., 2011), and it has been proposed that lactate may account for exercise-
induced angiogenesis/neurogenesis (E et al., 2013a). In fact, subcutaneous administration 
of lactate promotes VEGF-mediated lung tumor angiogenesis in mice (Sonveaux et al., 
2012), and intraperitoneal lactate injection increases VEGF-A expression in mouse brain 
(E et al., 2013a). In the present study, we confirm that lactate treatment on a human 
neuronal background also significantly induces VEGF-A expression, further supporting 
the view that lactate generated from exercising muscles mediates the exercise-induced 
brain angiogenesis and neurogenesis. 
In endothelial cells, PI3K/Akt signaling pathway activation is involved in lactate-
induced angiogenesis (Ruan & Kazlauskas, 2013). How exogenous lactate alters Akt 
signaling pathway in brain has not been defined yet. Interestingly, we found that Akt 
phosphorylation decreased lactate treatment. Akt signaling pathway regulates the 
activities of two proteins that play key roles in slowing aging and increasing mammalian 
lifespan: mTOR and FOXO1. Lower mTOR expression has been considered to slow the 
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entire aging process in mammals (Wilkinson et al., 2012). I another study, mTOR 
hypomorphic mice with much less mTORC1 and mTORC2 activity than wild-type mice 
exhibited an 20% increase in median survival (Wu et al., 2013). One the other hand, 
increased FOXO1 expression has been consistently linked with longevity, possibly due to 
its important roles in detoxification of ROS and repair of damaged DNA (Daitoku & 
Fukamizu, 2007; Kenyon, 2010). In lactate-treated SH-SY5Y cells, reduced 
phosphorylation of Akt leads to less activation of mTOR but more nuclear translocation 
of FOXO1. These results suggest that lactate increases expression of key factors of 
longevity pathway(s) or at least it provides the possibility of functional preservation of 
brain during aging. Further research is needed to investigate the longevity effects of 
lactate in an aging model system. 
In conclusion, our data demonstrate that lactate treatment shifts bioenergetic 
fluxes towards a more aerobic state, and induces mitochondrial respiration-related gene 
expression in human neuronal cells. These effects are accompanied by activation of 
AMPK, p38 MAPK, and Akt signaling pathways to alter bioenergetic infrastructures to 
induce mitochondrial biogenesis, and also to increase the expression of proteins that may 
be involved in longevity (Fig. 10). Our results suggest that lactate may have potential 
therapeutic implications for neurological disorders with perturbed brain bioenergetic 
metabolism, such as Alzheimer’s and Parkinson’s diseases.  
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Figure 1. Mitochondrial respiratory flux of SH-SY5Y cells pre-treated with lactate 
for 6 hours (mitochondrial stress test).  
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Figure 1. Mitochondrial respiratory flux of SH-SY5Y cells pre-treated with lactate 
for 6 hours (mitochondrial stress test) (continued). 
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Figure 1. Mitochondrial respiratory flux of SH-SY5Y cells pre-treated with lactate 
for 6 hours (mitochondrial stress test) (continued). (For figure legend, see next page). 
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Figure 1. Mitochondrial respiratory flux of SH-SY5Y cells pre-treated with lactate 
for 6 hours (mitochondrial stress test) (continued). (A) Oxygen consumption rates 
(OCR) of SH-SY5Y cells untreated, pre-treated with 10 mM lactate, or 25 mM lactate for 
6 hours were measured using a Seahorse XF24 Extracellular Flux Analyzer. At the times 
indicated, oligomycin (1 µM, final concentration), FCCP (0.3 µM, final concentration) or 
rotenone (1 µM, final concentration) plus antimycin (0.2 µM, final concentration) was 
injected. (B) OCR AUC at baseline was determined from (A). 10 mM LAC and 25 mM 
LAC groups had significantly higher basal OCR AUC than that in CT group, while no 
difference was seen between 10 mM LAC and 25 mM LAC groups. (C) After injecting 
oligomycin to inhibit ATP synthase, AUC of proton leak associated OCR was calculated, 
and it was elevated only in 25 mM LAC group. (D) Percentage of proton leak associated 
OCR in basal respiration OCR was comparable between groups. (E) Percentage of ATP 
production associated OCR in basal respiration OCR was comparable between groups. (F) 
Maximal respiration OCR AUC was determined with FCCP injection, and it was higher 
in both 10 mM LAC and 25 mM LAC groups when each group was compared with CT 
group, but comparable between 10 mM LAC and 25 mM LAC groups. (G) Maximal 
respiratory capacity was calculated by dividing maximal respiratory OCR AUC by basal 
respiration OCR AUC, but no inter-group difference was observed. (H) Spare respiratory 
capacity was calculated by subtracting basal respiration OCR AUC from maximal 
respiration OCR AUC; no significant inter-group difference was observed. ANOVA 
analysis with LSD post-hoc test. *p < 0.05. AUC, area under the curve; CT, control 
group; FCCP, carbonylcyanide p-trifluoromethoxyphenylhydrazone; LAC, lactate; OCR, 
oxygen consumption rate. 
160 
 
 
 
Figure 2. Glycolysis flux of SH-SY5Y cells pre-treated with lactate for 6 hours 
(glycolysis stress test) (continued).  
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Figure 2. Glycolysis flux of SH-SY5Y cells pre-treated with lactate for 6 hours 
(glycolysis stress test) (continued). (For figure legend, see next page). 
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Figure 2. Glycolysis flux of SH-SY5Y cells pre-treated with lactate for 6 hours 
(glycolysis stress test) (continued). (A) ECAR of SH-SY5Y cells, untreated, pre-treated 
with 10 mM lactate, or 25 mM lactate for 6 hours were measured using a Seahorse XF24 
Extracellular Flux Analyzer. At the times indicated, glucose, oligomycin and 2-DG were 
injected at final concentrations of 25 mM, 1 µM and 100 mM, respectively. (B) When 25 
mM glucose was present in the medium, glycolysis ECAR AUC was significantly lower 
in both 10 mM LAC and 25 mM LAC groups than that in CT group. The glycolysis 
ECAR AUC was lower in 25 mM LAC group when compared to 10 mM LAC group. (C) 
Glycolysis capacity was determined with subsequent oligomycin injection, and no inter-
group difference was observed. (D) Glycolysis reserve was calculated by subtracting the 
glycolysis rate from glycolysis capacity. Both 10 mM and 25 mM lactate treatments 
significantly increased glycolysis reserve in SH-SY5Y cells. ANOVA analysis with LSD 
post-hoc test. *p < 0.05; **p < 0.001. 2-DG, 2-deoxyglucose; AUC, area under the curve; 
CT, control group; ECAR, extracellular acidification rate; LAC, lactate. 
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Figure 3. Mitochondrial respiration, glycolysis in SH-SY5Y cells with acute lactate 
treatment.  
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Figure 3. Mitochondrial respiration, glycolysis in SH-SY5Y cells with acute lactate 
treatment (continued). 
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Figure 3. Mitochondrial respiration, glycolysis in SH-SY5Y cells with acute lactate 
treatment (continued). (For figure legend, see next page). 
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Figure 3. Mitochondrial respiration, glycolysis in SH-SY5Y cells with acute lactate 
treatment (continued). (A) OCR of SH-SY5Y cells was measured in a Seahorse 
Analyzer. At the first injection point indicated, assay medium, or lactate at final 
concentrations of 10 mM or 25 mM was injected. Subsequently, final concentrations of 
1 µM oligomycin, 0.3 µM FCCP and 1 µM rotenone plus 0.2 µM antimycin were 
injected automatically. (B) OCR AUC between measuring points 7 and 8 was calculated 
as basal respiration for each group. Basal respiration was trending higher in lactate 
injected groups compared to CT group, but no statistically significant inter-group 
difference was observed. (C) Proton leak associated OCR AUC, and (D) maximal 
respiration OCR AUC were also comparable between groups. (E) ECAR was measured 
simultaneously in this experiment. ECAR decreased immediately after lactate injection in 
10 mM and 25 mM LAC groups, and the effect was more obvious in 25 mM LAC group 
than that in 10 mM LAC group. No ECAR changes were observed in CT group where 
medium was injected. AUC, area under the curve; CT, control group; FCCP, 
carbonylcyanide p-trifluoromethoxyphenylhydrazone; MED, assay medium; LAC, lactate; 
OCR, oxygen consumption rate. 
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Figure 4. Prolonged effects of lactate pre-treatment on mitochondrial respiration 
and glycolysis rate in SH-SY5Y cells.  
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Figure 4. Prolonged effects of lactate pre-treatment on mitochondrial respiration 
and glycolysis rate in SH-SY5Y cells (continued). (For figure legend, see next page). 
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Figure 4. Prolonged effects of lactate pre-treatment on mitochondrial respiration 
and glycolysis rate in SH-SY5Y cells (continued). The cells in group LAC-1 and LAC-
2 were pre-treated with 25 mM lactate for 6 hours. Cells in CT group was untreated. 
Fluxes were measured in a Seahorse Analyzer for ~5.5 hours, and rotenone and 
antimycin were injected at last at final concentrations of 1 µM and 0.2 µM, respectively. 
In LAC-1 group, 25 mM lactate was present in the assay running medium throughout the 
flux assay. In LAC-2 group, at the end of 6-hour pre-treatment, lactate was washed out 
and was absent in the running medium throughout the flux assay. (A) OCR in LAC-1 and 
LAC-2 groups started with higher readings compared to CT group. During the ~5.5-hour 
assay, OCR in LAC-1 group kept increasing, while LAC-2 and CT groups maintained 
their OCR level unchanged throughout the assay. (B) OCR AUC was calculated between 
measuring point 1 and 30 for each group. LAC-1 group had significantly higher OCR 
AUC than those in LAC-1 and CT groups. OCR AUC in LAC-2 group was higher than 
that in CT group but was lower compared to LAC-1 group. (C) ECAR was comparable 
between LAC-2 and CT groups, while LAC-1 group had considerably lower glycolysis 
rate than those in LAC-2 and CT groups. (D) OCR/ECAR ratio was calculated to 
evaluate cellular preference for OXPHOS versus glycolysis. While OCR/ECAR ratios of 
CT and LAC-2 group were maintained around ~3 and ~4.5 pmoles/mpH, respectively, 
OCR/ECAR in LAC-1 group was constantly increasing over the entire course of the 
assay. ANOVA analysis with LSD post-hoc test. *p < 0.05. AUC, area under the curve; 
CT, control group; ECAR, extracellular acidification rate; LAC, lactate; OCR, oxygen 
consumption rate. 
170 
 
 
 
Figure 5. Energy intermediates in lactate pre-treated SH-SY5Y cells. (A) ATP levels 
in all groups were referenced to the mean value of CT group. Relative ATP levels were 
significantly reduced in 2-DG group and LAC + 2-DG group, compared to CT group. No 
difference was observed between CT and LAC groups, as well as between 2-DG and 
LAC + 2-DG groups. (B) ADP/ATP levels were significantly increased in 2-DG group. 
Lactate treatment lowered ADP/ATP levels compared to CT group. ADP/ATP levels in 
LAC + 2-DG group were significantly lower than those in 2-DG group. ADP/ATP levels 
in LAC + 2-DG group were even lower than those in CT group. ANOVA analysis with 
LSD post-hoc test. *p < 0.05; **p < 0.001. 2DG, 2-deoxyglucose; CT, control group; 
LAC, lactate. 
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Figure 6. Redox intermediates of lactate pre-treated SH-SY5Y cells.  
(A) NAD+/NADH ratio was significantly higher in LAC group compared to CT group. (B) 
NADH levels corrected for protein amount were significantly lower in LAC group 
compared to CT group. (C) NADH levels corrected for protein amount were comparable 
between groups. *p < 0.05 compared to CT group. CT, control group; LAC, lactate group. 
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Figure 7. Complex IV and citrate synthase Vmax activities of lactate pre-treated 
SH-SY5Y cells. (A) COX Vmax activities normalized to protein content were 
significantly higher in LAC group compared to CT group. (B) CS Vmax activities 
normalized to protein content were also increased in LAC group compared to CT group. 
(C) After normalization to CS activity, COX Vmax activities in LAC group were still 
significantly higher than those in CT group. *p < 0.05 compared to CT group. COX, 
cytochrome c oxidase; CS, citrate synthase; CT, control group; LAC, lactate group. 
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Figure 8. Effects of lactate treatment on the expression of components involved in 
bioenergetics.  
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
1.6
1.8
2
PGC1A PGC1B PRC NRF1 TFAM COX1 COX4
*
CT         LAC 10mM     LAC 25mM
A
m
R
N
A
 e
xp
re
ss
io
n
(r
e
la
ti
ve
 t
o
 G
A
P
D
H
)
*
*
*
*
*
*
*
174 
 
 
Figure 8. Effects of lactate treatment on the expression of components involved in 
bioenergetics (continued). (For figure legend, see next page). 
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Figure 8. Effects of lactate treatment on the expression of components involved in 
bioenergetics (continued). (A) PGC-1β mRNA levels were significantly increased in 25 
mM LAC group but were comparable between CT and 10 mM LAC groups. PRC mRNA 
levels were decreased in both LAC groups compared to CT group. NRF-1 and COX4 
mRNA levels were both higher in 25 mM LAC group but were comparable between CT 
and 10 mM LAC groups. No inter-group differences were detected in mRNA levels of 
PGC-1α, TFAM, or COX4. ANOVA analysis with LSD post-hoc test. (B) Nuclear PGC-
1β protein levels were significantly higher in LAC group compared to CT group, but 
inter-group differences were not observed in the protein levels of PGC-1α, NRF-1, 
TFAM, COXIV, or CS. (C) VEGF-A mRNA expression was increased with 25 mM 
lactate pre-treatment but was unchanged with 10 mM lactate treatment. ANOVA analysis 
with LSD post-hoc test. *p < 0.05. COX1, cytochrome c oxidase subunit 1; COX4 or 
COX IV, cytochrome c oxidase subunit 4; CS, citrate synthase; CT, control group; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HDAC1, histone deacetylase 1; 
LAC, lactate; NRF1, nuclear respiratory factor 1; PGC-1, peroxisomal proliferator-
activated receptor-gamma co-activator 1; PRC, PGC-1 related co-activator; TFAM, 
mitochondrial transcription factor A; VEGF-A, vascular endothelial growth factor A.  
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Figure 9. Effects of lactate pre-treatment on energy metabolism sensitive proteins in 
SH-SY5Y cells. (For figure legend, see next page). 
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Figure 9. Effects of lactate pre-treatment on energy metabolism sensitive proteins in 
SH-SY5Y cells. 6 hours of 25 mM lactate pre-treatment significantly increased AMPK 
phosphorylation and p38 phosphorylation in cytoplasm. Cytoplasmic Akt 
phosphorylation at Ser 473 and mTOR phosphorylation at Ser 2448 were decreased with 
lactate treatment. LAC group had higher CREB phosphorylation levels in nuclear fraction 
when compared to CT group. Lactate pre-treatment induced a significant translocation of 
FOXO1 protein from cytoplasm to nucleus. *p < 0.05; **p < 0.001. AMPK, AMP-
activated protein kinase; CT, control group; CREB, cAMP-response element binding 
protein; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; FOXO1, forkhead box 
protein O1; HDAC1, histone deacetylase 1; LAC, lactate; mTOR, mammalian target of 
rapamycin.  
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Figure 10. Effects of lactate pre-treatment on pyruvate decarboxylation and 
pyruvate carboxylation. (For figure legend, see next page). 
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Figure 10. Effects of lactate pre-treatment on pyruvate decarboxylation and 
pyruvate carboxylation. (A) PDHA1 mRNA levels were lower in both 10 mM and 25 
mM LAC groups compared to CT group. PDK4 mRNA levels were increased in 25 mM 
LAC group but were comparable between CT and 10 mM LAC groups. (B) 
Phosphorylation of PDHA1 at Ser 293 was significantly decreased with 25 mM lactate 
pre-treatment. (C) No inter-group differences were observed in mRNA expression of PC, 
ME1 and ME2. *p < 0.05. CT, control group; GAPDH, glyceraldehyde-3-phosphate 
dehydrogenase; LAC, lactate; ME, malic enzyme; PC, pyruvate carboxylase; PDHA1, 
pyruvate dehydrogenase alpha 1; PDK4, pyruvate dehydrogenase kinase 4. 
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Figure 11. Illustration summarizing lactate-induced activation of bioenergetics-
related signaling pathways. AMPK, AMP-activated protein kinase; CREB, cAMP-
response element binding protein; FOXO1, forkhead box protein O1; mTOR, mammalian 
target of rapamycin; p38 MAPK, p38 mitogen-activated protein kinase; PGC-1; 
peroxisomal proliferator-activated receptor-gamma co-activator 1. 
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Summary of Findings 
Summary of Chapter II. Effect of Exercise on Mouse Liver and Brain Bioenergetic 
Infrastructures 
 To assess the effects of exercise on liver and brain bioenergetic infrastructures, 
young, 4-month old C57BL/6 mice were subjected to 6 weeks of treadmill exercise below 
the lactate threshold. We analyzed pathways and proteins that sense cell energy and redox 
states. Here, we especially considered the potential role that muscle-generated lactate 
might play in liver and brain bioenergetics.  
 Metabolically, we found that body weights were maintained over the 6 weeks in 
exercised mice, and fasting blood glucose level was lowered by exercise training. At 
week 6, the decrease of post-running plasma lactate levels, compared to the resting levels 
in untrained mice, indicated that exercise intensity was below the lactate threshold.  
This plasma lactate level decrease was accompanied by a significant increase in 
the protein level of liver MCT2 that is responsible for liver lactate uptake. Exercise 
increased liver PGC-1 expression, likely mediated by the increase in SIRT1 and p38 
protein levels, and AMPK phosphorylation. Despite this, liver mtDNA copy number, 
TFAM and COX2 expression, and CREB phosphorylation, were all reduced. Our results 
suggest that 6-week treadmill exercise training below the lactate threshold strategically 
shifts the liver’s bioenergetic profile in ways that should promote gluconeogenesis, as 
well as some aspects of mitochondrial biogenesis, but not oxidative phosphorylation. 
These effects are possibly lactate-mediated. Although our moderate-intensity exercise 
training protocol decreased brain TNF- expression which was the only altered brain 
parameter in the study, the training below the lactate threshold seemed unable to modify 
brain bioenergetic infrastructures.  
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 Liver lactate import appears to be favored over brain lactate import, possibly 
limiting the ability of exercise-generated lactate to modify brain bioenergetics. Therefore, 
exercise-mediated brain effects may be robust only when lactate production exceeds the 
lactate threshold.  
 
Summary of Chapter III. Lactate Administration Reproduces Specific Brain and Liver 
Exercise-related Changes 
 To better understand how exercise impacts non-muscle tissues, we considered and 
focused on lactate’s ability to mediate exercise-induced changes in liver and brain 
bioenergetics.  
 In one set of experiments, young, 4-month old C57BL/6 mice underwent 7 weeks 
of treadmill exercise sessions at intensities intended to exceed the lactate threshold. Over 
the course of the study, the mice dramatically increased their lactate threshold, and to 
ensure plasma lactate accumulated, during the final week the mice were run to exhaustion. 
In liver, expression of gluconeogenesis-promoting genes and PGC-1α increased. PGC-1β 
and NRF-1 expression decreased. The expression levels of other respiration-related genes 
were also down-regulated. In brain, PGC-1α and PGC-1β were unchanged while PRC 
expression and mtDNA copy number increased, indicating mitochondrial biogenesis was 
induced. These changes were accompanied by a decrease of TNF-α expression, and an 
increase in expression of VEGF-A, an angiogenic/neurogenic factor.  
 In another set of experiments, exogenous lactate administration, over 14 days 
consecutively, was found to reproduce some but not all of above-mentioned liver and 
brain changes induced by intensive exercise training. Specifically, similar to what we 
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observed in exercise trained mice, exogenous lactate administration enhanced hepatic 
gluconeogenesis while probably limiting hepatocyte respiration, shown by an increase in 
expression of gluconeogenic genes and PGC-1α but a decrease in PGC-1β and NRF-1 
levels. In brain, mtDNA copy number was not altered. However, the exercise-induced 
increases in brain PRC and VEGF-A expression were reproduced by lactate 
administration, which implies that exercise-induced brain angiogenesis and neurogenesis 
may be driven by lactate released from contracting muscles. 
 In conclusion, our data suggest that lactate, a muscle-generated exercise 
byproduct, may account for at least some exercise-associated brain and liver bioenergetic 
infrastructure changes and bioenergetic-associated adaptations. For this reason, we 
consider that lactate may be a partial exercise mimetic, and it is worth testing in 
conditions with perturbed brain bioenergetics, such as Alzheimer’s and Parkinson’s 
diseases. 
 
Summary of Chapter IV. Supra-lactate Threshold Exercise Training Induces Brain 
Mitochondrial Biogenesis in Aged Mice: Is There a Connection Between Brain 
Mitochondrial Bioenergetics, Inflammation, and Neurogenesis? 
 Intensive exercise training has been shown to improve brain mitochondrial 
bioenergetics in young, 4-month old mice, while few studies have focused on aging 
model. In this study, we investigated the effects of supra-lactate threshold intensive 
exercise training on brain mitochondrial biogenesis in 19-month old C57BL/6 mice. We 
also assessed the expression of neurogenesis-related factors, and central/systemic levels 
of inflammatory cytokines/chemokines, to test the relations between mitochondrial 
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function, inflammation, and neurogenesis, for a better understanding of the connections 
between different exercise-induced benefits on brain. 
 8-week supra-lactate threshold exercise did not alter metabolic parameters 
including blood glucose level, plasma insulin level, and HOMA-IR, while the body 
weights were lowered in the exercised mice. Our training protocol significantly increased 
brain expression of PGC-1α and CS. In addition, brain mtDNA content assessed by ND1, 
COX2, and ATP6 copy number was also increased in exercise group, suggesting 
mitochondrial biogenesis was induced. 
 Brain mitochondrial biogenesis was accompanied by a slight increase in brain 
VEGF-A expression in exercised mice, possibly mediated by excess lactate in the blood, 
but our training protocol was not able to alter the brain expression of DCX, and BDNF. A 
strong positive correlated between brain PRC expression and VEGF-A expression was 
observed. This result is in agreement with what we reported in Chapter III. While 
mitochondrial biogenesis seemed not clearly associated with neurogenesis in exercise 
trained aged mice, a transcription factor and a coactivator (FOXO3a and PRC) that play 
important roles in regulating bioenergetic network were likely influencing a 
neurogenesis-related factor (VEGF-A). 
 Central and systemic inflammatory factors were not altered by intensive exercise 
training, no significant associations between brain mtDNA content and these 
inflammatory factors were observed. However, plasma CCL11 was negatively correlated 
with hippocampal DCX expression, supporting the view that systemic inflammation may 
have a suppressive effect on neurogenesis, while our exercise protocol did not affect the 
aging-associated increase of plasma CCL11 levels in these aged mice. 
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 Together with the results from Chapter III, we conclude that supra-lactate 
threshold exercise training induces brain mitochondrial biogenesis in both young and 
aged mice. It certainly has therapeutic implications for neurological disorders with 
perturbed brain bioenergetics. Yet mechanistic study is needed to identify the causal 
relationships between mitochondrial biogenesis, neurogenesis, and inflammation under 
the condition of exercise training. 
 
Summary of Chapter V. Lactate Treatment Modifies Bioenergetic Fluxes and 
Infrastructures in Cultured Human Neuronal Cells   
 In this study, we investigated the possibility of lactate treatment as a strategy for 
bioenergetic flux manipulation using SH-SY5Y human neuronal cells. The underlying 
mechanisms were also discussed.  
 Our results showed that, in SH-SY5Y cells, treatment with lactate for 6 hours 
significantly decreased glycolysis flux and had a prolonged enhancement of 
mitochondrial respiration. Similar effects were also induced with acute lactate treatment. 
Interestingly, over time exogenous lactate gradually shifted the bioenergetic metabolism 
towards a more aerobic state in SH-SY5Y cells. An increase of NAD+/NADH ratio was 
observed with lactate treatment, likely induced by a decrease in NADH levels. The 
changes in these fluxes were not accompanied by alteration of mitochondrial coupling 
efficiency or overall ATP production, while lactate treatment seemed to improve electron 
transfer via the mitochondrial ETC.    
 Although we did not observe changes in mtDNA copy number with lactate 
treatment, some components of mitochondrial biogenesis were up-regulated. Specifically, 
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expression of PGC-1β, NRF-1, and COX1 was significantly increased in lactate-treated 
cells. Vmax activities of COX and CS were also increased. These lactate-induced effects 
were likely mediated by activation of AMPK, p38 MAPK, and Akt signaling pathways to 
modify cellular bioenergetic infrastructure. Similar to what we found in Chapter III and 
IV, lactate treatment also increased VEGF-A expression in human neuronal cells, further 
supporting the view that lactate may account for exercise-induced brain 
angiogenesis/neurogenesis. Additionally, our results suggest a potential role for lactate in 
longevity, as lactate treatment decreased the activity of mTOR but induced nuclear 
translocation of FOXO1. 
 This study demonstrates that lactate can shift energy metabolism of SH-SY5Y 
human neuronal cells towards mitochondrial respiration resulting in a more aerobic state, 
and can activate several signaling pathways to modify bioenergetic infrastructures. Our 
data provide novel insights into bioenergetics-based pharmacological therapies for 
neurodegenerative diseases with perturbed brain bioenergetic fluxes. 
 
Limitations and Future Directions 
Chapter II, III, IV 
 For Chapter II-IV, our work may lack a strict comparison, between moderate-
intensity training and supra-lactate threshold training, as well as between young adult 
mice and aged mice. We did not include two different exercise intensities, or both young 
and aged mice in the same study. Similarly, in Chapter III, exercise group was subjected 
to excise training for 7 weeks, while lactate group and PBS vehicle group received 
injections for only 14 days. One may argue that these two interventions should not be 
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compared. As a matter of fact, we did not perform statistical analyses for above 
mentioned comparisons. Our primary intent was not to compare the intensities, mice of 
different ages, or exercise versus lactate injection, but rather to provide insights into the 
potential of exercise or lactate mediated changes of brain bioenergetics. 
 In Chapter III, although we observed that lactate administration reproduced some 
supra-lactate threshold exercise-induced changes in liver and brain bioenergetic 
infrastructures, we could not ensure lactate in the blood was able to reach the brain, or 
remain enriched in the brain for a period of time. Liver gluconeogenesis was enhanced 
with lactate administration, suggesting considerable amount of blood lactate probably 
was cleared by liver. This could be the same case for mice subjected to supra-lactate 
threshold exercise. As a future direction, one may use magnetic resonance spectroscopy 
techniques to assess the brain lactate levels in vivo, after lactate injection of supra-lactate 
threshold exercise. Administrating specific inhibitors targeting liver MCTs along with 
lactate treatment, or exercise training may also to some extent reduce this limitation. 
More specifically, mechanistic studies can be conducted by giving lactate injection and 
exercise training to mice of neuron-specific conditional knockout of MCTs, to see 
whether or not supra-lactate threshold exercise-induced benefits on brain would be 
observed.  
 In Chapter IV, our results and interpretation regarding the relations between brain 
mitochondrial biogenesis, neurogenesis and inflammatory factors were limited by a 
technical issue. Neurogenesis is often evaluated by BrdU or DCX staining with 
quantitative fluorescence microscopy (Wojtowicz & Kee, 2006). We alternatively 
measured DCX mRNA levels in hippocampus, while currently we do not know to what 
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extent hippocampal DCX mRNA expression is suggestive of ongoing neurogenesis in the 
area. We will continue to attempt immunofluorescent estimation of DCX positive 
neurons in the dentate gyrus of these aged mice.  
 
Chapter V 
 One limitation in Chapter V is that SH-SY5Y cells are neuroblastoma cells. 
Although undifferentiated SH-SY5Y cells possess some neuronal characteristics, their 
innate tumor-like features, such as Warburg effect, may confound our study results. Thus, 
the interpretation of experimental results in this chapter needs to take these factors into 
account. As a future direction, differentiated SH-SY5Y cells with more mature neuronal 
characteristics may be used to further explore the effect of lactate from the perspective of 
bioenergetics. Also, primary mouse neurons may ensure a more appropriate neuronal 
background to study this topic. Future experiments to apply lactate treatment in 
cytoplasmic hybrids (cybrids) harboring mtDNA from AD patients may further provide 
evidence for lactate’s therapeutic potentials. 
 
Clinical Implications 
 The results from this work may provide guidance for clinicians to prescribe 
customized exercise programs, or provide scientific evidence for designing clinical trials 
intended to evaluate effects of exercise training in persons with perturbed brain energy 
metabolism or on preventing these conditions.  
 The type, duration, frequency and intensity have always been a question when it 
comes to prescribing or recommending exercise to different populations. In fact, for 
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different purposes, and different target organs, these parameters may need adjustment. In 
this study, we have demonstrated that moderate-intensity exercise is sufficient for 
improving mouse liver gluconeogenesis. However, beneficial effects for brain, in terms 
of improved mitochondrial bioenergetics, are only robust when exercise intensity is 
above the lactate threshold. Although verification of these findings is definitely needed in 
human subject studies, given that altered brain bioenergetics have shown and may play a 
pathogenic role in many neurodegenerative disorders, our results suggest that regular 
supra-lactate threshold exercise may be beneficial for healthy population to prevent or 
delay the onset of neurodegeneration. For persons with neurodegenerative diseases or 
other neurological disorders with perturbed brain bioenergetics, we hope that this 
exercise strategy will have therapeutic effects or a potential to delay the disease 
progression. 
 However, altered brain energy metabolism, either physiologically or 
pathologically, are often associated with aging. These populations are not very likely able 
to tolerate or comply with high-intensity regular exercise training. For this reason and 
others, exercise mimetics are needed. From this point of view, this body of work provides 
the mechanistic groundwork for proposing lactate as a partial exercise mimetic or 
bioenergetic medicine intervention, by virtue of its ability to modify neuronal 
bioenergetics towards a healthier state. Future studies are also expected to explore 
lactate’s potential for lifespan extension. Meantime, attempts should be undertaken for 
discovering and developing other pharmacological candidates intended to improve brain 
bioenergetic balance.  
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Conclusion 
 This dissertation work aimed to investigate whether and how, from the 
perspective of bioenergetics, exercise training influences non-muscle tissues, particularly 
brain. We have demonstrated that intensive, supra-lactate threshold exercise training 
robustly induces mitochondrial biogenesis and increases expression of 
angiogenic/neurogenic factors in the brains of both young and aged mice. Moreover, we 
have identified a role for lactate in mediating some of the exercise-induced benefits for 
brain, implying the possibility of lactate serving as a partial exercise mimetic. These 
results could provide guidance for designing clinical studies intended to investigate the 
roles of exercise in prevention and treatment of various diseases. At the same time, the 
benefits of lactate treatment may be further explored not only as a potential exercise 
mimetic, but also as a therapeutic candidate to modify brain bioenergetic infrastructures 
towards a healthy, balanced state, especially for persons with perturbed brain energy 
metabolism, such as neurodegenerative diseases. We believe that this dissertation work 
will open an insight and avenue for searching and chemically developing more 
bioenergetics-based therapies for brain health. 
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